BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 018991
(348 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 177 bits (448), Expect = 1e-44, Method: Compositional matrix adjust.
Identities = 91/193 (47%), Positives = 127/193 (65%), Gaps = 2/193 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEV HLG + ++LREL+ A+ +N++G GG+G VY+G L+DGT VAVK L R Q
Sbjct: 18 PEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQ 76
Query: 190 A-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
E +F+ EVE+I H+NL+RL G+C+ R+LVY Y+ NG++ L PL
Sbjct: 77 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 136
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
W R I LG+A+GLAYLH+ +PK++HRDVK++NILLD ++ A V DFGLAKL+ +
Sbjct: 137 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 196
Query: 309 SYVTTRVMGTFGY 321
+V V GT G+
Sbjct: 197 XHVXXAVRGTIGH 209
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 171 bits (434), Expect = 4e-43, Method: Compositional matrix adjust.
Identities = 89/193 (46%), Positives = 125/193 (64%), Gaps = 2/193 (1%)
Query: 130 PEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
PEV HLG + ++LREL+ A+ +N++G GG+G VY+G L+DG VAVK L R Q
Sbjct: 10 PEV-HLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQ 68
Query: 190 A-EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
E +F+ EVE+I H+NL+RL G+C+ R+LVY Y+ NG++ L PL
Sbjct: 69 GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
W R I LG+A+GLAYLH+ +PK++HRDVK++NILLD ++ A V DFGLAKL+ +
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD 188
Query: 309 SYVTTRVMGTFGY 321
+V V G G+
Sbjct: 189 XHVXXAVRGXIGH 201
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 124 bits (312), Expect = 6e-29, Method: Compositional matrix adjust.
Identities = 71/180 (39%), Positives = 112/180 (62%), Gaps = 4/180 (2%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIG 202
L +LE AT+ + +IG G +G VY+G+L DG KVA+K Q +EF+ E+E +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 203 RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
RH +LV L+G+C E +L+Y+Y++NGNL + L+G ++W+ R+ I +G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGY 321
GL YLH ++HRDVKS NILLD + +++DFG++K +++++ V GT GY
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGY 207
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 122 bits (307), Expect = 2e-28, Method: Compositional matrix adjust.
Identities = 71/180 (39%), Positives = 111/180 (61%), Gaps = 4/180 (2%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIG 202
L +LE AT+ + +IG G +G VY+G+L DG KVA+K Q +EF+ E+E +
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 203 RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
RH +LV L+G+C E +L+Y+Y++NGNL + L+G ++W+ R+ I +G A+
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSYVTTRVMGTFGY 321
GL YLH ++HRDVKS NILLD + +++DFG++K ++++ V GT GY
Sbjct: 151 GLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGY 207
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 120 bits (302), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 73/194 (37%), Positives = 115/194 (59%), Gaps = 20/194 (10%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N +GEGG+G+VY+G +++ T VAVK L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSW 132
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
+R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 187
Query: 309 -SYVTTRVMGTFGY 321
+ + +R++GT Y
Sbjct: 188 QTVMXSRIVGTTAY 201
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 120 bits (300), Expect = 2e-27, Method: Compositional matrix adjust.
Identities = 73/194 (37%), Positives = 114/194 (58%), Gaps = 20/194 (10%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N +GEGG+G+VY+G +++ T VAVK L +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL+W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSW 132
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
+R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 187
Query: 309 -SYVTTRVMGTFGY 321
+ + R++GT Y
Sbjct: 188 QTVMXXRIVGTTAY 201
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 119 bits (297), Expect = 3e-27, Method: Compositional matrix adjust.
Identities = 73/194 (37%), Positives = 113/194 (58%), Gaps = 20/194 (10%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N +GEGG+G+VY+G +++ T VAVK L +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V+ + +H+NLV LLG+ +G LVY Y+ NG+L L G PL+W
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG-TPPLSW 126
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
+R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 181
Query: 309 -SYVTTRVMGTFGY 321
+ R++GT Y
Sbjct: 182 QXVMXXRIVGTTAY 195
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 115 bits (288), Expect = 4e-26, Method: Compositional matrix adjust.
Identities = 73/194 (37%), Positives = 109/194 (56%), Gaps = 20/194 (10%)
Query: 141 YTLRELEAATSGLCEE------NVIGEGGYGIVYRGILSDGTKVAVKNLLN----NRGQA 190
++ EL+ T+ E N GEGG+G+VY+G +++ T VAVK L +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
+++F E++V + +H+NLV LLG+ +G LVY Y NG+L L G PL+W
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDG-TPPLSW 123
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER-- 308
R I G A G+ +LHE +HRD+KS+NILLD + A++SDFGLA+ SE+
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR--ASEKFA 178
Query: 309 -SYVTTRVMGTFGY 321
+R++GT Y
Sbjct: 179 QXVXXSRIVGTTAY 192
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 94.4 bits (233), Expect = 8e-20, Method: Compositional matrix adjust.
Identities = 59/158 (37%), Positives = 90/158 (56%), Gaps = 8/158 (5%)
Query: 154 CEENV---IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK--EFKVEVEVIGRVRHKN 208
C+ N+ IG G +G V+R G+ VAVK L+ AE+ EF EV ++ R+RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V +G + +V EY+ G+L + LH G L R+++ AKG+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
P +VHRD+KS N+L+D+++ +V DFGL++L S
Sbjct: 155 -NRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 92.8 bits (229), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 58/158 (36%), Positives = 90/158 (56%), Gaps = 8/158 (5%)
Query: 154 CEENV---IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK--EFKVEVEVIGRVRHKN 208
C+ N+ IG G +G V+R G+ VAVK L+ AE+ EF EV ++ R+RH N
Sbjct: 37 CDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+V +G + +V EY+ G+L + LH G L R+++ AKG+ YLH
Sbjct: 96 IVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS-GAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
P +VHR++KS N+L+D+++ +V DFGL++L S
Sbjct: 155 -NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 83.6 bits (205), Expect = 1e-16, Method: Compositional matrix adjust.
Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEA---SVIHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
D+ + N L+ +VSDFG+ + + ++ +T
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/177 (35%), Positives = 96/177 (54%), Gaps = 18/177 (10%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGIL--SDGTK---VAVKNLLNNRGQAEKE---FKVEV 198
E S + + VIG G +G VY+G+L S G K VA+K L G EK+ F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M++ EY++NG LD++L G+ S L + ++
Sbjct: 98 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVTT 313
G A G+ YL VHRD+ + NIL++ +VSDFGL+++L E +Y T+
Sbjct: 155 GIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
D+ + N L+ +VSDFG+ + + ++ +T
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 162
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 53/160 (33%), Positives = 95/160 (59%), Gaps = 19/160 (11%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVKNLL--NNRGQAE-----KEFKVEVEVIGRVRHK 207
E IG+GG+G+V++G ++ D + VA+K+L+ ++ G+ E +EF+ EV ++ + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+L G + RM V E+V G+L H + P+ W +++ ++L A G+ Y+
Sbjct: 84 NIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 268 HEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAK 302
+ P +VHRD++S NI L + A+V+DFGL++
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ 177
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 83.6 bits (205), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 125
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
D+ + N L+ +VSDFG+ + + ++ +T
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 83.2 bits (204), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 49/155 (31%), Positives = 85/155 (54%), Gaps = 7/155 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 130
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
D+ + N L+ +VSDFG+ + + ++ +T
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 82.8 bits (203), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E +F E EV+ ++ H LV+L G C+E
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLE 93
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV+E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 94 QAPICLVFEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
D+ + N L+ +VSDFG+ + + ++ +T
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 182
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 94/160 (58%), Gaps = 19/160 (11%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVKNLL--NNRGQAE-----KEFKVEVEVIGRVRHK 207
E IG+GG+G+V++G ++ D + VA+K+L+ ++ G+ E +EF+ EV ++ + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+L G + RM V E+V G+L H + P+ W +++ ++L A G+ Y+
Sbjct: 84 NIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 268 HEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAK 302
+ P +VHRD++S NI L + A+V+DF L++
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ 177
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 81.3 bits (199), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 94/160 (58%), Gaps = 19/160 (11%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVKNLL--NNRGQAE-----KEFKVEVEVIGRVRHK 207
E IG+GG+G+V++G ++ D + VA+K+L+ ++ G+ E +EF+ EV ++ + H
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
N+V+L G + RM V E+V G+L H + P+ W +++ ++L A G+ Y+
Sbjct: 84 NIVKLYG-LMHNPPRM-VMEFVPCGDL---YHRLLDKAHPIKWSVKLRLMLDIALGIEYM 138
Query: 268 HEGLEPKVVHRDVKSSNILL-----DRQWNARVSDFGLAK 302
+ P +VHRD++S NI L + A+V+DFG ++
Sbjct: 139 -QNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ 177
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 81.3 bits (199), Expect = 9e-16, Method: Compositional matrix adjust.
Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 7/155 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G+V+ G + KVA+K + +E++F E EV+ ++ H LV+L G C+E
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
A LV E++++G L +L G + T + + L +G+AYL E V+HR
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAET---LLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
D+ + N L+ +VSDFG+ + + ++ +T
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 79.7 bits (195), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 57/185 (30%), Positives = 96/185 (51%), Gaps = 16/185 (8%)
Query: 137 WGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK 192
WG +E++ + + E VIG G +G V RG L K VA+K L + ++
Sbjct: 2 WGSMEFAKEIDVSYVKI--EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR 59
Query: 193 -EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
EF E ++G+ H N++RL G M++ E+++NG LD +L + G + +
Sbjct: 60 REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL- 118
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---CSER 308
+ ++ G A G+ YL E VHRD+ + NIL++ +VSDFGL++ L S+
Sbjct: 119 --VGMLRGIASGMRYLAEM---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP 173
Query: 309 SYVTT 313
+Y ++
Sbjct: 174 TYTSS 178
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 78.6 bits (192), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 52/154 (33%), Positives = 82/154 (53%), Gaps = 11/154 (7%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E VIG G +G V RG L K VA+K L + ++ EF E ++G+ H N++
Sbjct: 21 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
RL G M++ E+++NG LD +L + G + + + ++ G A G+ YL E
Sbjct: 81 RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQL---VGMLRGIASGMRYLAEM 137
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
VHRD+ + NIL++ +VSDFGL++ L
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFL 168
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 78.2 bits (191), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 60/183 (32%), Positives = 96/183 (52%), Gaps = 16/183 (8%)
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEK- 192
GR +T RE+EA S + E +IG G G V G L VA+K L + ++
Sbjct: 39 GRSFT-REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI 252
+F E ++G+ H N++RL G G M+V EY++NG+LD +L G + +
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-- 153
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSY 310
+ ++ G G+ YL + VHRD+ + N+L+D +VSDFGL+++L + +Y
Sbjct: 154 -VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 311 VTT 313
TT
Sbjct: 210 TTT 212
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 77.4 bits (189), Expect = 1e-14, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 94/185 (50%), Gaps = 14/185 (7%)
Query: 138 GRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEK- 192
GR +T RE+EA S + E +IG G G V G L VA+K L + ++
Sbjct: 39 GRSFT-REIEA--SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRR 95
Query: 193 EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDI 252
+F E ++G+ H N++RL G G M+V EY++NG+LD +L G + +
Sbjct: 96 DFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQL-- 153
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312
+ ++ G G+ YL + VHRD+ + N+L+D +VSDFGL+++L +
Sbjct: 154 -VGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 313 TRVMG 317
T G
Sbjct: 210 TTTGG 214
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 77.0 bits (188), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 59/195 (30%), Positives = 98/195 (50%), Gaps = 23/195 (11%)
Query: 146 LEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVI 201
LE + L E +IG GG+G VYR G +VAVK ++ Q + + E ++
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 202 GRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTA 261
++H N++ L G C++ LV E+ G L++ L G + P DI +N + A
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPP---DILVNWAVQIA 115
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWN--------ARVSDFGLAKLLCSERSYVTT 313
+G+ YLH+ ++HRD+KSSNIL+ ++ +++DFGLA+ + TT
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTT 170
Query: 314 RVMGTFGYAHFIVQV 328
++ YA +V
Sbjct: 171 KMSAAGAYAWMAPEV 185
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 76.6 bits (187), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 53/157 (33%), Positives = 89/157 (56%), Gaps = 19/157 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+GI + +G VA+K L G +A EF E ++ + H +LV
Sbjct: 44 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + LV + + +G L +++H ++G L W +++ AKG+ YL
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 156
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
E ++VHRD+ + N+L+ + +++DFGLA+LL
Sbjct: 157 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 190
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 75.9 bits (185), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 53/157 (33%), Positives = 89/157 (56%), Gaps = 19/157 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+GI + +G VA+K L G +A EF E ++ + H +LV
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + LV + + +G L +++H ++G L W +++ AKG+ YL
Sbjct: 81 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
E ++VHRD+ + N+L+ + +++DFGLA+LL
Sbjct: 134 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 167
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 74.7 bits (182), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGLA++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTT 207
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 74.3 bits (181), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 83/167 (49%), Gaps = 18/167 (10%)
Query: 159 IGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F E E++ ++H+++V+
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---------SPLTWDIRMNIILGTAKG 263
G CVEG ++V+EY+ +G+L+++L D + LT ++I A G
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
+ YL VHRD+ + N L+ ++ DFG+++ + S Y
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 74.3 bits (181), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 50/162 (30%), Positives = 86/162 (53%), Gaps = 11/162 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E VIG G +G V G L K VA+K L + + ++ +F E ++G+ H N++
Sbjct: 38 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L G + M++ E+++NG+LD +L + G + + + ++ G A G+ YL +
Sbjct: 98 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLADM 154
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312
VHRD+ + NIL++ +VSDFGL++ L + S T
Sbjct: 155 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 73.9 bits (180), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 21/172 (12%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G GG VY L++ T KVA+K + + + K F+ EV ++ H+N+V
Sbjct: 19 LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++ E LV EY++ L +++ HG PL+ D +N G+ + H+
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHG------PLSVDTAINFTNQILDGIKHAHD 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++VHRD+K NIL+D ++ DFG+AK L T V+GT Y
Sbjct: 130 M---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 73.6 bits (179), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 56/176 (31%), Positives = 94/176 (53%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+E+EA S + E VIG G +G V G L K VA+K L + + ++F E
Sbjct: 17 KEIEA--SCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++ L G + M+V EY++NG+LD +L + G + + + ++
Sbjct: 75 SIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL---VGMLR 131
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G + G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 132 GISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 184
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 28 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 85
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 86 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 142
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 143 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 195
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 93/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 38 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 95
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 96 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 152
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 153 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 205
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 51/166 (30%), Positives = 89/166 (53%), Gaps = 13/166 (7%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 11 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQ---LVGMLR 125
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L
Sbjct: 126 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 168
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 73.2 bits (178), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 56/179 (31%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A+ + E VIG G +G V G L K VA+K L + + ++F E
Sbjct: 38 KELDASCIKI--ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEA 95
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N+V L G G M+V E+++NG LD +L G + + + ++
Sbjct: 96 SIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL---VGMLR 152
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG 317
G A G+ YL + VHRD+ + NIL++ +VSDFGL++++ + V T G
Sbjct: 153 GIAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGG 208
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 136 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 184
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 185 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 242 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 298
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
VHRD++++NIL+ +V+DFGLA+L+
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLI 330
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/176 (30%), Positives = 92/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V EY++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL ++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTT 207
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 136 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 184
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 185 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 242 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 298
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
VHRD++++NIL+ +V+DFGLA+L+
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLI 330
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 72.8 bits (177), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 56 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 114
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 115 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 170
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 171 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 208
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 94 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 150 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 187
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 55 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 113
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 114 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 169
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 170 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 207
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 90
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 91 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 146
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 72.4 bits (176), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 29 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 87
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 88 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 143
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 144 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 181
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 189
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 189
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 95 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 150
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 151 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 188
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E V+G G +G+V + VA+K + + K F VE+ + RV H N+V+L G
Sbjct: 14 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR---MNIILGTAKGLAYLHEGLE 272
C+ LV EY + G+L LHG PL + M+ L ++G+AYLH ++
Sbjct: 71 CLNPV--CLVMEYAEGGSLYNVLHG----AEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQ 123
Query: 273 PK-VVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTT 313
PK ++HRD+K N+LL ++ DFG A C ++++T
Sbjct: 124 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTN 163
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 81/146 (55%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY++ G+L +L G+ G L + M+ + A G+AY+ VHR
Sbjct: 82 EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHR 135
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI 161
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 219 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 267
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 268 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 324
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 325 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 381
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
VHRD++++NIL+ +V+DFGLA+L+
Sbjct: 382 M---NYVHRDLRAANILVGENLVCKVADFGLARLI 413
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 72.4 bits (176), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 54/161 (33%), Positives = 90/161 (55%), Gaps = 16/161 (9%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 92
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 93 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
K VHRD+ + N +LD ++ +V+DFGLA+ + + Y
Sbjct: 149 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 186
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 81/146 (55%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY++ G+L +L G+ G L + M+ + A G+AY+ VHR
Sbjct: 82 EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQI--ASGMAYVERM---NYVHR 135
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLI 161
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 72.0 bits (175), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 54/163 (33%), Positives = 85/163 (52%), Gaps = 18/163 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
E V+G G +G+V + VA+K + + K F VE+ + RV H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR---MNIILGTAKGLAYLHEGLE 272
C+ LV EY + G+L LHG PL + M+ L ++G+AYLH ++
Sbjct: 70 CLNPV--CLVMEYAEGGSLYNVLHG----AEPLPYYTAAHAMSWCLQCSQGVAYLH-SMQ 122
Query: 273 PK-VVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSYVTT 313
PK ++HRD+K N+LL ++ DFG A C ++++T
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTN 162
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 136 RTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSK-------PQTQGLAKDAWEIPRE---- 184
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 185 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKL 241
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G+ G L + M + A G+AY+
Sbjct: 242 VQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVER 298
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
VHRD++++NIL+ +V+DFGLA+L+
Sbjct: 299 M---NYVHRDLRAANILVGENLVCKVADFGLARLI 330
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 72.0 bits (175), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 53/153 (34%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 36 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 94
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ YL
Sbjct: 95 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKYLAS 150
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 151 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR 180
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 71.6 bits (174), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 55/176 (31%), Positives = 93/176 (52%), Gaps = 21/176 (11%)
Query: 159 IGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ +L + K VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG-------DVS--PLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG DV+ PL + + A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY-VTTRVM 316
G+ YL GL VHRD+ + N L+ + ++ DFG+++ + S Y V R M
Sbjct: 169 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 221
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 71.6 bits (174), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G+ G L + M + A G+AY+ VHR
Sbjct: 75 EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLI 154
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 74 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 127
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI 153
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 20/169 (11%)
Query: 159 IGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ +L + K VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG-------DVS--PLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG DV+ PL + + A
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
G+ YL GL VHRD+ + N L+ + ++ DFG+++ + S Y
Sbjct: 146 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 191
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 76 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 129
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI 155
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 71.2 bits (173), Expect = 7e-13, Method: Compositional matrix adjust.
Identities = 52/169 (30%), Positives = 90/169 (53%), Gaps = 20/169 (11%)
Query: 159 IGEGGYGIVY----RGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ +L + K VAVK L A ++F+ E E++ ++H+++VR
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVG-------DVS--PLTWDIRMNIILGTA 261
G C EG ++V+EY+ +G+L+++L HG DV+ PL + + A
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
G+ YL GL VHRD+ + N L+ + ++ DFG+++ + S Y
Sbjct: 140 AGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 185
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G+ G L + M + A G+AY+ VHR
Sbjct: 78 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 131
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLI 157
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 71.2 bits (173), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 71.2 bits (173), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 70.9 bits (172), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 92/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V E ++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 154
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 155 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFLAS 210
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR 240
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 90 QVDIGKIEHRVVFSDRASSGESRGTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAA 149
+ ++ V + + + G + C T+ P+ L W RE
Sbjct: 137 RTQFSSLQQLVAYYSKHADGLCHRLTNVCPTSK-------PQTQGLAKDAWEIPRE---- 185
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
L E +G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ L
Sbjct: 186 --SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKL 242
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V+L E +V EY+ G+L +L G++G L + M + A G+AY+
Sbjct: 243 VQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVER 299
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
VHRD++++NIL+ +V+DFGL +L+
Sbjct: 300 M---NYVHRDLRAANILVGENLVCKVADFGLGRLI 331
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 70.9 bits (172), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 49/162 (30%), Positives = 85/162 (52%), Gaps = 11/162 (6%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLV 210
E VIG G +G V G L K VA+K L + + ++ +F E ++G+ H N++
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L G + M++ E+++NG+LD +L + G + + + ++ G A G+ YL +
Sbjct: 72 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQL---VGMLRGIAAGMKYLADM 128
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVT 312
VHR + + NIL++ +VSDFGL++ L + S T
Sbjct: 129 ---NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 167
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 75 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ + +++DFGLA+L+
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLI 154
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/179 (29%), Positives = 86/179 (48%), Gaps = 30/179 (16%)
Query: 159 IGEGGYGIVYR----GILS--DGTKVAVKNLLNN-RGQAEKEFKVEVEVIGRVRHKNLVR 211
IGEG +G V++ G+L T VAVK L + +F+ E ++ + N+V+
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL------------HGDVGD--------VSPLTWD 251
LLG C G L++EY+ G+L+++L H D+ PL+
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
++ I A G+AYL E K VHRD+ + N L+ +++DFGL++ + S Y
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 20 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLEPKVV 276
+V ++ + +L LH S ++++ ++I TA+G+ YLH ++
Sbjct: 80 PQL-AIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 130
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA 301
HRD+KS+NI L ++ DFGLA
Sbjct: 131 HRDLKSNNIFLHEDNTVKIGDFGLA 155
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFLAS 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR 181
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 9/165 (5%)
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W E+ T L E +G G +G V+ G + TKVAVK+L + F E
Sbjct: 13 WEDEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 69
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +++H+ LVRL + ++ EY++NG+L +L G LT + +++
Sbjct: 70 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQ 126
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A+G+A++ E +HRD++++NIL+ + +++DFGLA+L+
Sbjct: 127 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 168
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 9/165 (5%)
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W E+ T L E +G G +G V+ G + TKVAVK+L + F E
Sbjct: 12 WEDEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 68
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +++H+ LVRL + ++ EY++NG+L +L G LT + +++
Sbjct: 69 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQ 125
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A+G+A++ E +HRD++++NIL+ + +++DFGLA+L+
Sbjct: 126 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 167
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 9/165 (5%)
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W E+ T L E +G G +G V+ G + TKVAVK+L + F E
Sbjct: 10 WEDEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 66
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +++H+ LVRL + ++ EY++NG+L +L G LT + +++
Sbjct: 67 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQ 123
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A+G+A++ E +HRD++++NIL+ + +++DFGLA+L+
Sbjct: 124 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 165
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 9/165 (5%)
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W E+ T L E +G G +G V+ G + TKVAVK+L + F E
Sbjct: 14 WEDEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 70
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +++H+ LVRL + ++ EY++NG+L +L G LT + +++
Sbjct: 71 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQ 127
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A+G+A++ E +HRD++++NIL+ + +++DFGLA+L+
Sbjct: 128 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 169
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLEPKVV 276
+V ++ + +L LH S ++++ ++I TA+G+ YLH ++
Sbjct: 92 PQL-AIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA 301
HRD+KS+NI L ++ DFGLA
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 42 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 100
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 101 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 154
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 186
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 35 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 93
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 94 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFLAS 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 150 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR 179
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 97 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFLAS 152
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 153 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR 182
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 37 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 95
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 96 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFLAS 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 152 K---KFVHRDLAARNCMLDEKFTVKVADFGLAR 181
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ + +++DFGLA+L+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI 159
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 82 RLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 134
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 92/176 (52%), Gaps = 15/176 (8%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 40 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 97
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V E ++NG+LD +L + + + ++
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQL---VGMLR 154
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL--CSERSYVT 312
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L E +Y T
Sbjct: 155 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTT 207
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 89/165 (53%), Gaps = 9/165 (5%)
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W E+ T L E +G G +G V+ G + TKVAVK+L + F E
Sbjct: 10 WEDEWEVPRETLKLVER--LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 66
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +++H+ LVRL + ++ EY++NG+L +L G LT + +++
Sbjct: 67 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQ 123
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A+G+A++ E +HRD++++NIL+ + +++DFGLA+L+
Sbjct: 124 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 165
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 85 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ + +++DFGLA+L+
Sbjct: 139 DLRAANILVSDTLSCKIADFGLARLI 164
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 70.5 bits (171), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 82 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 135
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ + +++DFGLA+L+
Sbjct: 136 DLRAANILVSDTLSCKIADFGLARLI 161
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ +V+DFGLA+L+
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLI 164
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ + +++DFGLA+L+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI 159
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ + +++DFGLA+L+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLI 159
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 49/166 (29%), Positives = 88/166 (53%), Gaps = 13/166 (7%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+E++A+ + E VIG G +G V G L K VA+K L + ++F E
Sbjct: 24 KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 81
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++ L G + M++ EY++NG+LD +L + G + + + ++
Sbjct: 82 SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLR 138
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
G G+ YL + VHRD+ + NIL++ +VSDFG++++L
Sbjct: 139 GIGSGMKYLSDM---SAVHRDLAARNILVNSNLVCKVSDFGMSRVL 181
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 48/146 (32%), Positives = 79/146 (54%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G+G +G V+ G + T+VA+K L E F E +V+ ++RH+ LV+L E
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY+ G+L +L G++G L + M + A G+AY+ VHR
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI--ASGMAYVERM---NYVHR 138
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D+ ++NIL+ +V+DFGLA+L+
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLI 164
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 85 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 137
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 174
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 44/146 (30%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 81 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 134
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
D++++NIL+ + +++DFGLA+L+
Sbjct: 135 DLRAANILVSDTLSCKIADFGLARLI 160
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/153 (33%), Positives = 87/153 (56%), Gaps = 16/153 (10%)
Query: 158 VIGEGGYGIVYRGIL--SDGTKV--AVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
VIG G +G VY G L +DG K+ AVK+L + + G+ +F E ++ H N++
Sbjct: 38 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS-QFLTEGIIMKDFSHPNVLS 96
Query: 212 LLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C+ EG+ ++V Y+ +G+L ++ + + P D+ + L AKG+ +L
Sbjct: 97 LLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHN--PTVKDL-IGFGLQVAKGMKFL-- 150
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
K VHRD+ + N +LD ++ +V+DFGLA+
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 182
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 50/166 (30%), Positives = 88/166 (53%), Gaps = 13/166 (7%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+EL+A + + V+G G +G V G L +K VA+K L + + ++F E
Sbjct: 11 KELDATNISI--DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++RL G + M+V E ++NG+LD +L + + + ++
Sbjct: 69 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQ---LVGMLR 125
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
G A G+ YL + VHRD+ + NIL++ +VSDFGL+++L
Sbjct: 126 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 168
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 22 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 82 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 134
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 171
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 70.1 bits (170), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 27 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 87 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 139
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 140 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 176
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 11/145 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 90
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLEPKVV 276
+V ++ + +L LH S ++++ ++I TA+G+ YLH ++
Sbjct: 91 APQLAIVTQWCEGSSLYHHLHA-----SETKFEMKKLIDIARQTARGMDYLH---AKSII 142
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA 301
HRD+KS+NI L ++ DFGLA
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLA 167
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 31 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 91 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 144 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 180
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G YGIVY G LS+ ++A+K + + + E+ + ++HKN+V+ LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEGLEP 273
E + + E V G+L L G PL D I T + GL YLH+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWG---PLK-DNEQTIGFYTKQILEGLKYLHDN--- 141
Query: 274 KVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL-----CSERSYVTTRVMG 317
++VHRD+K N+L++ ++SDFG +K L C+E T + M
Sbjct: 142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 69.7 bits (169), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 24 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 84 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 136
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 137 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 173
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 172
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 69.7 bits (169), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 75 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 46 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 106 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 158
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 159 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 195
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 52/160 (32%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 54/170 (31%), Positives = 85/170 (50%), Gaps = 17/170 (10%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V+G+G YGIVY G LS+ ++A+K + + + E+ + ++HKN+V+ LG
Sbjct: 15 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEGLEP 273
E + + E V G+L L G PL D I T + GL YLH+
Sbjct: 75 SENGFIKIFMEQVPGGSLSALLRSKWG---PLK-DNEQTIGFYTKQILEGLKYLHDN--- 127
Query: 274 KVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL-----CSERSYVTTRVMG 317
++VHRD+K N+L++ ++SDFG +K L C+E T + M
Sbjct: 128 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 177
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 49/166 (29%), Positives = 88/166 (53%), Gaps = 13/166 (7%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+E++A+ + E VIG G +G V G L K VA+K L + ++F E
Sbjct: 3 KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++ L G + M++ EY++NG+LD +L + G + + + ++
Sbjct: 61 SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLR 117
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
G G+ YL + VHRD+ + NIL++ +VSDFG++++L
Sbjct: 118 GIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVL 160
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 129 GPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG 188
P + LG+G W E++ +E +G G +G+V G VA+K ++
Sbjct: 8 APSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 189 QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
+E EF E +V+ + H+ LV+L G C + ++ EY+ NG L +L +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ +L K + E LE K +HRD+ + N L++ Q +VSDFGL++ + +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 308 RSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVR 342
T +G+ F V+ SP +L+Y S +
Sbjct: 174 EE---TSSVGS----KFPVRWSPPEVLMYSKFSSK 201
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 69.3 bits (168), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 49/166 (29%), Positives = 88/166 (53%), Gaps = 13/166 (7%)
Query: 144 RELEAATSGLCEENVIGEGGYGIVYRGILSDGTK----VAVKNL-LNNRGQAEKEFKVEV 198
+E++A+ + E VIG G +G V G L K VA+K L + ++F E
Sbjct: 9 KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 66
Query: 199 EVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL 258
++G+ H N++ L G + M++ EY++NG+LD +L + G + + + ++
Sbjct: 67 SIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQL---VGMLR 123
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
G G+ YL + VHRD+ + NIL++ +VSDFG++++L
Sbjct: 124 GIGSGMKYLSDM---SYVHRDLAARNILVNSNLVCKVSDFGMSRVL 166
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 49/165 (29%), Positives = 88/165 (53%), Gaps = 9/165 (5%)
Query: 140 WYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVE 199
W E+ T L E +G G G V+ G + TKVAVK+L + F E
Sbjct: 4 WEDAWEVPRETLKLVER--LGAGQAGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEAN 60
Query: 200 VIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG 259
++ +++H+ LVRL + ++ EY++NG+L +L G LT + +++
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQ 117
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A+G+A++ E +HRD++++NIL+ + +++DFGLA+L+
Sbjct: 118 IAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLI 159
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 83/146 (56%), Gaps = 7/146 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVAVK+L + F E ++ +++H+ LVRL +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++ EY++NG+L +L G LT + +++ A+G+A++ E +HR
Sbjct: 76 EPI-YIITEYMENGSLVDFLKTPSG--IKLTINKLLDMAAQIAEGMAFIEER---NYIHR 129
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLL 304
+++++NIL+ + +++DFGLA+L+
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLI 155
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 68.9 bits (167), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 22/215 (10%)
Query: 129 GPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRG 188
P + LG+G W E++ +E +G G +G+V G VA+K ++
Sbjct: 8 APSTAGLGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGS 60
Query: 189 QAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPL 248
+E EF E +V+ + H+ LV+L G C + ++ EY+ NG L +L +
Sbjct: 61 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EM 113
Query: 249 TWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ +L K + E LE K +HRD+ + N L++ Q +VSDFGL++ + +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173
Query: 308 RSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVR 342
T +G+ F V+ SP +L+Y S +
Sbjct: 174 E---YTSSVGS----KFPVRWSPPEVLMYSKFSSK 201
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 80/157 (50%), Gaps = 12/157 (7%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VAVK ++ +E EF E + + ++ H LV+ G C +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVK-MIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 219 GAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+V EY+ NG L +L HG + S L + + +G+A+L + +
Sbjct: 75 EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QFI 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
HRD+ + N L+DR +VSDFG+ + + ++ YV++
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVSS 162
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV 204
E+EA+ L IG G +G VY+G V + +++ + + F+ EV V+ +
Sbjct: 32 EIEASEVMLSTR--IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKT 89
Query: 205 RHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
RH N++ +GY + +V ++ + +L + LH V + + + ++I TA+G+
Sbjct: 90 RHVNILLFMGYMTKDNL-AIVTQWCEGSSLYKHLH--VQETKFQMFQL-IDIARQTAQGM 145
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
YLH ++HRD+KS+NI L ++ DFGLA
Sbjct: 146 DYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLA 179
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 68.6 bits (166), Expect = 5e-12, Method: Compositional matrix adjust.
Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEV 200
+L + E + + ++ +G G YG VY G+ VAVK L + + E EF E V
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILG 259
+ ++H NLV+LLG C ++ E++ GNL +L + +VS + ++L
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-------VLLY 113
Query: 260 TAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A ++ E LE K +HRD+ + N L+ +V+DFGL++L+
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 159
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 51/166 (30%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEV 200
+L + E + + ++ +G G YG VY G+ VAVK L + + E EF E V
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILG 259
+ ++H NLV+LLG C ++ E++ GNL +L + +VS + ++L
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLY 113
Query: 260 TAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A ++ E LE K +HRD+ + N L+ +V+DFGL++L+
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 159
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 68.2 bits (165), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 18 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 78 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 130
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLA 153
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 49/160 (30%), Positives = 86/160 (53%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLL-----NNRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV + + +A KE E V+ V + ++
Sbjct: 55 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 115 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 167
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 168 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 204
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 88/160 (55%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 18 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ A+G+ YL
Sbjct: 78 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AEGMNYL 130
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 131 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 167
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 76 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA 151
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 81 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLA 156
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 68.2 bits (165), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 21 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 81 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 133
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLA 156
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 76 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA 151
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 14/154 (9%)
Query: 158 VIGEGGYGIVYRGILSD-GTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++GEG YG+V + D G VA+K L ++ +K E++++ ++RH+NLV LL
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKGLAYLHEGLE 272
C + LV+E+VD+ LD ++ P L + + + G+ + H
Sbjct: 92 VCKKKKRWYLVFEFVDHTILDDL------ELFPNGLDYQVVQKYLFQIINGIGFCHSH-- 143
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
++HRD+K NIL+ + ++ DFG A+ L +
Sbjct: 144 -NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 36 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 96 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 148
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLA 171
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 67.8 bits (164), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+ G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 67.8 bits (164), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 43 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 155
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLA 178
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 156
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA 179
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 67.8 bits (164), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY +
Sbjct: 44 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLH---AKSIIHR 156
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLA 179
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 7/143 (4%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG G +G VY+G V + N+ Q + FK EV V+ + RH N++ +GY
Sbjct: 16 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST- 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V ++ + +L LH + ++I TA+G+ YLH ++HR
Sbjct: 75 APQLAIVTQWCEGSSLYHHLHIIETKFEMIKL---IDIARQTAQGMDYLHAK---SIIHR 128
Query: 279 DVKSSNILLDRQWNARVSDFGLA 301
D+KS+NI L ++ DFGLA
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLA 151
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+ G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+ G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFGLAKLL +E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 177
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 25 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 85 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 137
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFG AKLL +E
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 174
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +V+DFGL++L+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM 161
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +V+DFGL++L+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM 161
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 137
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +V+DFGL++L+
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLM 166
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +V+DFGL++L+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM 161
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 67.4 bits (163), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFG AKLL +E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFG AKLL +E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 49/149 (32%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 132
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRD+ + N L+ +V+DFGL++L+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLM 161
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 28 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 88 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 140
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFG AKLL +E
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 177
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 50/165 (30%), Positives = 84/165 (50%), Gaps = 9/165 (5%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEV 200
++ + E + + ++ +G G YG VY G+ VAVK L + + E EF E V
Sbjct: 23 SMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 81
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT 260
+ ++H NLV+LLG C +V EY+ GNL +L + ++ ++L
Sbjct: 82 MKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNRE------EVTAVVLLYM 135
Query: 261 AKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A ++ E LE K +HRD+ + N L+ +V+DFGL++L+
Sbjct: 136 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLM 180
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 9/161 (5%)
Query: 151 SGLCEENVIGEGGYGIVYRGILSDGTKVAV-KNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
S L V+G+G +G + + +V V K L+ + ++ F EV+V+ + H N+
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNV 69
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-SPLTWDIRMNIILGTAKGLAYLH 268
++ +G + + EY+ G L G + + S W R++ A G+AYLH
Sbjct: 70 LKFIGVLYKDKRLNFITEYIKGGTL----RGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
++HRD+ S N L+ N V+DFGLA+L+ E++
Sbjct: 126 SM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 23 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 83 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFG AKLL +E
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 172
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 43/153 (28%), Positives = 82/153 (53%), Gaps = 12/153 (7%)
Query: 157 NVIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAE----KEFKVEVEVIGRVRHKNLVR 211
N++G+G + VYR + G +VA+K +++ + + + + EV++ +++H +++
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIK-MIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILE 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L Y + Y LV E NG ++++L V P + + + + G+ YLH
Sbjct: 76 LYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV---KPFSENEARHFMHQIITGMLYLHSH- 131
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
++HRD+ SN+LL R N +++DFGLA L
Sbjct: 132 --GILHRDLTLSNLLLTRNMNIKIADFGLATQL 162
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 67.0 bits (162), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/160 (31%), Positives = 87/160 (54%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKV----AVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+G+ + +G KV A+K L +A KE E V+ V + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGD-VGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + L+ + + G L ++ H D +G L W +++ AKG+ YL
Sbjct: 81 RLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKGMNYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+ ++VHRD+ + N+L+ + +++DFG AKLL +E
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAE 170
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 16/172 (9%)
Query: 157 NVIGEGGYGIVYRGILS--DGT--KVAVKNL-LNNRGQAE-KEFKVEVEVIGRVRHKNLV 210
++GEG +G V G L DGT KVAVK + L+N Q E +EF E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 211 RLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKG 263
RLLG C+E + + M++ ++ G+L +L + P + + ++ A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+ YL +HRD+ + N +L V+DFGL+K + S Y R+
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRI 208
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 50/166 (30%), Positives = 86/166 (51%), Gaps = 11/166 (6%)
Query: 142 TLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEV 200
+L + E + + ++ +G G +G VY G+ VAVK L + + E EF E V
Sbjct: 2 SLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAV 60
Query: 201 IGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILG 259
+ ++H NLV+LLG C ++ E++ GNL +L + +VS + ++L
Sbjct: 61 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLY 113
Query: 260 TAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
A ++ E LE K +HRD+ + N L+ +V+DFGL++L+
Sbjct: 114 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 159
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 67.0 bits (162), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 173
>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A
Pyrrolo-Pyridine Inhibitor
Length = 273
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/181 (28%), Positives = 87/181 (48%), Gaps = 18/181 (9%)
Query: 126 GSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSD-GTKVAVKNLL 184
G++ P ++ W E + + ++ +G G YG VY G+ VAVK L
Sbjct: 1 GAMDPSPNYDKW---------EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK 51
Query: 185 NNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGD 244
+ + E EF E V+ ++H NLV+LLG C ++ E++ GNL +L
Sbjct: 52 EDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ 110
Query: 245 VSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKL 303
++ ++L A ++ E LE K +HRD+ + N L+ +V+DFGL++L
Sbjct: 111 ------EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164
Query: 304 L 304
+
Sbjct: 165 M 165
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 66.6 bits (161), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIIIEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLM 166
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLM 166
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM 161
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 71 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 66.2 bits (160), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 81 REPPFYIIIEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLM 162
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 22 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 81 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 134
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLM 162
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLM 163
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 133
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLM 161
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLM 166
>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine
Analog
pdb|2GDO|A Chain A, 4-(aminoalkylamino)-3-benzimidazole-quinolinones As Potent
Chk1 Inhibitors
Length = 295
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 66.2 bits (160), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLM 163
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 56/149 (37%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 217 VE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
VE G Y +V EY+ G+L +L V L D + L + + YL EG
Sbjct: 256 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL-EG--N 308
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+ + N+L+ A+VSDFGL K
Sbjct: 309 NFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 34 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 93 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 146
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLM 174
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 26 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLM 166
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/182 (34%), Positives = 89/182 (48%), Gaps = 22/182 (12%)
Query: 124 GSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNL 183
GS + E GW ++EL+ + IG+G +G V G G KVAVK +
Sbjct: 3 GSVAAQDEFYRSGWA--LNMKELKLLQT-------IGKGEFGDVMLGDYR-GNKVAVKCI 52
Query: 184 LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE---GAYRMLVYEYVDNGNLDQWLHG 240
N+ + F E V+ ++RH NLV+LLG VE G Y +V EY+ G+L +L
Sbjct: 53 KND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY--IVTEYMAKGSLVDYLRS 108
Query: 241 DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300
V L D + L + + YL EG VHRD+ + N+L+ A+VSDFGL
Sbjct: 109 RGRSV--LGGDCLLKFSLDVCEAMEYL-EG--NNFVHRDLAARNVLVSEDNVAKVSDFGL 163
Query: 301 AK 302
K
Sbjct: 164 TK 165
>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor
Length = 269
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG YG V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 65.9 bits (159), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 9/148 (6%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 23 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 135
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD+ + N L+ +V+DFGL++L+
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLM 163
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 55/170 (32%), Positives = 87/170 (51%), Gaps = 21/170 (12%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG 214
+G G +G V +G+ K VA+K L +A+ +E E +++ ++ + +VRL+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRMNIILGTAKGLAYLHE 269
C A MLV E G L ++L G V +V+ L + M G+ YL E
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM--------GMKYLEE 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
VHRD+ + N+LL + A++SDFGL+K L ++ SY T R G +
Sbjct: 129 K---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 175
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 65.9 bits (159), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 48/164 (29%), Positives = 86/164 (52%), Gaps = 20/164 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDVSP-----------LTWDIRMNIIL 258
LLG C Y L EY +GNL +L V + P L+ ++
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++
Sbjct: 140 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 180
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 135 LGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEF 194
LG+G W E++ +E +G G +G+V G VA+K ++ +E EF
Sbjct: 5 LGYGSW----EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEF 57
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM 254
E +V+ + H+ LV+L G C + ++ EY+ NG L +L + +
Sbjct: 58 IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------EMRHRFQT 110
Query: 255 NIILGTAKGLAYLHEGLEPK-VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
+L K + E LE K +HRD+ + N L++ Q +VSDFGL++ + + T
Sbjct: 111 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YT 167
Query: 314 RVMGTFGYAHFIVQVSPLFILLYILLSVR 342
+G+ F V+ SP +L+Y S +
Sbjct: 168 SSVGS----KFPVRWSPPEVLMYSKFSSK 192
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 48/164 (29%), Positives = 86/164 (52%), Gaps = 20/164 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDVSP-----------LTWDIRMNIIL 258
LLG C Y L EY +GNL +L V + P L+ ++
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL + + +HRD+ + NIL+ + A+++DFGL++
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 190
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 24/179 (13%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNN-RGQAEKEFK 195
L+E+ + EE +GE +G VY+G L VA+K L + G +EF+
Sbjct: 20 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 77
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV----- 245
E + R++H N+V LLG + +++ Y +G+L ++L H DVG
Sbjct: 78 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 137
Query: 246 --SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
S L ++++ A G+ YL VVH+D+ + N+L+ + N ++SD GL +
Sbjct: 138 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 193
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/149 (37%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 18 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 217 VE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
VE G Y +V EY+ G+L +L V L D + L + + YL EG
Sbjct: 75 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL-EG--N 127
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+ + N+L+ A+VSDFGL K
Sbjct: 128 NFVHRDLAARNVLVSEDNVAKVSDFGLTK 156
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 65.5 bits (158), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 56/149 (37%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V G G KVAVK + N+ + F E V+ ++RH NLV+LLG
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 217 VE---GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
VE G Y +V EY+ G+L +L V L D + L + + YL EG
Sbjct: 69 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYL-EG--N 121
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAK 302
VHRD+ + N+L+ A+VSDFGL K
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 65.5 bits (158), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 54/170 (31%), Positives = 87/170 (51%), Gaps = 21/170 (12%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLG 214
+G G +G V +G+ K VA+K L +A+ +E E +++ ++ + +VRL+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRMNIILGTAKGLAYLHE 269
C A MLV E G L ++L G V +V+ L + M G+ YL E
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM--------GMKYLEE 454
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
VHR++ + N+LL + A++SDFGL+K L ++ SY T R G +
Sbjct: 455 K---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 501
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 80/146 (54%), Gaps = 9/146 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+VY+ + G A+K + L + + E+ ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+LV+E++D +L + L G + +T + +L G+AY H+ +V+
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT---AKSFLLQLLNGIAYCHDR---RVL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+K N+L++R+ +++DFGLA+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR 148
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 80/146 (54%), Gaps = 9/146 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+VY+ + G A+K + L + + E+ ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+LV+E++D +L + L G + +T + +L G+AY H+ +V+
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT---AKSFLLQLLNGIAYCHDR---RVL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+K N+L++R+ +++DFGLA+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR 148
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 65.1 bits (157), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 80/146 (54%), Gaps = 9/146 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+VY+ + G A+K + L + + E+ ++ ++H N+V+L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+LV+E++D +L + L G + +T + +L G+AY H+ +V+
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT---AKSFLLQLLNGIAYCHDR---RVL 122
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+K N+L++R+ +++DFGLA+
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLAR 148
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 65.1 bits (157), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 24/179 (13%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGIL------SDGTKVAVKNLLNN-RGQAEKEFK 195
L+E+ + EE +GE +G VY+G L VA+K L + G +EF+
Sbjct: 3 LKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFR 60
Query: 196 VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----HGDVGDV----- 245
E + R++H N+V LLG + +++ Y +G+L ++L H DVG
Sbjct: 61 HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120
Query: 246 --SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
S L ++++ A G+ YL VVH+D+ + N+L+ + N ++SD GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR 176
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 64.7 bits (156), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 52/185 (28%), Positives = 90/185 (48%), Gaps = 16/185 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 76 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYI 337
RD+ + N L++ Q +VSDFGL++ + + Y ++R + F V+ SP +L+Y
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYTSSRG------SKFPVRWSPPEVLMYS 181
Query: 338 LLSVR 342
S +
Sbjct: 182 KFSSK 186
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 11/152 (7%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 218 EGAYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-V 275
++ E++ GNL +L + +VS + ++L A ++ E LE K
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAV-------VLLYMATQISSAMEYLEKKNF 339
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+HR++ + N L+ +V+DFGL++L+ +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 21/170 (12%)
Query: 159 IGEGGYGIVYRG------ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V+ D VAVK L + A K+F+ E E++ ++H+++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGD----VGDVSP------LTWDIRMNIILGT 260
G C +G ++V+EY+ +G+L+++L HG + D P L ++I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
A G+ YL VHRD+ + N L+ ++ DFG+++ + S Y
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 64.7 bits (156), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 20/196 (10%)
Query: 112 RGTGSACETASFGSGSVGPEVSHLGWGR--WYTLRELEAATSGLCEENVIGEGGYGIVYR 169
+G C+ S S P+ W + W RE L E +G G +G V+
Sbjct: 156 KGNDGLCQKLSVPCMSSKPQKP---WEKDAWEIPRE------SLKLEKKLGAGQFGEVWM 206
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRMLVYEY 228
+ TKVAVK + E F E V+ ++H LV+L E Y ++ E+
Sbjct: 207 ATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVTKEPIY--IITEF 263
Query: 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+ G+L +L D G PL I + + A+G+A++ + +HRD++++NIL+
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVS 318
Query: 289 RQWNARVSDFGLAKLL 304
+++DFGLA+++
Sbjct: 319 ASLVCKIADFGLARVI 334
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 64.7 bits (156), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 19/157 (12%)
Query: 157 NVIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G VY+GI + DG VA+K L N +A KE E V+ V +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLH---GDVGDVSPLTWDIRMNIILGTAKGLAYL 267
RLLG C+ + LV + + G L + G +G L W +++ AKG++YL
Sbjct: 83 RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI------AKGMSYL 135
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ ++VHRD+ + N+L+ + +++DFGLA+LL
Sbjct: 136 EDV---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 169
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 64.3 bits (155), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 126 GSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVA 179
SV PE + Y E E A + +G+G +G+VY +G++ D T+VA
Sbjct: 2 ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 180 VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL 238
+K + E+ EF E V+ ++VRLLG +G +++ E + G+L +L
Sbjct: 60 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 239 H------GDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
+ ++P + + + A G+AYL+ K VHRD+ + N ++ +
Sbjct: 120 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 293 ARVSDFGLAK 302
++ DFG+ +
Sbjct: 177 VKIGDFGMTR 186
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + + G F YA
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 64.3 bits (155), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IGEG YG V++ + + VA+K + ++ G + E+ ++ ++HKN+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+ D +L ++ GD+ P +I + + KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGFCHSR---N 121
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++R +++DFGLA+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLAR 149
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 126 GSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVA 179
SV PE + Y E E A + +G+G +G+VY +G++ D T+VA
Sbjct: 2 ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 59
Query: 180 VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL 238
+K + E+ EF E V+ ++VRLLG +G +++ E + G+L +L
Sbjct: 60 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 119
Query: 239 HGDVGDV------SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
++ +P + + + A G+AYL+ K VHRD+ + N ++ +
Sbjct: 120 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 176
Query: 293 ARVSDFGLAK 302
++ DFG+ +
Sbjct: 177 VKIGDFGMTR 186
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 64.3 bits (155), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 54/195 (27%), Positives = 91/195 (46%), Gaps = 20/195 (10%)
Query: 112 RGTGSACETASFGSGSVGPEVSHLGWGR--WYTLRELEAATSGLCEENVIGEGGYGIVYR 169
+G C+ S S P+ W + W RE L E +G G +G V+
Sbjct: 150 KGNDGLCQKLSVPCMSSKPQKP---WEKDAWEIPRE------SLKLEKKLGAGQFGEVWM 200
Query: 170 GILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV-EGAYRMLVYEY 228
+ TKVAVK + E F E V+ ++H LV+L E Y ++ E+
Sbjct: 201 ATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAVVTKEPIY--IITEF 257
Query: 229 VDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+ G+L +L D G PL I + + A+G+A++ + +HRD++++NIL+
Sbjct: 258 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQR---NYIHRDLRAANILVS 312
Query: 289 RQWNARVSDFGLAKL 303
+++DFGLA++
Sbjct: 313 ASLVCKIADFGLARV 327
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQA--EKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V++ D G VA+K L + +K E+ ++ +++H NLV LL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 216 CVEGAYRMLVYEYVDNG---NLDQWLHGDVGD-VSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV+EY D+ LD++ G V +TW T + + + H+
Sbjct: 71 FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHKH- 121
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
+HRDVK NIL+ + ++ DFG A+LL Y V
Sbjct: 122 --NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV 163
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 18/190 (9%)
Query: 126 GSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVA 179
SV PE + Y E E A + +G+G +G+VY +G++ D T+VA
Sbjct: 24 ASVNPE--YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVA 81
Query: 180 VKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWL 238
+K + E+ EF E V+ ++VRLLG +G +++ E + G+L +L
Sbjct: 82 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 141
Query: 239 HGDVGDV------SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN 292
++ +P + + + A G+AYL+ K VHRD+ + N ++ +
Sbjct: 142 RSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 198
Query: 293 ARVSDFGLAK 302
++ DFG+ +
Sbjct: 199 VKIGDFGMTR 208
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G ++ TKVAVK L + F E ++ ++H LVRL
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ EY+ G+L +L D G + P D I A+G+AY+ +
Sbjct: 80 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERK---NYI 132
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD++++N+L+ +++DFGLA+++
Sbjct: 133 HRDLRAANVLVSESLMCKIADFGLARVI 160
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 147 EAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH 206
E L E +G G +G V+ + TKVAVK + E F E V+ ++H
Sbjct: 11 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQH 69
Query: 207 KNLVRLLGYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
LV+L E Y ++ E++ G+L +L D G PL I + + A+G+A
Sbjct: 70 DKLVKLHAVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI--AEGMA 125
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
++ + +HRD++++NIL+ +++DFGLA+++
Sbjct: 126 FIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVI 161
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL---LQYTSQICKGMEYLGTK- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 63.9 bits (154), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 42/159 (26%), Positives = 85/159 (53%), Gaps = 8/159 (5%)
Query: 148 AATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVR 205
+++S + +G G Y VY+G+ + G VA+K + + + + E+ ++ ++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP--LTWDIRMNIILGTAKG 263
H+N+VRL LV+E++DN +L +++ +P L ++ +G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
LA+ HE K++HRD+K N+L++++ ++ DFGLA+
Sbjct: 121 LAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLAR 156
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 76/148 (51%), Gaps = 10/148 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G ++ TKVAVK L + F E ++ ++H LVRL +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGD--VSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ E++ G+L +L D G + P D I A+G+AY+ +
Sbjct: 79 EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERK---NYI 131
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLL 304
HRD++++N+L+ +++DFGLA+++
Sbjct: 132 HRDLRAANVLVSESLMCKIADFGLARVI 159
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 379
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
HR++ + N L+ +V+DFGL++L+ +
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGD 410
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 63.5 bits (153), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 48/161 (29%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G V+ G + TKVA+K L E F E +++ +++H LV+L E
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
+V EY++ G+L +L G+ L +++ A G+AY+ +HR
Sbjct: 76 EPI-YIVTEYMNKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHR 129
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
D++S+NIL+ +++DFGLA+L+ E + T R F
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKF 168
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + C S T + GT Y
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDY 173
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HR++ + NIL++ + ++ DFGL K+L ++ Y + G F YA
Sbjct: 135 --RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 186
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 86/164 (52%), Gaps = 20/164 (12%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKV--AVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
++VIGEG +G V + I DG ++ A+K + + + ++F E+EV+ ++ H N++
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDVSP-----------LTWDIRMNIIL 258
LLG C Y L EY +GNL +L V + P L+ ++
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL + + +HR++ + NIL+ + A+++DFGL++
Sbjct: 147 DVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSR 187
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/196 (28%), Positives = 86/196 (43%), Gaps = 27/196 (13%)
Query: 133 SHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY-------RGILSDGTKVAVKNLLN 185
SH+ R + L + E +G+G +G VY + IL+ KV K L
Sbjct: 2 SHMSKKRQWALEDFEIGRP-------LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLE 52
Query: 186 NRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV 245
G E + + EVE+ +RH N++RL GY + L+ EY G ++ ++ +
Sbjct: 53 KAG-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKL 107
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
S I A L+Y H +V+HRD+K N+LL +++DFG +
Sbjct: 108 SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 164
Query: 306 SERSYVTTRVMGTFGY 321
S R T + GT Y
Sbjct: 165 SSRR---TDLCGTLDY 177
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 63.5 bits (153), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 46/151 (30%), Positives = 77/151 (50%), Gaps = 9/151 (5%)
Query: 159 IGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G YG VY G+ + VAVK L + + E EF E V+ ++H NLV+LLG C
Sbjct: 225 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCT 283
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VV 276
++ E++ GNL +L ++ ++L A ++ E LE K +
Sbjct: 284 REPPFYIITEFMTYGNLLDYLRECNRQ------EVNAVVLLYMATQISSAMEYLEKKNFI 337
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
HR++ + N L+ +V+DFGL++L+ +
Sbjct: 338 HRNLAARNCLVGENHLVKVADFGLSRLMTGD 368
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 75 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 127
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYI 337
RD+ + N L++ Q +VSDFGL++ + + T +G+ F V+ SP +L+Y
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGS----KFPVRWSPPEVLMYS 180
Query: 338 LLSVR 342
S +
Sbjct: 181 KFSSK 185
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 71 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 123
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYI 337
RD+ + N L++ Q +VSDFGL++ + + T +G+ F V+ SP +L+Y
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGS----KFPVRWSPPEVLMYS 176
Query: 338 LLSVR 342
S +
Sbjct: 177 KFSSK 181
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 63.2 bits (152), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 177
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 52/185 (28%), Positives = 89/185 (48%), Gaps = 16/185 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +G+V G VA+K ++ +E EF E +V+ + H+ LV+L G C +
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK-VVH 277
++ EY+ NG L +L + + +L K + E LE K +H
Sbjct: 76 QRPIFIITEYMANGCLLNYLR-------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 128
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYI 337
RD+ + N L++ Q +VSDFGL++ + + T +G+ F V+ SP +L+Y
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGS----KFPVRWSPPEVLMYS 181
Query: 338 LLSVR 342
S +
Sbjct: 182 KFSSK 186
>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 50/168 (29%), Positives = 79/168 (47%), Gaps = 10/168 (5%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRLLG 214
+GEG G V + VAVK + R + K E+ + + H+N+V+ G
Sbjct: 12 QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ EG + L EY G L + D+G P ++ G+ YLH G+
Sbjct: 72 HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLH-GI--G 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLL-CSERSYVTTRVMGTFGY 321
+ HRD+K N+LLD + N ++SDFGLA + + R + ++ GT Y
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 9 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G +++ E + G+L +L ++ +P
Sbjct: 69 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 62.8 bits (151), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 53/190 (27%), Positives = 85/190 (44%), Gaps = 46/190 (24%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNL 209
+GEG +G V + + T VAVK L N +E ++ E V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------------------HGD----- 241
++L G C + +L+ EY G+L +L H D
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+GD+ W I ++G+ YL E K+VHRD+ + NIL+ ++SDFGL+
Sbjct: 149 MGDLISFAWQI--------SQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 302 KLLCSERSYV 311
+ + E SYV
Sbjct: 198 RDVYEEDSYV 207
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 5 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLH------GDVGDVSP 247
F E V+ ++VRLLG +G +++ E + G+L +L + ++P
Sbjct: 65 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 124
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 125 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 176
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 165 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 216
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 131
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 132 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 183
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 137
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 138 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 189
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 133 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 184
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 138
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 139 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 190
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 62.4 bits (150), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 141 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 192
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 139
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 140 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 191
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 9 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G +++ E + G+L +L ++ +P
Sbjct: 69 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 128
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 129 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 180
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 78/148 (52%), Gaps = 12/148 (8%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLL---NNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IGEG YG V++ + + VA+K + ++ G + E+ ++ ++HKN+VRL
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLHD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+ D +L ++ GD+ P +I + + KGL + H
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDP---EIVKSFLFQLLKGLGFCHSR---N 121
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++R ++++FGLA+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLAR 149
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G V++G+ + +G V +K + + G Q+ + + IG + H ++V
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYL 267
RLLG C G+ LV +Y+ G+L + G + P L W +++ AKG+ YL
Sbjct: 97 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 149
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
E +VHR++ + N+LL +V+DFG+A LL +
Sbjct: 150 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 186
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 49/160 (30%), Positives = 84/160 (52%), Gaps = 19/160 (11%)
Query: 157 NVIGEGGYGIVYRGI-LSDG----TKVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLV 210
V+G G +G V++G+ + +G V +K + + G Q+ + + IG + H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP---LTWDIRMNIILGTAKGLAYL 267
RLLG C G+ LV +Y+ G+L + G + P L W +++ AKG+ YL
Sbjct: 79 RLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI------AKGMYYL 131
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
E +VHR++ + N+LL +V+DFG+A LL +
Sbjct: 132 EEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD 168
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 185
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G +++ E + G+L +L ++ +P
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 55/194 (28%), Positives = 86/194 (44%), Gaps = 27/194 (13%)
Query: 135 LGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY-------RGILSDGTKVAVKNLLNNR 187
LG R +TL + + +G+G +G VY + IL+ KV K L
Sbjct: 3 LGSKRQWTLEDFDIGRP-------LGKGKFGNVYLARERQSKFILA--LKVLFKTQLEKA 53
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
G E + + EVE+ +RH N++RL GY + L+ EY G ++ ++ +S
Sbjct: 54 G-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSR 108
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
I A L+Y H +V+HRD+K N+LL +++DFG + S
Sbjct: 109 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAPSS 165
Query: 308 RSYVTTRVMGTFGY 321
R T + GT Y
Sbjct: 166 RR---TTLCGTLDY 176
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 84/175 (48%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 8 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G +++ E + G+L +L ++ +P
Sbjct: 68 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 127
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 128 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 179
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 48/147 (32%), Positives = 82/147 (55%), Gaps = 11/147 (7%)
Query: 159 IGEGGYGIVYRGI--LSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+GEG Y VY+G L+D VA+K + L + A EV ++ ++H N+V L
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+EY+D +L Q+L D G++ + ++++ + +GLAY H KV
Sbjct: 69 IHTEKSLTLVFEYLDK-DLKQYL-DDCGNIINM-HNVKL-FLFQLLRGLAYCHRQ---KV 121
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+K N+L++ + +++DFGLA+
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 62.4 bits (150), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ EY+ G+L +L + + + KG+ YL
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 203
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 11/143 (7%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 70 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 129
Query: 235 DQWLHG------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+L D D PL ++ A+G+A+L +HRDV + N+LL
Sbjct: 130 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLT 186
Query: 289 RQWNARVSDFGLAKLLCSERSYV 311
A++ DFGLA+ + ++ +Y+
Sbjct: 187 NGHVAKIGDFGLARDIMNDSNYI 209
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 62.0 bits (149), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 45/174 (25%), Positives = 86/174 (49%), Gaps = 16/174 (9%)
Query: 159 IGEGGYGIV----YRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G V Y + + G VAVK L ++ + ++F+ E+E++ ++H N+V+
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G C R L+ E++ G+L ++L + + + KG+ YL
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL---LQYTSQICKGMEYLGTK- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ +HRD+ + NIL++ + ++ DFGL K+L ++ + G F YA
Sbjct: 137 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYA 188
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 18/176 (10%)
Query: 157 NVIGEGGYGIV--YRGILSDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVR 211
IG G YG+V R L+ G +VA+K + N A++ + E++++ +H N++
Sbjct: 61 ETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIA 118
Query: 212 L---LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ L V VY +D D LH + PLT + + +GL Y+H
Sbjct: 119 IKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 176
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS---ERSYVTTRVMGTFGY 321
+V+HRD+K SN+L++ ++ DFG+A+ LC+ E Y T + T Y
Sbjct: 177 SA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 229
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 11/143 (7%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLHG------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
+L D D PL ++ A+G+A+L +HRDV + N+LL
Sbjct: 138 LNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLT 194
Query: 289 RQWNARVSDFGLAKLLCSERSYV 311
A++ DFGLA+ + ++ +Y+
Sbjct: 195 NGHVAKIGDFGLARDIMNDSNYI 217
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TELCGTLDY 172
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 18/176 (10%)
Query: 157 NVIGEGGYGIV--YRGILSDGTKVAVKNLLNNRG---QAEKEFKVEVEVIGRVRHKNLVR 211
IG G YG+V R L+ G +VA+K + N A++ + E++++ +H N++
Sbjct: 60 ETIGNGAYGVVSSARRRLT-GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIA 117
Query: 212 L---LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+ L V VY +D D LH + PLT + + +GL Y+H
Sbjct: 118 IKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH 175
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS---ERSYVTTRVMGTFGY 321
+V+HRD+K SN+L++ ++ DFG+A+ LC+ E Y T + T Y
Sbjct: 176 SA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY 228
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 42 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 99 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 153
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 154 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 198
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 62.0 bits (149), Expect = 5e-10, Method: Compositional matrix adjust.
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ R++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLAR 205
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 175
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 15 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 71
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 72 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 126
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 127 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 171
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 172
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 33 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 89
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 90 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 145 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 189
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 61.6 bits (148), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 177
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 177
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 61.6 bits (148), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TXLCGTLDY 172
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 61.2 bits (147), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 20 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 76
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 77 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 131
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 132 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 176
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 485
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 486 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 175
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVE 197
E E A + +G+G +G+VY +G++ D T+VA+K + E+ EF E
Sbjct: 10 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWD 251
V+ ++VRLLG +G +++ E + G+L +L ++ +P +
Sbjct: 70 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 129
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 130 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 177
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDY 172
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDY 173
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 81/156 (51%), Gaps = 20/156 (12%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
V G +G V++ L + VAVK + ++ + E+ EV + ++H+N+++ +G
Sbjct: 31 VKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAE 87
Query: 217 VEGAY----RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE--- 269
G L+ + + G+L +L +V ++W+ +I A+GLAYLHE
Sbjct: 88 KRGTSVDVDLWLITAFHEKGSLSDFLKANV-----VSWNELCHIAETMARGLAYLHEDIP 142
Query: 270 ----GLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
G +P + HRD+KS N+LL A ++DFGLA
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 21 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 77
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 78 LYGYFHDATRVYLILEYAPRGE----VYKELQKLSKFDEQRTATYITELANALSYCHSK- 132
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R + GT Y
Sbjct: 133 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---XXLXGTLDY 177
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 13 LGKGKFGNVYLAREKQRKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 69
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 70 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 124
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 125 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDY 169
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 42/168 (25%), Positives = 87/168 (51%), Gaps = 15/168 (8%)
Query: 142 TLRELEAATSGLCEENV------IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE-KEF 194
++++ E T L E+ +G+G +G VY+ + + +A +++ + + E +++
Sbjct: 22 SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 195 KVEVEVIGRVRHKNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
VE++++ H N+V+LL + E +L+ E+ G +D + + PLT
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQI 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ T L YLH+ K++HRD+K+ NIL + +++DFG++
Sbjct: 138 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVE 197
E E A + +G+G +G+VY +G++ D T+VA+K + E+ EF E
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWD 251
V+ ++VRLLG +G +++ E + G+L +L ++ +P +
Sbjct: 64 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 123
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 124 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 171
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 61.2 bits (147), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 42/168 (25%), Positives = 87/168 (51%), Gaps = 15/168 (8%)
Query: 142 TLRELEAATSGLCEENV------IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE-KEF 194
++++ E T L E+ +G+G +G VY+ + + +A +++ + + E +++
Sbjct: 22 SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 195 KVEVEVIGRVRHKNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
VE++++ H N+V+LL + E +L+ E+ G +D + + PLT
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQI 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ T L YLH+ K++HRD+K+ NIL + +++DFG++
Sbjct: 138 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL +++DFG + S R T + GT Y
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TDLCGTLDY 172
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 44/171 (25%), Positives = 83/171 (48%), Gaps = 16/171 (9%)
Query: 145 ELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-EFKVE 197
E E A + +G+G +G+VY +G++ D T+VA+K + E+ EF E
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 198 VEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWD 251
V+ ++VRLLG +G +++ E + G+L +L ++ +P +
Sbjct: 66 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLS 125
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 126 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 173
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 42/168 (25%), Positives = 87/168 (51%), Gaps = 15/168 (8%)
Query: 142 TLRELEAATSGLCEENV------IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE-KEF 194
++++ E T L E+ +G+G +G VY+ + + +A +++ + + E +++
Sbjct: 22 SMKQYEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDY 81
Query: 195 KVEVEVIGRVRHKNLVRLL-GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
VE++++ H N+V+LL + E +L+ E+ G +D + + PLT
Sbjct: 82 MVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQI 137
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ T L YLH+ K++HRD+K+ NIL + +++DFG++
Sbjct: 138 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVS 182
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 61.2 bits (147), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 43/160 (26%), Positives = 81/160 (50%), Gaps = 25/160 (15%)
Query: 157 NVIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
+ G +G V++ +++D V + L Q ++ ++ E E+ ++H+NL++ +
Sbjct: 21 EIKARGRFGCVWKAQLMNDFVAVKIFPL-----QDKQSWQSEREIFSTPGMKHENLLQFI 75
Query: 214 GYCVEGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G+ L+ + D G+L +L G++ +TW+ ++ ++GL+YLHE
Sbjct: 76 AAEKRGSNLEVELWLITAFHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHE 130
Query: 270 --------GLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
G +P + HRD KS N+LL A ++DFGLA
Sbjct: 131 DVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 60.8 bits (146), Expect = 9e-10, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 486
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 487 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 17/186 (9%)
Query: 159 IGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V + G +VAVK+L G + K E+E++ + H+N+V+
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 213 LGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C E G L+ E++ +G+L ++L + ++ ++ + KG+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN---LKQQLKYAVQICKGMDYLGSR 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT---RVMGTFGYAHFIVQ 327
+ VHRD+ + N+L++ + ++ DFGL K + +++ T R F YA +
Sbjct: 146 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 328 VSPLFI 333
S +I
Sbjct: 203 QSKFYI 208
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+VD +L +++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEHVDQ-DLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLAR 154
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 45/175 (25%), Positives = 83/175 (47%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVY----RGILSDG--TKVAVKNLLNNRGQAEK-E 193
Y E E A + +G+G +G+VY +G++ D T+VA+K + E+ E
Sbjct: 2 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G +++ E + G+L +L ++ +P
Sbjct: 62 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 121
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ + + A G+AYL+ K VHRD+ + N + + ++ DFG+ +
Sbjct: 122 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR 173
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 11/170 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
HRD+KS NILL + +++DFG + E+S +T V + A +V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 49/162 (30%), Positives = 85/162 (52%), Gaps = 14/162 (8%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK----VAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLV 210
+ VIG+G +G+VY G D + A+K+L Q + F E ++ + H N++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 211 RLLGYCV--EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
L+G + EG +L+ Y+ +G+L Q++ +P D+ ++ L A+G+ YL
Sbjct: 86 ALIGIMLPPEGLPHVLL-PYMCHGDLLQFIRS--PQRNPTVKDL-ISFGLQVARGMEYLA 141
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
E K VHRD+ + N +LD + +V+DFGLA+ + Y
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 49/186 (26%), Positives = 91/186 (48%), Gaps = 17/186 (9%)
Query: 159 IGEGGYGIVYRGIL-----SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V + G +VAVK+L G + K E+E++ + H+N+V+
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 213 LGYCVE--GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C E G L+ E++ +G+L ++L + ++ ++ + KG+ YL
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN---LKQQLKYAVQICKGMDYLGSR 133
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT---RVMGTFGYAHFIVQ 327
+ VHRD+ + N+L++ + ++ DFGL K + +++ T R F YA +
Sbjct: 134 ---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 328 VSPLFI 333
S +I
Sbjct: 191 QSKFYI 196
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 60.8 bits (146), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVS--PLTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 251
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 24/172 (13%)
Query: 135 LGWGRWYTLRELEAATSGLCEENVIGEGGYGIVY-------RGILSDGTKVAVKNLLNNR 187
LG R +TL + + +G+G +G VY + IL+ KV K L
Sbjct: 3 LGSKRQWTLEDFDIGRP-------LGKGKFGNVYLARERQSKFILA--LKVLFKTQLEKA 53
Query: 188 GQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
G E + + EVE+ +RH N++RL GY + L+ EY G ++ ++ +S
Sbjct: 54 G-VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT----VYRELQKLSR 108
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG 299
I A L+Y H +V+HRD+K N+LL +++DFG
Sbjct: 109 FDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFG 157
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 60.5 bits (145), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 60.5 bits (145), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKNSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDSTRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
KV+HRD+K N+LL +++DFG + S R + GT Y
Sbjct: 128 --KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---AALCGTLDY 172
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 55/165 (33%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---RHKNLVRLL- 213
+IG G YG VY+G L D VAVK A ++ + + I RV H N+ R +
Sbjct: 20 LIGRGRYGAVYKGSL-DERPVAVKVF----SFANRQNFINEKNIYRVPLMEHDNIARFIV 74
Query: 214 -GYCVEGAYRM---LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V RM LV EY NG+L ++L D W + +GLAYLH
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVTRGLAYLHT 129
Query: 270 GL------EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
L +P + HRD+ S N+L+ +SDFGL+ L R
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 29 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 89 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 141
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 142 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 19/175 (10%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+GEG YG VY+ I + G VA+K + +E E+ ++ + ++V+ G
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ +V EY G+ V D+ LT D I+ T KGL YLH
Sbjct: 95 KNTDLWIVMEYCGAGS--------VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM-- 144
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQ 327
+ +HRD+K+ NILL+ + +A+++DFG+A L + + F A ++Q
Sbjct: 145 -RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQ 198
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 47/175 (26%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-E 193
Y E E + + +G+G +G+VY G D T+VAVK + + E+ E
Sbjct: 7 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G ++V E + +G+L +L + P
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
T + + A G+AYL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 91 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 144 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 91 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 144 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
YL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
YL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 60.1 bits (144), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 90 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLAR 192
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 82 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
YL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 142 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 175
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SPLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 85 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
YL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 145 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 178
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 95 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 197
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 47/166 (28%), Positives = 82/166 (49%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ EY GNL ++L D+ V +T+ ++
Sbjct: 92 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 194
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLGY 215
V+ EGG+ VY + G + A+K LL+N + + EV + ++ H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 216 CV-------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
G L+ + G L ++L + PL+ D + I T + + ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+P ++HRD+K N+LL Q ++ DFG A
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVR 211
+G+G +G+VY G D T+VAVK + + E+ EF E V+ ++VR
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS------PLTWDIRMNIILGTAKGLA 265
LLG +G ++V E + +G+L +L + P T + + A G+A
Sbjct: 84 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
YL+ K VHRD+ + N ++ + ++ DFG+ +
Sbjct: 144 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 177
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 133
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 134 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 18 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 74
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 75 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 129
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL ++++FG + S R T + GT Y
Sbjct: 130 --RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDY 174
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 42 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 99 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 153
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 154 --RVIHRDIKPENLLLGSAGELKIADFG 179
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 18 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 74
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 75 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 129
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 130 --RVIHRDIKPENLLLGSAGELKIADFG 155
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 123
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 124 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 59.7 bits (143), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFG 153
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I ++ H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V+ G L +D T VAVK+ K +F E ++ + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E V G+ +L + + T + ++ A G+ YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL---LQMVGDAAAGMEYLESKC---CI 235
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+ + N L+ + ++SDFG+++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR 261
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 49/170 (28%), Positives = 78/170 (45%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+LL ++++FG + S R T + GT Y
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR---TTLCGTLDY 175
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFG 156
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 75 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 128 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFG 156
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 52/190 (27%), Positives = 84/190 (44%), Gaps = 46/190 (24%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNL 209
+GEG +G V + + T VAVK L N +E ++ E V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------------------HGD----- 241
++L G C + +L+ EY G+L +L H D
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+GD+ W I ++G+ YL E K+VHRD+ + NIL+ ++SDFGL+
Sbjct: 149 MGDLISFAWQI--------SQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 302 KLLCSERSYV 311
+ + E S V
Sbjct: 198 RDVYEEDSXV 207
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 59.7 bits (143), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 17 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 74 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFG 154
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 48/172 (27%), Positives = 84/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 9 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 69 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIE------LVHQVSMGMKYL 121
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ +Y + G +
Sbjct: 122 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 42/146 (28%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 159 IGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYC 216
IG G +G V+ G L +D T VAVK+ K +F E ++ + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E V G+ +L + + T + ++ A G+ YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL---LQMVGDAAAGMEYLESKC---CI 235
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAK 302
HRD+ + N L+ + ++SDFG+++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSR 261
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 16 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 72
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 73 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 128 --RVIHRDIKPENLLLGSAGELKIADFG 153
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 74/157 (47%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I ++ H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-------RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G VY + IL+ KV K L G E + + EVE+ +RH N++R
Sbjct: 19 LGKGKFGNVYLAREKQSKFILA--LKVLFKAQLEKAG-VEHQLRREVEIQSHLRHPNILR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L GY + L+ EY G ++ ++ +S I A L+Y H
Sbjct: 76 LYGYFHDATRVYLILEYAPLGT----VYRELQKLSKFDEQRTATYITELANALSYCHSK- 130
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
+V+HRD+K N+LL +++DFG
Sbjct: 131 --RVIHRDIKPENLLLGSAGELKIADFG 156
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 90 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 183
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 218
>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
pdb|3OZ6|B Chain B, Crystal Structure Of Mapk From Cryptosporidium Parvum,
Cgd2_1960
Length = 388
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 50/163 (30%), Positives = 89/163 (54%), Gaps = 23/163 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVR-HKNLVRLL 213
+G+G YGIV++ I G VAVK + + N A++ F+ E+ ++ + H+N+V LL
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLL 75
Query: 214 GYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
R LV++Y++ +L + ++ + P+ + ++ K + YLH G
Sbjct: 76 NVLRADNDRDVYLVFDYME-TDLHAVIRANI--LEPVH---KQYVVYQLIKVIKYLHSG- 128
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
++HRD+K SNILL+ + + +V+DFGL+ RS+V R
Sbjct: 129 --GLLHRDMKPSNILLNAECHVKVADFGLS------RSFVNIR 163
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 59.3 bits (142), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 98 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 58.9 bits (141), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 208
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 209
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 198
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 192
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEK-----EFKVEVEVIGRVRHKNLV 210
+ +G G +G V G G KVAVK L NR + + K E++ + RH +++
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+L +V EYV G L ++ HG V ++ + + Y H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA------RRLFQQILSAVDYCH 128
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTF 319
+ VVHRD+K N+LLD NA+++DFGL+ ++ C +Y V+
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGR 185
Query: 320 GYAHFIVQVSPLFILLYILLS 340
YA V + ++LY LL
Sbjct: 186 LYAGPEVDIWSCGVILYALLC 206
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 40/147 (27%), Positives = 79/147 (53%), Gaps = 10/147 (6%)
Query: 158 VIGE-GGYGIVYRGILSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLL-G 214
+IGE G +G VY+ + + +A +++ + + E +++ VE++++ H N+V+LL
Sbjct: 16 IIGELGDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 75
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ E +L+ E+ G +D + + PLT + T L YLH+ K
Sbjct: 76 FYYENNLWILI-EFCAGGAVDAVM---LELERPLTESQIQVVCKQTLDALNYLHDN---K 128
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLA 301
++HRD+K+ NIL + +++DFG++
Sbjct: 129 IIHRDLKAGNILFTLDGDIKLADFGVS 155
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 85/170 (50%), Gaps = 11/170 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 88 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 139
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
HR++KS NILL + +++DFG + E+S +T V + A +V
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 189
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 99 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ 192
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 28/201 (13%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEK-----EFKVEVEVIGRVRHKNLV 210
+ +G G +G V G G KVAVK L NR + + K E++ + RH +++
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKIL--NRQKIRSLDVVGKIKREIQNLKLFRHPHII 74
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+L +V EYV G L ++ HG V ++ + + Y H
Sbjct: 75 KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA------RRLFQQILSAVDYCH 128
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTF 319
+ VVHRD+K N+LLD NA+++DFGL+ ++ C +Y V+
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGR 185
Query: 320 GYAHFIVQVSPLFILLYILLS 340
YA V + ++LY LL
Sbjct: 186 LYAGPEVDIWSCGVILYALLC 206
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 58.9 bits (141), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 88 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 139
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
HRD+KS NILL + +++DFG + E+S + V + A +V
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 189
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
HRD+KS NILL + +++DFG + E+S + V + A +V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVV 188
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 42/154 (27%), Positives = 78/154 (50%), Gaps = 14/154 (9%)
Query: 159 IGEGGYGIVYRGIL----SDGTKVAVK--NLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IGEG +G + IL DG + +K N+ + +E + EV V+ ++H N+V+
Sbjct: 32 IGEGSFG---KAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
E +V +Y + G+L + ++ G + D ++ + L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKHVHDR-- 144
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
K++HRD+KS NI L + ++ DFG+A++L S
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 39/161 (24%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G+G +G VY+ + +A ++ + + E +++ VE+E++ H +V+LLG
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 218 EGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ E+ G +D L D G P + ++ + L +LH +++
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RII 131
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTT 313
HRD+K+ N+L+ + + R++DFG++ K L S++ T
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 172
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 39/161 (24%), Positives = 81/161 (50%), Gaps = 13/161 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G+G +G VY+ + +A ++ + + E +++ VE+E++ H +V+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 218 EGAYRMLVYEYVDNGNLDQ-WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ E+ G +D L D G P + ++ + L +LH +++
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---RII 139
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA----KLLCSERSYVTT 313
HRD+K+ N+L+ + + R++DFG++ K L S++ T
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGT 180
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 46/157 (29%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 159 IGEGGYGIVYRGILS------DGTKVAVKNLLN-NRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G +G VY G +S +VAVK L Q E +F +E +I + H+N+VR
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL---HGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+G ++ R ++ E + G+L +L S L +++ A G YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVS---DFGLAK 302
E +HRD+ + N LL RV+ DFG+A+
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 206
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 58.5 bits (140), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 84/170 (49%), Gaps = 11/170 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IG+G G VY + ++ G +VA++ + N + Q +KE + E+ V+ ++ N+V L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G +V EY+ G+L + D + R + + L +LH +V+
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHSN---QVI 138
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
HRD+KS NILL + +++DFG + E+S + V + A +V
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVV 188
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ Y GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 48/174 (27%), Positives = 87/174 (50%), Gaps = 12/174 (6%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + +V A+K + L ++ + E+ V+ + + + G
Sbjct: 31 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSY 90
Query: 217 VEGAYRMLVYEYVDNGN-LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++G+ ++ EY+ G+ LD G + T ++ KGL YLH K
Sbjct: 91 LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIAT------MLKEILKGLDYLHS---EKK 141
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
+HRD+K++N+LL Q + +++DFG+A L + T V F A ++Q S
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS 195
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 18 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 77 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 130
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLAR 158
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 58.2 bits (139), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-E 193
Y E E + + +G+G +G+VY G D T+VAVK + + E+ E
Sbjct: 7 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 66
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G ++V E + +G+L +L + P
Sbjct: 67 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
T + + A G+AYL+ K VHR++ + N ++ + ++ DFG+ +
Sbjct: 127 PTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 178
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 58.2 bits (139), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLAR 150
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLAR 153
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/183 (27%), Positives = 84/183 (45%), Gaps = 30/183 (16%)
Query: 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
E +IG GG+G V++ DG +K + N +AE+E V+ + ++ H N+V
Sbjct: 15 EIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVHYN 70
Query: 214 G------YCVEGAYR----------MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNII 257
G Y E + + + E+ D G L+QW+ G+ L + + +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLALELF 128
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE----RSYVTT 313
KG+ Y+H K+++RD+K SNI L ++ DFGL L ++ RS T
Sbjct: 129 EQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTL 185
Query: 314 RVM 316
R M
Sbjct: 186 RYM 188
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLAR 150
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 18 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 76
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 77 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 130
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLAR 158
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 81 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 132
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTFGYAHF 324
K+VHRD+K N+LLD N +++DFGL+ ++ C +Y V+ YA
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 325 IVQVSPLFILLYILLSVR 342
V V ++LY++L R
Sbjct: 193 EVDVWSCGVILYVMLCRR 210
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 16/175 (9%)
Query: 141 YTLRELEAATSGLCEENVIGEGGYGIVYRGILSD------GTKVAVKNLLNNRGQAEK-E 193
Y E E + + +G+G +G+VY G D T+VAVK + + E+ E
Sbjct: 8 YVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE 67
Query: 194 FKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV------SP 247
F E V+ ++VRLLG +G ++V E + +G+L +L + P
Sbjct: 68 FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
T + + A G+AYL+ K VHR++ + N ++ + ++ DFG+ +
Sbjct: 128 PTLQEMIQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR 179
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLAR 153
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLAR 150
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLAR 152
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 57.8 bits (138), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 51/168 (30%), Positives = 81/168 (48%), Gaps = 11/168 (6%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRH-KNLVRLLGY 215
IG G YG V + + G +AVK + + + E K+ ++++V+ R +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 216 CVEGAYRMLVYEYVDNG--NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ E + ++++ + DV P +I I L T K L +L E L
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIP--EEILGKITLATVKALNHLKENL-- 145
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
K++HRD+K SNILLDR N ++ DFG++ L S TR G Y
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD--SIAKTRDAGCRPY 191
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLAR 154
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLAR 153
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLAR 150
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 15 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 74 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 127
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLAR 155
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLAR 152
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 15 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 73
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 74 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 127
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLAR 155
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLAR 154
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 79
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 80 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 131
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTFGYAHF 324
K+VHRD+K N+LLD N +++DFGL+ ++ C +Y V+ YA
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 325 IVQVSPLFILLYILLSVR 342
V V ++LY++L R
Sbjct: 192 EVDVWSCGVILYVMLCRR 209
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLAR 152
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLAR 152
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLAR 154
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 57.8 bits (138), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ L G E + + E+E+ +RH N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMY 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + L+ E+ G L + L HG + T+ + A L Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
KV+HRD+K N+L+ + +++DFG
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFG 159
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 77/164 (46%), Gaps = 20/164 (12%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGYC 216
IG+G YG V+ G G KVAVK E + E E+ V RH+N++ +
Sbjct: 45 IGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 217 VEGA----YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL- 271
++G L+ +Y +NG+L +L D + + + + GL +LH +
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSM-----LKLAYSSVSGLCHLHTEIF 155
Query: 272 ----EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
+P + HRD+KS NIL+ + ++D GLA S+ + V
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEV 199
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 70
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 71 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 122
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTFGYAHF 324
K+VHRD+K N+LLD N +++DFGL+ ++ C +Y V+ YA
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 325 IVQVSPLFILLYILLSVR 342
V V ++LY++L R
Sbjct: 183 EVDVWSCGVILYVMLCRR 200
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 45/156 (28%), Positives = 75/156 (48%), Gaps = 24/156 (15%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 63 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 122
Query: 235 DQWLHG-------------------DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+L D D PL ++ A+G+A+L
Sbjct: 123 LNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NC 179
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
+HRDV + N+LL A++ DFGLA+ + ++ +Y+
Sbjct: 180 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ L G E + + E+E+ +RH N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMY 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + L+ E+ G L + L HG + T+ + A L Y HE
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 133
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
KV+HRD+K N+L+ + +++DFG
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFG 159
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 81/148 (54%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E+V + +L ++ D ++ + + + + +GLA+ H +
Sbjct: 69 VIHTENKLYLVFEHV-HQDLKTFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 122
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLAR 150
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 57.8 bits (138), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 49/153 (32%), Positives = 79/153 (51%), Gaps = 18/153 (11%)
Query: 159 IGEGGYGIV---YRGILSDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L + G Q +K E++++ + H+++++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 213 LGYCVEG--AYRMLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C + A LV EYV G+L +L +G L + ++ +G+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA 152
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+ + N+LLD ++ DFGLAK
Sbjct: 153 Q---HYIHRDLAARNVLLDNDRLVKIGDFGLAK 182
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 12 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 70
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 71 VIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 124
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLAR 152
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 46/190 (24%)
Query: 157 NVIGEGGYGIVYRGIL------SDGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNL 209
+GEG +G V + + T VAVK L N +E ++ E V+ +V H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWL-----------------------HGD----- 241
++L G C + +L+ EY G+L +L H D
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+GD+ W I ++G+ YL E +VHRD+ + NIL+ ++SDFGL+
Sbjct: 149 MGDLISFAWQI--------SQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 302 KLLCSERSYV 311
+ + E S V
Sbjct: 198 RDVYEEDSXV 207
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 88/198 (44%), Gaps = 23/198 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFK----VEVEVIGRVRHKNLVRLL 213
+GEG +G V + G KVA+K ++N + A+ + + E+ + +RH ++++L
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALK-IINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY 74
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
++V EY N D + D ++ + Y H
Sbjct: 75 DVIKSKDEIIMVIEYAGNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRH--- 126
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTFGYAHF 324
K+VHRD+K N+LLD N +++DFGL+ ++ C +Y V+ YA
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 325 IVQVSPLFILLYILLSVR 342
V V ++LY++L R
Sbjct: 187 EVDVWSCGVILYVMLCRR 204
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ L G E + + E+E+ +RH N++R+
Sbjct: 23 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEG-VEHQLRREIEIQSHLRHPNILRMY 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
Y + L+ E+ G L + L HG + T+ + A L Y HE
Sbjct: 82 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF------MEELADALHYCHER- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
KV+HRD+K N+L+ + +++DFG
Sbjct: 135 --KVIHRDIKPENLLMGYKGELKIADFG 160
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 17/148 (11%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLHGD-----------VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
+L + + + T D+ ++ A+G+A+L +HRDV +
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDL-LHFSSQVAQGMAFL---ASKNCIHRDVAAR 193
Query: 284 NILLDRQWNARVSDFGLAKLLCSERSYV 311
N+LL A++ DFGLA+ + ++ +Y+
Sbjct: 194 NVLLTNGHVAKIGDFGLARDIMNDSNYI 221
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLAR 154
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 43/146 (29%), Positives = 75/146 (51%), Gaps = 12/146 (8%)
Query: 159 IGEGGYGIVYRGILSDGTK--VAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG+G +G VY+GI + TK VA+K + L ++ + E+ V+ + + R G
Sbjct: 27 IGKGSFGEVYKGI-DNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGS 85
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
++ ++ EY+ G+ D+ PL I+ KGL YLH +
Sbjct: 86 YLKSTKLWIIMEYLGGGSA-----LDLLKPGPLEETYIATILREILKGLDYLHSE---RK 137
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLA 301
+HRD+K++N+LL Q + +++DFG+A
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVA 163
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 25/172 (14%)
Query: 151 SGLCEENV-------IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV--EVE 199
GLC + IGEG YG V+ R + + G VA+K + G+ EV
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 200 VIGRVR---HKNLVRLLGYCV-----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
V+ + H N+VRL C LV+E+VD +L +L V + T
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTET 121
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
I+ +++ +GL +LH +VVHRD+K NIL+ +++DFGLA++
Sbjct: 122 IK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 169
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 46/166 (27%), Positives = 81/166 (48%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDGTK----VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V GI D K VAVK L ++ + + + E+E++ + +HKN
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG----------DVGDVSP--LTWDIRMNI 256
++ LLG C + ++ Y GNL ++L D+ V +T+ ++
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR 205
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 132
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G F YA
Sbjct: 133 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 185
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L +++ N
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 57.4 bits (137), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 81/148 (54%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L ++ D ++ + + + + +GLA+ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLAR 151
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 79/148 (53%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 13 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ ++D D ++ + + + + +GLA+ H +
Sbjct: 72 VIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 125
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLAR 153
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 133
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G F YA
Sbjct: 134 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 186
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 24/198 (12%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEK-----EFKVEVEVIGRVRHKNLV 210
+ +G G +G V G G KVAVK L NR + + + E++ + RH +++
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKIL--NRQKIRSLDVVGKIRREIQNLKLFRHPHII 79
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+L + +V EYV G L ++ + L + G+ Y H
Sbjct: 80 KLYQVISTPSDIFMVMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH 135
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTFGY 321
+ VVHRD+K N+LLD NA+++DFGL+ ++ C +Y V+ Y
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192
Query: 322 AHFIVQVSPLFILLYILL 339
A V + ++LY LL
Sbjct: 193 AGPEVDIWSSGVILYALL 210
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 81/148 (54%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 14 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L ++ D ++ + + + + +GLA+ H +
Sbjct: 73 VIHTENKLYLVFEFL-HQDLKTFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---R 126
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLAR 154
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 57.0 bits (136), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 25/172 (14%)
Query: 151 SGLCEENV-------IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV- 200
GLC + IGEG YG V+ R + + G VA+K + G+ EV
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 201 ----IGRVRHKNLVRLLGYCV-----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
+ H N+VRL C LV+E+VD +L +L V + T
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTET 121
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
I+ +++ +GL +LH +VVHRD+K NIL+ +++DFGLA++
Sbjct: 122 IK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 169
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 57.0 bits (136), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/176 (29%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 145
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ Y R G F YA
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 50/181 (27%), Positives = 85/181 (46%), Gaps = 30/181 (16%)
Query: 158 VIGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
V+G G +G V GI G +VAVK L +E+E E++++ ++ H+N+
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG-------------------DVGDVSPLTW 250
V LLG C L++EY G+L +L + D++ LT+
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
+ + AKG+ +L VHRD+ + N+L+ ++ DFGLA+ + S+ +Y
Sbjct: 172 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 311 V 311
V
Sbjct: 229 V 229
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 41/148 (27%), Positives = 82/148 (55%), Gaps = 11/148 (7%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IGEG YG+VY R L+ G VA+K + L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLT-GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 69
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
LV+E++ + +L +++ D ++ + + + + +GL++ H +
Sbjct: 70 VIHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLSFCHSH---R 123
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK 302
V+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L +++ N
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 239
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L +++ N
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 145 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 187
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L +++ N
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L +++ N
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 149 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 191
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 25/172 (14%)
Query: 151 SGLCEENV-------IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV- 200
GLC + IGEG YG V+ R + + G VA+K + G+ EV
Sbjct: 4 DGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVA 63
Query: 201 ----IGRVRHKNLVRLLGYCV-----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
+ H N+VRL C LV+E+VD +L +L V + T
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL-DKVPEPGVPTET 121
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
I+ +++ +GL +LH +VVHRD+K NIL+ +++DFGLA++
Sbjct: 122 IK-DMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 169
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 44/147 (29%), Positives = 76/147 (51%), Gaps = 15/147 (10%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLH--GDVGDVSP--------LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSN 284
+L V + P L+ ++ A+G+A+L +HRDV + N
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARN 194
Query: 285 ILLDRQWNARVSDFGLAKLLCSERSYV 311
+LL A++ DFGLA+ + ++ +Y+
Sbjct: 195 VLLTNGHVAKIGDFGLARDIMNDSNYI 221
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L +++ N
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L +++ N
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 148 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 190
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/172 (27%), Positives = 83/172 (48%), Gaps = 17/172 (9%)
Query: 155 EENVIGEGGYGIVYRGI--LSDGTKVAVKNLLNNRGQA---EKEFKVEVEVIGRVRHKNL 209
E+ +G G +G V +G + K +L N + E E V+ ++ + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDIRMNIILGTAKGLAYL 267
VR++G C E MLV E + G L+++L + V D + + ++ + G+ YL
Sbjct: 75 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII------ELVHQVSMGMKYL 127
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
E VHRD+ + N+LL Q A++SDFGL+K L ++ + + G +
Sbjct: 128 EES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/147 (26%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
IGEG YG+VY R L+ K L+ + + E+ ++ + H N+V+LL
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+E++ + +L +++ D ++ + + + + +GLA+ H +V
Sbjct: 71 IHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 124
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+K N+L++ + +++DFGLA+
Sbjct: 125 LHRDLKPQNLLINTEGAIKLADFGLAR 151
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 39/147 (26%), Positives = 77/147 (52%), Gaps = 9/147 (6%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGY 215
IGEG YG+VY R L+ K L+ + + E+ ++ + H N+V+LL
Sbjct: 10 IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
LV+E++ + +L +++ D ++ + + + + +GLA+ H +V
Sbjct: 70 IHTENKLYLVFEFL-HQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RV 123
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAK 302
+HRD+K N+L++ + +++DFGLA+
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLAR 150
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 56.6 bits (135), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/186 (31%), Positives = 88/186 (47%), Gaps = 36/186 (19%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV + +L G VAVK L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q +H ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELDHE-------RMSYLLYQMLCGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR------VM 316
+LH ++HRD+K SNI++ ++ DFGLA+ C+ YV TR V+
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 317 GTFGYA 322
GYA
Sbjct: 198 LGMGYA 203
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 21/176 (11%)
Query: 159 IGEGGYGIV---YRGILSDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L + G Q +K E++++ + H+++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C + + LV EYV G+L +L +G L + ++ +G+AYLH
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CEGMAYLHS 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYA 322
+HR++ + N+LLD ++ DFGLAK + Y R G F YA
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 47/165 (28%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ L V EY + G+L + + L + + ++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 273 --PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
V+HRD+K +N+ LD + N ++ DFGLA++L + S+ T V
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV 177
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 56.2 bits (134), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 32/193 (16%)
Query: 120 TASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVA 179
+ + GSGS P + R TL E +G+G YG V+RG G VA
Sbjct: 18 SCTSGSGSGLPFLVQRTVARQITLLE------------CVGKGRYGEVWRGSWQ-GENVA 64
Query: 180 VKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGYCVEGAYR----MLVYEYVDNGN 233
VK + ++R EK + E E+ V RH+N++ + + + L+ Y + G+
Sbjct: 65 VK-IFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 121
Query: 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL-----EPKVVHRDVKSSNILLD 288
L +L D + I+L A GLA+LH + +P + HRD+KS NIL+
Sbjct: 122 LYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 176
Query: 289 RQWNARVSDFGLA 301
+ ++D GLA
Sbjct: 177 KNGQCCIADLGLA 189
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVYR----GILSDGTK--VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP--------LTWDIRMNIILGTA 261
LLG C + G M++ E+ GNL +L + P LT + + A
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
KG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYV 201
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 21/176 (11%)
Query: 159 IGEGGYGIV---YRGILSDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L + G Q +K E++++ + H+++++
Sbjct: 22 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWL-HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G C + + LV EYV G+L +L +G L + ++ +G+AYLH
Sbjct: 82 KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQI------CEGMAYLHA 135
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYA 322
+HR++ + N+LLD ++ DFGLAK + Y R G F YA
Sbjct: 136 Q---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 188
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGY 215
+G+G YG V+RG G VAVK + ++R EK + E E+ V RH+N++ +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVK-IFSSRD--EKSWFRETELYNTVMLRHENILGFIAS 70
Query: 216 CVEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + L+ Y + G+L +L D + I+L A GLA+LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEI 125
Query: 272 -----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+P + HRD+KS NIL+ + ++D GLA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L ++ N
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 141 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 183
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 56.2 bits (134), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 159 IGEGGYGIVYR----GILSDG----TKVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKN 208
+GEG +G V G+ D TKVAVK L ++ + + + E+E++ + +HKN
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------------I 256
++ LLG C + ++ EY GNL ++L ++ N
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
A+G+ YL K +HRD+ + N+L+ +++DFGLA+
Sbjct: 156 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR 198
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 20/170 (11%)
Query: 159 IGEGGYGIVYR----GILSDGTK--VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP--------LTWDIRMNIILGTA 261
LLG C + G M++ E+ GNL +L + P LT + + A
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 262 KGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
KG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 155 KGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 201
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 20/155 (12%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGY 215
+G+G YG V+RG G VAVK + ++R EK + E E+ V RH+N++ +
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVK-IFSSRD--EKSWFRETELYNTVMLRHENILGFIAS 70
Query: 216 CVEGAYR----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + L+ Y + G+L +L D + I+L A GLA+LH +
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSC-----LRIVLSIASGLAHLHIEI 125
Query: 272 -----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+P + HRD+KS NIL+ + ++D GLA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL---- 212
+G GG+G V R I D G +VA+K +E + +E++++ ++ H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 213 --LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L EY + G+L ++L+ IR ++ + L YLHE
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 140
Query: 271 LEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+++HRD+K NI+L ++ ++ D G AK L ++ + T +GT Y
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQY 189
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 55.8 bits (133), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 47/174 (27%), Positives = 83/174 (47%), Gaps = 17/174 (9%)
Query: 159 IGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL---- 212
+G GG+G V R I D G +VA+K +E + +E++++ ++ H N+V
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 82
Query: 213 --LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L EY + G+L ++L+ IR ++ + L YLHE
Sbjct: 83 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISSALRYLHEN 141
Query: 271 LEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+++HRD+K NI+L ++ ++ D G AK L ++ + T +GT Y
Sbjct: 142 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQY 190
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 28/161 (17%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+ IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 14 QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 68
Query: 216 CVEGAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLA 265
+ + DNG Q WL HG + D +T + + + L TA GLA
Sbjct: 69 --------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 120
Query: 266 YLHEGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+LH + +P + HRD+KS NIL+ + ++D GLA
Sbjct: 121 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 28/158 (17%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 11 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 62
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 63 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 117
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ +P + HRD+KS NIL+ + ++D GLA
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 83/198 (41%), Gaps = 43/198 (21%)
Query: 155 EENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
E +IG GG+G V++ DG ++ + N +AE+E V+ + ++ H N+V
Sbjct: 16 EIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYN 71
Query: 214 GYCVEG------------------------------AYRMLVYEYVDNGNLDQWLHGDVG 243
G C +G + E+ D G L+QW+ G
Sbjct: 72 G-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 244 DVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
+ L + + + KG+ Y+H K++HRD+K SNI L ++ DFGL
Sbjct: 131 E--KLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 304 LCSERSYVTTRVMGTFGY 321
L ++ TR GT Y
Sbjct: 186 LKNDGK--RTRSKGTLRY 201
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 55.5 bits (132), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 50/158 (31%), Positives = 80/158 (50%), Gaps = 28/158 (17%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 12 IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF--- 63
Query: 219 GAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLAYLH 268
+ + DNG Q WL HG + D +T + + + L TA GLA+LH
Sbjct: 64 -----IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLH 118
Query: 269 EGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+ +P + HRD+KS NIL+ + ++D GLA
Sbjct: 119 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 28/161 (17%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+ IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 11 QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 65
Query: 216 CVEGAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLA 265
+ + DNG Q WL HG + D +T + + + L TA GLA
Sbjct: 66 --------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 117
Query: 266 YLHEGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+LH + +P + HRD+KS NIL+ + ++D GLA
Sbjct: 118 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 28/161 (17%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+ IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 34 QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 88
Query: 216 CVEGAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLA 265
+ + DNG Q WL HG + D +T + + + L TA GLA
Sbjct: 89 --------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 140
Query: 266 YLHEGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+LH + +P + HRD+KS NIL+ + ++D GLA
Sbjct: 141 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 159 IGEGGYGIV---YRGILSDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L G Q ++ E+E++ + H+++V+
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C + + LV EYV G+L +L ++ L + +G+AYLH
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYA 322
+HR + + N+LLD ++ DFGLAK + Y R G F YA
Sbjct: 131 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 182
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 40/154 (25%), Positives = 73/154 (47%), Gaps = 12/154 (7%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHKNLVRLLGYC 216
++G G YG VY+G ++A +++ G E+E K E+ ++ + H+N+ G
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 217 VE------GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
++ LV E+ G++ + G+ W I +GL++LH+
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW--IAYICREILRGLSHLHQH 148
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
KV+HRD+K N+LL ++ DFG++ L
Sbjct: 149 ---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 179
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 55.5 bits (132), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 28/161 (17%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+ IG+G +G V+RG G +VAVK + ++R + + E+ +RH+N+ LG+
Sbjct: 47 QESIGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENI---LGF 101
Query: 216 CVEGAYRMLVYEYVDNGNLDQ-WL------HGDVGDV---SPLTWDIRMNIILGTAKGLA 265
+ + DNG Q WL HG + D +T + + + L TA GLA
Sbjct: 102 --------IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLA 153
Query: 266 YLHEGL-----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+LH + +P + HRD+KS NIL+ + ++D GLA
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 192 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 242
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 103 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 157
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 158 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 216
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 217 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 53/175 (30%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 159 IGEGGYGIV---YRGILSDGT--KVAVKNLLNNRG-QAEKEFKVEVEVIGRVRHKNLVRL 212
+GEG +G V +DGT VAVK L G Q ++ E+E++ + H+++V+
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 213 LGYCVEGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G C + + LV EYV G+L +L ++ L + +G+AYLH
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ 131
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMG---TFGYA 322
+HR + + N+LLD ++ DFGLAK + Y R G F YA
Sbjct: 132 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 183
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 52 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 106
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 107 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 165
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 166 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 214
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 55.1 bits (131), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 62 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 116
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLH-GDVGDVSPLTWDIRMNIILGTAKGLA 265
G + Y LV +YV H P+ + +++ + + LA
Sbjct: 117 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKL-YMYQLFRSLA 174
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
Y+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 175 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 224
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 60 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 114
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 115 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 173
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 174 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 222
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 29 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 83
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 84 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 142
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 143 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 191
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 52/173 (30%), Positives = 83/173 (47%), Gaps = 23/173 (13%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 112
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLH-GDVGDVSPLTWDIRMNIILGTAKGLA 265
G + Y LV +YV H P+ + +++ + + LA
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKL-YMYQLFRSLA 170
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
Y+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 220
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 157 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 207
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 37 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 91
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 92 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 150
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 151 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 199
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 21/172 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
+H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 15 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 75 LKDTKLWIIMEYLGGGS-----ALDLLEPGPLDETQIATILREILKGLDYLHSE---KKI 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
HRD+K++N+LL +++DFG+A L + T V F A +++ S
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 179
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 55.1 bits (131), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/174 (28%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 196
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 49/160 (30%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 58 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 112
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLH-GDVGDVSPLTWDIRMNIILGTAKGLA 265
G + Y LV +YV H P+ + +++ + + LA
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY-VKL-YMYQLFRSLA 170
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
Y+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 171 YIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 17/150 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRLL 213
+GEG YG+VY+ S G VA+K + R AE E E+ ++ + H N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLAYLHEGLE 272
LV+E+++ +L + L + + D ++ I L +G+A+ H+
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH-- 138
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+++HRD+K N+L++ +++DFGLA+
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLAR 167
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 46/173 (26%), Positives = 83/173 (47%), Gaps = 10/173 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 35 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 95 LKDTKLWIIMEYLGGGS-----ALDLLEPGPLDETQIATILREILKGLDYLHSE---KKI 146
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
HRD+K++N+LL +++DFG+A L + T V F A +++ S
Sbjct: 147 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS 199
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 78/159 (49%), Gaps = 21/159 (13%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRLLGYC 216
VIG G +G+V++ L + +VA+K +L +K FK E++++ V+H N+V L +
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 217 V------EGAYRMLVYEYVDNGNLDQWLH-GDVGDVSP-LTWDIRMNIILGTAKGLAYLH 268
+ + LV EYV H + P L + M +L + LAY+H
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYIH 158
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCS 306
+ HRD+K N+LLD ++ DFG AK+L +
Sbjct: 159 SI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 79/150 (52%), Gaps = 17/150 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRLL 213
+GEG YG+VY+ S G VA+K + R AE E E+ ++ + H N+V L+
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRI---RLDAEDEGIPSTAIREISLLKELHHPNIVSLI 85
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLAYLHEGLE 272
LV+E+++ +L + L + + D ++ I L +G+A+ H+
Sbjct: 86 DVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQ----DSQIKIYLYQLLRGVAHCHQH-- 138
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+++HRD+K N+L++ +++DFGLA+
Sbjct: 139 -RILHRDLKPQNLLINSDGALKLADFGLAR 167
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 54.7 bits (130), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 43 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 97
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 98 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 156
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 157 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 36 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 90
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 91 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 149
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 150 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 36 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 90
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 91 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 149
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 150 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 32 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 86
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 87 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 145
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 146 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 54.7 bits (130), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 25 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 79
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 80 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 138
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 139 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 28 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 82
Query: 213 L------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
G + Y LV +YV H + +++ + + LAY
Sbjct: 83 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 141
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 142 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ G+ EV ++ R+ H N+VRL
Sbjct: 12 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ C LV+E+VD +L +L D L + +++ +GL +L
Sbjct: 72 MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
H +VHRD+K NIL+ +++DFGLA++
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 46/165 (27%), Positives = 78/165 (47%), Gaps = 7/165 (4%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ L V EY + G+L + + L + + ++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 273 --PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRV 315
V+HRD+K +N+ LD + N ++ DFGLA++L + S+ V
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV 177
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L D G VA+K +L + + E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLR 79
Query: 214 ------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
G + Y LV +YV H + +++ + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 28/198 (14%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 49 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 105
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 106 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 160
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+ L+ ++ DFGLA K+LC +Y+ V+ G+
Sbjct: 161 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 322 AHFIVQVSPLFILLYILL 339
+ F V V + ++Y LL
Sbjct: 219 S-FEVDVWSIGCIMYTLL 235
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ G+ EV ++ R+ H N+VRL
Sbjct: 12 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ C LV+E+VD +L +L D L + +++ +GL +L
Sbjct: 72 MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
H +VHRD+K NIL+ +++DFGLA++
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 48/171 (28%), Positives = 79/171 (46%), Gaps = 19/171 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L D G VA+K +L + + E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLR 79
Query: 214 ------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
G + Y LV +YV H + +++ + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLLC---SERSYVTTR 314
H + HRD+K N+LLD ++ DFG AK L SY+ +R
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 186
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 28/198 (14%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 23 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 80 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 134
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+ L+ ++ DFGLA K+LC +Y+ V+ G+
Sbjct: 135 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 322 AHFIVQVSPLFILLYILL 339
+ F V V + ++Y LL
Sbjct: 193 S-FEVDVWSIGCIMYTLL 209
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 54.3 bits (129), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 87/198 (43%), Gaps = 28/198 (14%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 47 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 103
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 104 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 158
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+ L+ ++ DFGLA K+LC +Y+ V+ G+
Sbjct: 159 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 322 AHFIVQVSPLFILLYILL 339
+ F V V + ++Y LL
Sbjct: 217 S-FEVDVWSIGCIMYTLL 233
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 17/156 (10%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFKV--EVEVIGRVR---HKNLVRL 212
IG G YG VY+ G VA+K++ G+ EV ++ R+ H N+VRL
Sbjct: 12 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRL 71
Query: 213 LGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+ C LV+E+VD +L +L D L + +++ +GL +L
Sbjct: 72 MDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGLDFL 128
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
H +VHRD+K NIL+ +++DFGLA++
Sbjct: 129 HANC---IVHRDLKPENILVTSGGTVKLADFGLARI 161
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 42/159 (26%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G GG+G+V+ D A+K + L NR A ++ EV+ + ++ H +VR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70
Query: 215 YCVEG------------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
+E Y + + NL W++G + + ++I L A+
Sbjct: 71 AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAE 129
Query: 263 GLAYLH-EGLEPKVVHRDVKSSNILLDRQWNARVSDFGL 300
+ +LH +GL +HRD+K SNI +V DFGL
Sbjct: 130 AVEFLHSKGL----MHRDLKPSNIFFTMDDVVKVGDFGL 164
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/181 (31%), Positives = 88/181 (48%), Gaps = 24/181 (13%)
Query: 152 GLCEENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNL 209
C ++V+G G G IVYRG+ D VAVK +L A++E ++ E H N+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILPECFSFADREVQLLRE---SDEHPNV 80
Query: 210 VRLLGYCVEGAYRMLVYEYVD--NGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+R +C E R Y ++ L +++ + D + L + + ++ T GLA+L
Sbjct: 81 IRY--FCTEKD-RQFQYIAIELCAATLQEYV--EQKDFAHLGLE-PITLLQQTTSGLAHL 134
Query: 268 HEGLEPKVVHRDVKSSNILLDR-----QWNARVSDFGLAKLLCSERSYVTTR--VMGTFG 320
H +VHRD+K NIL+ + A +SDFGL K L R + R V GT G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 321 Y 321
+
Sbjct: 192 W 192
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 18/159 (11%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFK-VEVEVIGRVRHKNLVRL 212
+ VIG G +G+VY+ L D G VA+K +L +K FK E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRL 78
Query: 213 LGYCVEG------AYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ Y LV +YV H + +++ + + LAY
Sbjct: 79 RYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAY 137
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
+H + HRD+K N+LLD ++ DFG AK L
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 48/168 (28%), Positives = 89/168 (52%), Gaps = 17/168 (10%)
Query: 157 NVIGEGGYGIVYRGILSDGTK-VAVKNL-LNNRGQAEKEFKV----EVEVIGRVRHKNLV 210
+ +GEG + VY+ + + VA+K + L +R +A+ E++++ + H N++
Sbjct: 16 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LL + LV+++++ +L+ + + ++P M L T +GL YLH+
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM---LMTLQGLEYLHQH 131
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS-ERSY---VTTR 314
++HRD+K +N+LLD +++DFGLAK S R+Y V TR
Sbjct: 132 W---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTR 176
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 54.3 bits (129), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
IG G +G VY + + VA+K + + Q+ ++++ EV + ++RH N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLHE 269
+ LV EY G D+ PL + G +GLAYLH
Sbjct: 122 CYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++HRDVK+ NILL ++ DFG A ++ +V T
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 213
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 159 IGEGGYG---IVYRGILSD--GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G + L D G VAVK L ++ +++F+ E++++ + +V+
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 214 G--YCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G Y LV EY+ +G L +L H D S L + KG+ YL
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRL-----LLYSSQICKGMEYLGS 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGT---FGYA 322
+ VHRD+ + NIL++ + + +++DFGLAKLL ++ R G F YA
Sbjct: 130 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA 182
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 28/198 (14%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 29 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 85
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 86 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+ L+ ++ DFGLA K LC +Y+ V+ G+
Sbjct: 141 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 322 AHFIVQVSPLFILLYILL 339
+ F V V + ++Y LL
Sbjct: 199 S-FEVDVWSIGCIMYTLL 215
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 17/149 (11%)
Query: 177 KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNLVRLLGYCVEGAYRMLVYEYVDNGNL 234
KVAVK L + EKE E++++ + +H+N+V LLG C G +++ EY G+L
Sbjct: 78 KVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137
Query: 235 DQWLH-----GDVGDVSP-------LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
+L G +P L+ ++ A+G+A+L +HRDV +
Sbjct: 138 LNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 194
Query: 283 SNILLDRQWNARVSDFGLAKLLCSERSYV 311
N+LL A++ DFGLA+ + ++ +Y+
Sbjct: 195 RNVLLTNGHVAKIGDFGLARDIMNDSNYI 223
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V + G K+AVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 59 VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 118 VFTPATS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 173
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 174 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 215
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 21/164 (12%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLG 214
IG G +G VY + + VA+K + + Q+ ++++ EV + ++RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV-----SPLTWDIRMNIILGTAKGLAYLHE 269
+ LV EY G D+ PL + G +GLAYLH
Sbjct: 83 CYLREHTAWLVMEYC---------LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTT 313
++HRDVK+ NILL ++ DFG A ++ +V T
Sbjct: 134 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 53.9 bits (128), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 28/198 (14%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 25 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 81
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 82 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+ L+ ++ DFGLA K LC +Y+ V+ G+
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 322 AHFIVQVSPLFILLYILL 339
+ F V V + ++Y LL
Sbjct: 195 S-FEVDVWSIGCIMYTLL 211
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 50/198 (25%), Positives = 86/198 (43%), Gaps = 28/198 (14%)
Query: 159 IGEGGYGIVYRGILSDGT-------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+GG+ + +SD K+ K+LL Q EK +E+ + + H+++V
Sbjct: 25 LGKGGFAKCFE--ISDADTKEVFAGKIVPKSLLLKPHQREK-MSMEISIHRSLAHQHVVG 81
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
G+ + + +V E +L + P I+LG YLH
Sbjct: 82 FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YLHRN- 136
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGY 321
+V+HRD+K N+ L+ ++ DFGLA K LC +Y+ V+ G+
Sbjct: 137 --RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 322 AHFIVQVSPLFILLYILL 339
+ F V V + ++Y LL
Sbjct: 195 S-FEVDVWSIGCIMYTLL 211
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/175 (27%), Positives = 77/175 (44%), Gaps = 25/175 (14%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + RMN + L + L+ LH
Sbjct: 219 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 266
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
V+HRD+KS +ILL ++SDFG C++ S R G +++
Sbjct: 267 --GVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWMA 315
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 37/213 (17%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRH 206
LCE VIG+G + +V R I + G + AVK ++ G + ++ K E + ++H
Sbjct: 28 LCE--VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNL--DQWLHGDVGDV-SPLTWDIRMNIILGTAKG 263
++V LL +V+E++D +L + D G V S M IL +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EA 142
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFG 320
L Y H+ ++HRDVK N+LL + N+ ++ DFG+A L E V G G
Sbjct: 143 LRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAG---GRVG 195
Query: 321 YAHFI-------------VQVSPLFILLYILLS 340
HF+ V V ++L+ILLS
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 39/205 (19%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 21 TIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK------GL 264
LV EY G + +L HG RM AK +
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RMKEKEARAKFRQIVSAV 126
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRV 315
Y H+ +VHRD+K+ N+LLD N +++DFG + C Y +
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 316 MGTFGYAHFIVQVSPLFILLYILLS 340
Y V V L ++LY L+S
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVS 208
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 39/205 (19%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 21 TIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK------GL 264
LV EY G + +L HG RM AK +
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RMKEKEARAKFRQIVSAV 126
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRV 315
Y H+ +VHRD+K+ N+LLD N +++DFG + C Y +
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 316 MGTFGYAHFIVQVSPLFILLYILLS 340
Y V V L ++LY L+S
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVS 208
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV G +VAVK + + Q + EV ++ H N+V + +
Sbjct: 53 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
G +V E+++ G L D+ + + + + L + L+YLH V+H
Sbjct: 113 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 164
Query: 278 RDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
RD+KS +ILL ++SDFG + E
Sbjct: 165 RDIKSDSILLTSDGRIKLSDFGFCAQVSKE 194
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 16/158 (10%)
Query: 155 EENVIGEGGYGIVYRGILSD-GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +G+VY+ L D G VA+K +L + + E++++ ++ H N+VRL
Sbjct: 24 DTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR----ELQIMRKLDHCNIVRLR 79
Query: 214 ------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
G + Y LV +YV H + +++ + + LAY+
Sbjct: 80 YFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYI 138
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNA-RVSDFGLAKLL 304
H + HRD+K N+LLD ++ DFG AK L
Sbjct: 139 HSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + + RMN + L + L+ LH
Sbjct: 88 VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 135
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
V+HRD+KS +ILL ++SDFG + E
Sbjct: 136 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 169
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 25/174 (14%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + + RMN + L + L+ LH
Sbjct: 99 VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
V+HRD+KS +ILL ++SDFG C++ S R G +++
Sbjct: 147 --GVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWM 194
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + + RMN + L + L+ LH
Sbjct: 92 VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 139
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
V+HRD+KS +ILL ++SDFG + E
Sbjct: 140 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 173
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 53.5 bits (127), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 21/156 (13%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + + RMN + L + L+ LH
Sbjct: 97 VGDELWVVMEFLEGGAL-----------TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
V+HRD+KS +ILL ++SDFG + E
Sbjct: 145 --GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 178
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 58/205 (28%), Positives = 86/205 (41%), Gaps = 39/205 (19%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 21 TIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK------GL 264
LV EY G + +L HG RM AK +
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RMKEKEARAKFRQIVSAV 126
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRV 315
Y H+ +VHRD+K+ N+LLD N +++DFG + C Y +
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPEL 183
Query: 316 MGTFGYAHFIVQVSPLFILLYILLS 340
Y V V L ++LY L+S
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVS 208
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP-----------LTWDIRMNIIL 258
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 96 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 259 GTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AKG+ +L K +HRD+ + NILL + ++ DFGLA+
Sbjct: 156 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 196
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 10/173 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 90 LKDTKLWIIMEYLGGGSA-----LDLLEPGPLDETQIATILREILKGLDYLHSE---KKI 141
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
HRD+K++N+LL +++DFG+A L + V F A +++ S
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 194
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 22/163 (13%)
Query: 159 IGEGGYGIVYR----GILSDGTK--VAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP----------LTWDIRMNIILG 259
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 97 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 260 TAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AKG+ +L K +HRD+ + NILL + ++ DFGLA+
Sbjct: 157 VAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLAR 196
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 53.1 bits (126), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 25/174 (14%)
Query: 159 IGEGGYGIV-YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
IGEG GIV + S G VAVK + + Q + EV ++ +H+N+V + +
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN------IILGTAKGLAYLHEGL 271
G +V E+++ G L + RMN + L + L+ LH
Sbjct: 142 VGDELWVVMEFLEGGALTD-----------IVTHTRMNEEQIAAVCLAVLQALSVLHAQ- 189
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
V+HRD+KS +ILL ++SDFG C++ S R G +++
Sbjct: 190 --GVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKEVPRRKXLVGTPYWM 237
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 7/161 (4%)
Query: 158 VIGEGGYGIVYR-GILSDGTKVAVKNL-LNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLG 214
IG G YG + SDG + K L + +AEK+ V EV ++ ++H N+VR
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 215 YCVEGAYRML--VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
++ L V EY + G+L + + L + + ++ L H +
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 273 --PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
V+HRD+K +N+ LD + N ++ DFGLA++L + +
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFA 173
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 20/159 (12%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL-LNNRGQAEKEFKV----EVEVIGRVR---HKNL 209
IG G YG VY+ G VA+K++ + N G + EV ++ R+ H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 210 VRLLGYCVEGAYR-----MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGL 264
VRL+ C LV+E+VD +L +L D L + +++ +GL
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAETIKDLMRQFLRGL 133
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
+LH +VHRD+K NIL+ +++DFGLA++
Sbjct: 134 DFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI 169
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AKG+ +L K +HRD+ + NILL + ++ DFGLA+
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 187
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AKG+ +L K +HRD+ + NILL + ++ DFGLA+
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 196
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 45/173 (26%), Positives = 82/173 (47%), Gaps = 10/173 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKV-AVKNL-LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
IG+G +G V++GI + KV A+K + L ++ + E+ V+ + + + G
Sbjct: 15 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
++ ++ EY+ G+ D+ + PL I+ KGL YLH K +
Sbjct: 75 LKDTKLWIIMEYLGGGSA-----LDLLEPGPLDETQIATILREILKGLDYLHSE---KKI 126
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVS 329
HRD+K++N+LL +++DFG+A L + V F A +++ S
Sbjct: 127 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQS 179
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 86 NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AKG+ +L K +HRD+ + NILL + ++ DFGLA+
Sbjct: 146 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 187
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 40/166 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 83 IEICRTKASPYNRCKGSIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 130
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
GL Y+H K++HRD+K++N+L+ R +++DFGLA+
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 45/193 (23%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ +++YE++ G L + + + + ++ D + + KGL ++HE VH
Sbjct: 225 DDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 278
Query: 278 RDVKSSNILL--DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH--------FIVQ 327
D+K NI+ R ++ DFGL L ++S T F +
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 328 VSPLFILLYILLS 340
+ + +L YILLS
Sbjct: 339 MWSVGVLSYILLS 351
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 45/193 (23%), Positives = 85/193 (44%), Gaps = 17/193 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G+V+R + G A K ++ ++ + E++ + +RH LV L
Sbjct: 59 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 218 EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVH 277
+ +++YE++ G L + + + + ++ D + + KGL ++HE VH
Sbjct: 119 DDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVH 172
Query: 278 RDVKSSNILL--DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH--------FIVQ 327
D+K NI+ R ++ DFGL L ++S T F +
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTD 232
Query: 328 VSPLFILLYILLS 340
+ + +L YILLS
Sbjct: 233 MWSVGVLSYILLS 245
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKNLVRLL 213
++G GG V+ L D VAVK L + + F+ E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G +V EYVD L +H + P+T + +I + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGY 321
++HRDVK +NIL+ +V DFG+A+ + + V T V+GT Y
Sbjct: 135 N---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQY 185
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/165 (29%), Positives = 75/165 (45%), Gaps = 24/165 (14%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V GI T VAVK L +E + E++++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 211 RLLGYCVE-GAYRMLVYEYVDNGNLDQWLHGDVGDVSP------------LTWDIRMNII 257
LLG C + G M++ E+ GNL +L + P LT + +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 258 LGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
AKG+ +L K +HRD+ + NILL + ++ DFGLA+
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLAR 196
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 21/195 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK-EFKVEVEVIGRVRHKNLVRLLGYCV 217
+G G +G+V+R + +V V +N +K K E+ ++ ++ H L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHD-AF 117
Query: 218 EGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
E Y M L+ E++ G L + + +S +N + +GL ++HE +V
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE---VINYMRQACEGLKHMHEH---SIV 171
Query: 277 HRDVKSSNILLD--RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSP---- 330
H D+K NI+ + + + ++ DFGLA L + T F A IV P
Sbjct: 172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA-APEIVDREPVGFY 230
Query: 331 -----LFILLYILLS 340
+ +L Y+LLS
Sbjct: 231 TDMWAIGVLGYVLLS 245
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 24/196 (12%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 161
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGYAH 323
+V+HRD+K N+ L+ + ++ DFGLA K LC +Y+ V+ G++
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHS- 220
Query: 324 FIVQVSPLFILLYILL 339
F V + L +LY LL
Sbjct: 221 FEVDIWSLGCILYTLL 236
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 52.8 bits (125), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR 193
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 17 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 76
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 77 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 130
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSE--------RSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG++ L E RSY++ R+ GT H+ VQ
Sbjct: 131 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSYMSPERLQGT----HYSVQ 186
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 52.4 bits (124), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 24/196 (12%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 161
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGYAH 323
+V+HRD+K N+ L+ + ++ DFGLA K LC +Y+ V+ G++
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHS- 220
Query: 324 FIVQVSPLFILLYILL 339
F V + L +LY LL
Sbjct: 221 FEVDIWSLGCILYTLL 236
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 57/205 (27%), Positives = 86/205 (41%), Gaps = 39/205 (19%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+G + V R IL+ G +VAV+ + N +K F+ EV ++ + H N+V+L
Sbjct: 21 TIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK------GL 264
LV EY G + +L HG RM AK +
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RMKEKEARAKFRQIVSAV 126
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRV 315
Y H+ +VHRD+K+ N+LLD N +++DFG + C Y +
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPEL 183
Query: 316 MGTFGYAHFIVQVSPLFILLYILLS 340
Y V V L ++LY L+S
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVS 208
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V+ R + T KV K ++ + K E ++ V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V L+ G L+ EY+ G L L + D + + L +LH+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQ 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+++RD+K NI+L+ Q + +++DFGL K + + VT GT Y
Sbjct: 140 K---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEY 187
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKNLVRLL 213
++G GG V+ L D VAVK L + + F+ E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G +V EYVD L +H + P+T + +I + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGY 321
++HRDVK +NI++ +V DFG+A+ + + V T V+GT Y
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 39/205 (19%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+G + V R IL+ G +VAV+ + N +K F+ EV ++ + H N+V+L
Sbjct: 21 TIGKGNFAKVKLARHILT-GKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK------GL 264
LV EY G + +L HG RM AK +
Sbjct: 79 FEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RMKEKEARAKFRQIVSAV 126
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA-------KL--LCSERSYVTTRV 315
Y H+ +VHRD+K+ N+LLD N +++DFG + KL C Y +
Sbjct: 127 QYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPEL 183
Query: 316 MGTFGYAHFIVQVSPLFILLYILLS 340
Y V V L ++LY L+S
Sbjct: 184 FQGKKYDGPEVDVWSLGVILYTLVS 208
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 16/172 (9%)
Query: 158 VIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+GGYG V+ R + T KV K ++ + K E ++ V+H +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
V L+ G L+ EY+ G L L + D + + L +LH+
Sbjct: 84 VDLIYAFQTGGKLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQ 139
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+++RD+K NI+L+ Q + +++DFGL K + + VT GT Y
Sbjct: 140 K---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEY 187
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 46/174 (26%), Positives = 76/174 (43%), Gaps = 17/174 (9%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEK---EFKVEVEVIGRVRHKNLVRLL 213
++G GG V+ L D VAVK L + + F+ E + + H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 214 ----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
G +V EYVD L +H + P+T + +I + L + H+
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQ 134
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGY 321
++HRDVK +NI++ +V DFG+A+ + + V T V+GT Y
Sbjct: 135 N---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 52.4 bits (124), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 157 NVIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVR 211
IG+G + V R IL+ G +VA+K + N +K F+ EV ++ + H N+V+
Sbjct: 18 KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVK 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
L L+ EY G + +L HG + + + + I+ + Y H+
Sbjct: 76 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVSAVQ---YCHQ 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRVMGTFG 320
++VHRD+K+ N+LLD N +++DFG + C Y +
Sbjct: 130 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 321 YAHFIVQVSPLFILLYILLS 340
Y V V L ++LY L+S
Sbjct: 187 YDGPEVDVWSLGVILYTLVS 206
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 53/172 (30%), Positives = 82/172 (47%), Gaps = 30/172 (17%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV + +L G VAVK L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 30 IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISL 86
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q +H ++ RM+ +L G+
Sbjct: 87 LNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIHMELDHE-------RMSYLLYQMLCGIK 138
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
+LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 139 HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTR 187
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 42/168 (25%), Positives = 80/168 (47%), Gaps = 25/168 (14%)
Query: 159 IGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL---- 213
+G GG G+V+ + +D K VA+K ++ Q+ K E+++I R+ H N+V++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 214 ----------GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
G E +V EY++ +V + PL + + +G
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETD------LANVLEQGPLLEEHARLFMYQLLRG 132
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQ-WNARVSDFGLAKLLCSERSY 310
L Y+H V+HRD+K +N+ ++ + ++ DFGLA+++ S+
Sbjct: 133 LKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 158 VIGEGGYGIVYRGILSD--GTK--VAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
++GEG +G VY G+ ++ G K VAVK + KE F E ++ + H ++V+L
Sbjct: 31 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+G +E ++ E G L +L + + LT + L K +AYL
Sbjct: 91 IGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI-- 144
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
VHRD+ NIL+ ++ DFGL++ + E Y
Sbjct: 145 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 181
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 40/166 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 129
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
GL Y+H K++HRD+K++N+L+ R +++DFGLA+
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 52.0 bits (123), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 24/190 (12%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE----------- 191
+ EL A S + I G YG V G+ S+G VA+K + N
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 192 KEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
K E+ ++ H N++ L V +++ + + +L Q +H +SP
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
M IL GL LHE VVHRD+ NILL + + DF LA+ ++
Sbjct: 134 QHIQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 308 RS---YVTTR 314
+ YVT R
Sbjct: 188 ANKTHYVTHR 197
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/190 (27%), Positives = 78/190 (41%), Gaps = 24/190 (12%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE----------- 191
+ EL A S + I G YG V G+ S+G VA+K + N
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 192 KEFKVEVEVIGRVRHKNLVRLLGYCVE----GAYRMLVYEYVDNGNLDQWLHGDVGDVSP 247
K E+ ++ H N++ L V +++ + + +L Q +H +SP
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133
Query: 248 LTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
M IL GL LHE VVHRD+ NILL + + DF LA+ ++
Sbjct: 134 QHIQYFMYHIL---LGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 308 RS---YVTTR 314
+ YVT R
Sbjct: 188 ANKTHYVTHR 197
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 158 VIGEGGYGIVYRGILSD--GTK--VAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
++GEG +G VY G+ ++ G K VAVK + KE F E ++ + H ++V+L
Sbjct: 15 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+G +E ++ E G L +L + + LT + L K +AYL
Sbjct: 75 IGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI-- 128
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
VHRD+ NIL+ ++ DFGL++ + E Y
Sbjct: 129 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 165
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 46/158 (29%), Positives = 75/158 (47%), Gaps = 12/158 (7%)
Query: 158 VIGEGGYGIVYRGILSD--GTK--VAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
++GEG +G VY G+ ++ G K VAVK + KE F E ++ + H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+G +E ++ E G L +L + + LT + L K +AYL
Sbjct: 79 IGI-IEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS---LQICKAMAYLESI-- 132
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSY 310
VHRD+ NIL+ ++ DFGL++ + E Y
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 45/164 (27%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
IG G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 50/197 (25%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 159 IGEGGYGIV-----YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEV--IGRVRHKNLVR 211
+GEG +G V Y+ K + LL +++ +VE E+ + +RH ++++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLK---KSDMHMRVEREISYLKLLRHPHIIK 73
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L ++V EY G L + + + +T D + Y H
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDY----IVEKKRMTEDEGRRFFQQIICAIEYCHRH- 127
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL---------CSERSYVTTRVMGTFGYA 322
K+VHRD+K N+LLD N +++DFGL+ ++ C +Y V+ YA
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYA 185
Query: 323 HFIVQVSPLFILLYILL 339
V V I+LY++L
Sbjct: 186 GPEVDVWSCGIVLYVML 202
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 52.0 bits (123), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 89/200 (44%), Gaps = 27/200 (13%)
Query: 157 NVIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVR 211
IG+G + V R IL+ G +VA+K + N +K F+ EV ++ + H N+V+
Sbjct: 21 KTIGKGNFAKVKLARHILT-GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVK 78
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
L L+ EY G + +L HG + + + + I+ + Y H+
Sbjct: 79 LFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS---KFRQIVSAVQ---YCHQ 132
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRVMGTFG 320
++VHRD+K+ N+LLD N +++DFG + C Y +
Sbjct: 133 ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKK 189
Query: 321 YAHFIVQVSPLFILLYILLS 340
Y V V L ++LY L+S
Sbjct: 190 YDGPEVDVWSLGVILYTLVS 209
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 40/166 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 83 IEICRTKASPYNRCKASIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 130
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
GL Y+H K++HRD+K++N+L+ R +++DFGLA+
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 158 VIGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------N 255
V LLG C G +++ EY G+L +L SP + +
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 150 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 39/158 (24%), Positives = 78/158 (49%), Gaps = 12/158 (7%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + T+VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 51 IGEGAYGMVSSAYDHVRK--TRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIR 107
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 108 DILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRGLKYIHSA--- 163
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
V+HRD+K SN+L++ + ++ DFGLA++ E +
Sbjct: 164 NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHT 201
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 158 VIGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+
Sbjct: 46 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 105
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------N 255
V LLG C G +++ EY G+L +L SP + +
Sbjct: 106 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 165
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 166 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 218
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 82/164 (50%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ + LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 45/166 (27%), Positives = 84/166 (50%), Gaps = 40/166 (24%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKE-FKV----EVEVIGRVRHKNLVRL 212
IG+G +G V++ G KVA+K +L + EKE F + E++++ ++H+N+V L
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVL---MENEKEGFPITALREIKILQLLKHENVVNL 82
Query: 213 LGYCVEGAYRM--------LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK-- 262
+ C A LV+++ ++ D++ L ++ + L K
Sbjct: 83 IEICRTKASPYNRCKGSIYLVFDFCEH------------DLAGLLSNVLVKFTLSEIKRV 130
Query: 263 ------GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
GL Y+H K++HRD+K++N+L+ R +++DFGLA+
Sbjct: 131 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 173
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 158 VIGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+
Sbjct: 53 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------N 255
V LLG C G +++ EY G+L +L SP + +
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 173 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYV 225
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 51.6 bits (122), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 39/207 (18%)
Query: 156 ENVIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLV 210
+ IG+G + V R +L+ G +VAVK + N +K F+ EV ++ + H N+V
Sbjct: 20 QKTIGKGNFAKVKLARHVLT-GREVAVKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIV 77
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAK------ 262
+L LV EY G + +L HG RM AK
Sbjct: 78 KLFEVIETEKTLYLVMEYASGGEVFDYLVAHG------------RMKEKEARAKFRQIVS 125
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTT 313
+ Y H+ +VHRD+K+ N+LLD N +++DFG + C Y
Sbjct: 126 AVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAP 182
Query: 314 RVMGTFGYAHFIVQVSPLFILLYILLS 340
+ Y V V L ++LY L+S
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVS 209
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 96 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 151
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 152 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 193
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 24/196 (12%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 50 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 108
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 161
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGYAH 323
+V+HRD+K N+ L+ + ++ DFGLA K LC +Y+ V+ G++
Sbjct: 162 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS- 220
Query: 324 FIVQVSPLFILLYILL 339
F V + L +LY LL
Sbjct: 221 FEVDIWSLGCILYTLL 236
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 158 VIGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+
Sbjct: 48 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 107
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------N 255
V LLG C G +++ EY G+L +L SP + +
Sbjct: 108 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 167
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 168 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 220
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 71/155 (45%), Gaps = 18/155 (11%)
Query: 204 VRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKG 263
V H ++R+ G + ++ +Y++ G L L +P+ + L
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA---- 118
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL-------LCSERSYVTTRVM 316
L YLH +++RD+K NILLD+ + +++DFG AK LC Y+ V+
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVV 175
Query: 317 GTFGYAHFIVQVSPLFILLYILL---SVRYNSSTI 348
T Y I S IL+Y +L + Y+S+T+
Sbjct: 176 STKPYNKSIDWWS-FGILIYEMLAGYTPFYDSNTM 209
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 90/205 (43%), Gaps = 41/205 (20%)
Query: 132 VSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAE 191
+S LG G + +++ SGL I+ R ++ K A++N
Sbjct: 21 ISELGAGNGGVVTKVQHRPSGL------------IMARKLIHLEIKPAIRN--------- 59
Query: 192 KEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
+ E++V+ +V G + E++D G+LDQ L + + +
Sbjct: 60 -QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----EAKRIPEE 114
Query: 252 IRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFG--------LAKL 303
I + + +GLAYL E + +++HRDVK SNIL++ + ++ DFG +A
Sbjct: 115 ILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS 172
Query: 304 LCSERSYVTT-RVMGTFGYAHFIVQ 327
RSY+ R+ GT H+ VQ
Sbjct: 173 FVGTRSYMAPERLQGT----HYSVQ 193
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 191
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 51.6 bits (122), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 158 VIGEGGYGIV-----YRGILSDGT-KVAVKNLLNNRGQAEKE-FKVEVEVIGRV-RHKNL 209
+G G +G V Y I SD VAVK L + E+E E++V+ + H N+
Sbjct: 53 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 112
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-----VGDVSPLTWDIRM---------N 255
V LLG C G +++ EY G+L +L SP + +
Sbjct: 113 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 172
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+A+L +HRD+ + NILL ++ DFGLA+ + ++ +YV
Sbjct: 173 FSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 225
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 51.2 bits (121), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 150 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 191
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 55/198 (27%), Positives = 87/198 (43%), Gaps = 27/198 (13%)
Query: 159 IGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IG+G + V R IL+ G +VAVK + N +K F+ EV ++ + H N+V+L
Sbjct: 15 IGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLF 72
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
LV EY G + +L HG + + + I+ + Y H+
Sbjct: 73 EVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARA---KFRQIVSAVQ---YCHQKF 126
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRVMGTFGYA 322
+VHRD+K+ N+LLD N +++DFG + C Y + Y
Sbjct: 127 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD 183
Query: 323 HFIVQVSPLFILLYILLS 340
V V L ++LY L+S
Sbjct: 184 GPEVDVWSLGVILYTLVS 201
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 29 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 87
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 88 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 143
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 144 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 185
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 112 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 209
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 147 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 188
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 76 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 135
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 136 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 189
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 190 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 245
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 101 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 101 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 100
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 101 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 156
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 157 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 198
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 186
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 49 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 108 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 205
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 86 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 183
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 151 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 192
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 109 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 100 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 156 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 197
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 93
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 94 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 150 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 28 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 86
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 87 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 142
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 143 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 184
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 51.2 bits (121), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 85
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 86 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 141
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 142 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 183
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 183
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 109 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 206
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 52/196 (26%), Positives = 87/196 (44%), Gaps = 24/196 (12%)
Query: 159 IGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+GG+ Y D KV K++L Q EK E+ + + + ++V
Sbjct: 34 LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEK-MSTEIAIHKSLDNPHVVGFH 92
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
G+ + + +V E +L + LH V+ M T +G+ YLH
Sbjct: 93 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMR---QTIQGVQYLHNN--- 145
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLA----------KLLCSERSYVTTRVMGTFGYAH 323
+V+HRD+K N+ L+ + ++ DFGLA K LC +Y+ V+ G++
Sbjct: 146 RVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHS- 204
Query: 324 FIVQVSPLFILLYILL 339
F V + L +LY LL
Sbjct: 205 FEVDIWSLGCILYTLL 220
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 183
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 99
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 100 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 155
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 156 --DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 197
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 49 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 107
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 108 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 163
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 164 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 205
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 183
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 51.2 bits (121), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 182
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 159 IGEGGYGIV--YRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+GEGG+ V G L DG A+K +L + Q +E + E ++ H N++RL+ YC
Sbjct: 37 LGEGGFSYVDLVEG-LHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 217 V--EGAYR--MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ GA L+ + G L + + LT D + ++LG +GL +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-- 153
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLC 305
HRD+K +NILL + + D G C
Sbjct: 154 -GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/157 (23%), Positives = 76/157 (48%), Gaps = 19/157 (12%)
Query: 173 SDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNG 232
S+ K+++K+ + +FK E+++I ++++ + G ++YEY++N
Sbjct: 76 SNNDKISIKSKYD-------DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMEND 128
Query: 233 NL---DQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD 288
++ D++ D + + II +Y+H E + HRDVK SNIL+D
Sbjct: 129 SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186
Query: 289 RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
+ ++SDFG ++ + V ++ G+ G F+
Sbjct: 187 KNGRVKLSDFGESEYM------VDKKIKGSRGTYEFM 217
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 186
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 91 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 146
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 147 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 188
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 90 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 145
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 85/199 (42%), Gaps = 27/199 (13%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLN---NRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG+G + V R IL+ G +VAVK + N +K F+ EV + + H N+V+L
Sbjct: 21 TIGKGNFAKVKLARHILT-GKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKVLNHPNIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
LV EY G + +L HG + + I+ + Y H+
Sbjct: 79 FEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARA---KFRQIVSAVQ---YCHQK 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK---------LLCSERSYVTTRVMGTFGY 321
+VHRD+K+ N+LLD N +++DFG + C Y + Y
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKY 189
Query: 322 AHFIVQVSPLFILLYILLS 340
V V L ++LY L+S
Sbjct: 190 DGPEVDVWSLGVILYTLVS 208
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 44/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 95 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 150
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 151 --DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 192
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 40 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 98
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 99 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 154
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + YV TR
Sbjct: 155 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 196
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKCQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRH 206
+S ++++GEG YG+V G VA+K + + A + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+N++ + ++ Y+ + LH V L+ D I T + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR-VISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
LH V+HRD+K SN+L++ + +V DFGLA+++
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + + +A +F EV + + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ YL + +HRD+ + N+LL + ++ DFGL + L
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRH 206
+S ++++GEG YG+V G VA+K + + A + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+N++ + ++ Y+ + LH V L+ D I T + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR-VISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
LH V+HRD+K SN+L++ + +V DFGLA+++
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 39/158 (24%), Positives = 76/158 (48%), Gaps = 8/158 (5%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRH 206
+S ++++GEG YG+V G VA+K + + A + + E++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
+N++ + ++ Y+ + LH V L+ D I T + +
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHR-VISTQMLSDDHIQYFIYQTLRAVKV 127
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
LH V+HRD+K SN+L++ + +V DFGLA+++
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 95 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 150
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 95
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 96 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 151
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 152 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 86
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 87 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 142
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 143 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 91
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 92 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 147
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 183
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 14 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 74 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 127
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 128 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 183
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + + +A +F EV + + H+NL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 133
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ YL + +HRD+ + N+LL + ++ DFGL + L
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + + +A +F EV + + H+NL+R
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 86 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 133
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ YL + +HRD+ + N+LL + ++ DFGL + L
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 88 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 143
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 39 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 97
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 98 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 153
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 154 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 90 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 145
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 146 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 87
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 88 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 143
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 144 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 109
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 110 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 165
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 166 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/148 (25%), Positives = 75/148 (50%), Gaps = 8/148 (5%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKL 303
+HRD+K SN+LL+ + ++ DFGLA++
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARV 177
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 32/120 (26%), Positives = 65/120 (54%), Gaps = 11/120 (9%)
Query: 184 LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEG--AYRMLVYEYVDNGNLDQWLHGD 241
+ RG E+ ++ E+ ++ ++ H N+V+L+ + + +V+E V+ G + +
Sbjct: 74 IQPRGPIEQVYQ-EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV-----ME 127
Query: 242 VGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
V + PL+ D KG+ YLH K++HRD+K SN+L+ + +++DFG++
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVS 184
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 37/148 (25%), Positives = 75/148 (50%), Gaps = 8/148 (5%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 94
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 95 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 150
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKL 303
+HRD+K SN+LL+ + ++ DFGLA++
Sbjct: 151 LHRDLKPSNLLLNTTCDLKICDFGLARV 178
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 154
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 210
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 13/165 (7%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG YG+V + + +VA+K + Q + + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ Y+ ++ L+ + L+ D + +GL Y+H V+
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NVL 150
Query: 277 HRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 151 HRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 50.8 bits (120), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 90 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 145
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 89
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 90 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 145
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 146 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + + +A +F EV + + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ YL + +HRD+ + N+LL + ++ DFGL + L
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 20/155 (12%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV--RHKNLVRLLGY 215
+G+G YG V+RG L G VAVK + ++R E+ + E E+ V RH N++ +
Sbjct: 15 CVGKGRYGEVWRG-LWHGESVAVK-IFSSRD--EQSWFRETEIYNTVLLRHDNILGFIAS 70
Query: 216 CV----EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ L+ Y ++G+L +L L + + + + A GLA+LH +
Sbjct: 71 DMTSRNSSTQLWLITHYHEHGSLYDFLQRQT-----LEPHLALRLAVSAACGLAHLHVEI 125
Query: 272 -----EPKVVHRDVKSSNILLDRQWNARVSDFGLA 301
+P + HRD KS N+L+ ++D GLA
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLA 160
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 21/180 (11%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+G G G+V++ V + L L + + E++V+ +V G
Sbjct: 33 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ E++D G+LDQ L + I + + KGL YL E + K++
Sbjct: 93 YSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE--KHKIM 146
Query: 277 HRDVKSSNILLDRQWNARVSDFG--------LAKLLCSERSYVTT-RVMGTFGYAHFIVQ 327
HRDVK SNIL++ + ++ DFG +A RSY++ R+ GT H+ VQ
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT----HYSVQ 202
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + + +A +F EV + + H+NL+R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 76 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 123
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ YL + +HRD+ + N+LL + ++ DFGL + L
Sbjct: 124 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 41/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 150 LHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 42/168 (25%), Positives = 81/168 (48%), Gaps = 19/168 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
IGEG YG+V Y + + +VA+K + ++ ++ + E++++ R RH+N++ +
Sbjct: 31 IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGIN 87
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ Y+ ++ L+ + L+ D + +GL Y+H
Sbjct: 88 DIIRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA--- 143
Query: 274 KVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
V+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + + +A +F EV + + H+NL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 80 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 127
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ YL + +HRD+ + N+LL + ++ DFGL + L
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 13/134 (9%)
Query: 194 FKVEVEVIGRVRHKNLVRLLGY----CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
F+ E + + H +V + G +V EYVD L +H + P+T
Sbjct: 59 FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMT 114
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+ +I + L + H+ ++HRDVK +NI++ +V DFG+A+ + +
Sbjct: 115 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 310 YV--TTRVMGTFGY 321
V T V+GT Y
Sbjct: 172 SVTQTAAVIGTAQY 185
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 50.4 bits (119), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 111
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 112 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 167
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E YV TR
Sbjct: 168 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR 209
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 30/161 (18%)
Query: 159 IGEGGYGIVYRGILSDGT----KVAVKNLLNN---RGQAEKEFKVEVEVIGRVRHKNLVR 211
+G+G +G+V RG + VAVK L + + +A +F EV + + H+NL+R
Sbjct: 20 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGT--------AKG 263
L G + +M V E G+L L G + +LGT A+G
Sbjct: 80 LYGVVLTPPMKM-VTELAPLGSLLDRLRKHQG-----------HFLLGTLSRYAVQVAEG 127
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ YL + +HRD+ + N+LL + ++ DFGL + L
Sbjct: 128 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRAL 165
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 50.4 bits (119), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/151 (26%), Positives = 67/151 (44%), Gaps = 21/151 (13%)
Query: 157 NVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+IG+G +G VY G + + ++ + K FK EV + RH+N+V +G C
Sbjct: 39 ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 217 VEGAYRMLVYEYVDNGNL-----DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + ++ L D + DV + +I KG+ YLH
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEI--------VKGMGYLHAK- 149
Query: 272 EPKVVHRDVKSSNILLDRQWNARV--SDFGL 300
++H+D+KS N+ D N +V +DFGL
Sbjct: 150 --GILHKDLKSKNVFYD---NGKVVITDFGL 175
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 13/134 (9%)
Query: 194 FKVEVEVIGRVRHKNLVRLL----GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLT 249
F+ E + + H +V + G +V EYVD L +H + P+T
Sbjct: 59 FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMT 114
Query: 250 WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+ +I + L + H+ ++HRDVK +NI++ +V DFG+A+ + +
Sbjct: 115 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 310 YV--TTRVMGTFGY 321
V T V+GT Y
Sbjct: 172 SVTQTAAVIGTAQY 185
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 42/148 (28%), Positives = 68/148 (45%), Gaps = 17/148 (11%)
Query: 159 IGEGGYGIVY-----RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+G+G +G VY + KV K+ + G E + + E+E+ + H N++RL
Sbjct: 31 LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEG-VEHQLRREIEIQAHLHHPNILRLY 89
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGL 271
Y + L+ EY G L + L T+D + I+ A L Y H
Sbjct: 90 NYFYDRRRIYLILEYAPRGELYKELQKSC------TFDEQRTATIMEELADALMYCHGK- 142
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFG 299
KV+HRD+K N+LL + +++DFG
Sbjct: 143 --KVIHRDIKPENLLLGLKGELKIADFG 168
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 50.1 bits (118), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ D+GLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR 186
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 44/170 (25%), Positives = 80/170 (47%), Gaps = 23/170 (13%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ R RH+N++
Sbjct: 51 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENII----- 104
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHG----DVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ R E + + L L G + L+ D + +GL Y+H
Sbjct: 105 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA- 163
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
V+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 164 --NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 211
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 80/166 (48%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA++ + ++ ++ + E++++ R RH+N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 149
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 150 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + +V TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR 186
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + +V TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR 186
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 84
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 85 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 140
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGLA+ E + +V TR
Sbjct: 141 --DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR 182
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 49.7 bits (117), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 18/169 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE---FKVEVEVIGRVRHKNLVRLLGY 215
IG G + VY+G+ ++ T L +R + E FK E E + ++H N+VR
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYDS 93
Query: 216 ---CVEGAYRM-LVYEYVDNGNLDQWLHG-DVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
V+G + LV E +G L +L V + L R + KGL +LH
Sbjct: 94 WESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL-----KGLQFLHTR 148
Query: 271 LEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGT 318
P ++HRD+K NI + + ++ D GLA L +R+ V+GT
Sbjct: 149 T-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGT 193
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 48/179 (26%), Positives = 79/179 (44%), Gaps = 25/179 (13%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVK------------NLLNNRGQAEKEFKVEVEVIG 202
++VIG G +V R + + G + AVK L R +E + +V G
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 203 RVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAK 262
H +++ L+ ++ LV++ + G L +L V L+ +I+ +
Sbjct: 159 ---HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA----LSEKETRSIMRSLLE 211
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+++LH +VHRD+K NILLD R+SDFG + L E + GT GY
Sbjct: 212 AVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL--EPGEKLRELCGTPGY 265
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 54 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 111
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 112 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 167
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
K+VHRD+K N+LL+ + N R+ DFGL S + ++ G A++I
Sbjct: 168 N---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIA 219
Query: 327 ------------QVSPLFILLYILLS 340
V ++LYILLS
Sbjct: 220 PEVLHGTYDEKCDVWSTGVILYILLS 245
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 31 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 144
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
K+VHRD+K N+LL+ + N R+ DFGL S + ++ G A++I
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIA 196
Query: 327 ------------QVSPLFILLYILLS 340
V ++LYILLS
Sbjct: 197 PEVLHGTYDEKCDVWSTGVILYILLS 222
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 49.7 bits (117), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 55 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 112
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 113 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 168
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
K+VHRD+K N+LL+ + N R+ DFGL S + ++ G A++I
Sbjct: 169 N---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIA 220
Query: 327 ------------QVSPLFILLYILLS 340
V ++LYILLS
Sbjct: 221 PEVLHGTYDEKCDVWSTGVILYILLS 246
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 9/105 (8%)
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
G +V EYVD L +H + P+T + +I + L + H+ ++HR
Sbjct: 105 GPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHR 157
Query: 279 DVKSSNILLDRQWNARVSDFGLAKLLCSERSYV--TTRVMGTFGY 321
DVK +NI++ +V DFG+A+ + + V T V+GT Y
Sbjct: 158 DVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 202
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 39/172 (22%), Positives = 78/172 (45%), Gaps = 12/172 (6%)
Query: 156 ENVIGEGGYGIVYRG-ILSDGTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
E IG G + VYR L DG VA+K +L++ + +A+ E++++ ++ H N+
Sbjct: 37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD--CIKEIDLLKQLNHPNV 94
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++ +E +V E D G+L + + + + L ++H
Sbjct: 95 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS 154
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+HRD+K +N+ + ++ D GL + S ++ ++GT Y
Sbjct: 155 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYY 202
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 54/206 (26%), Positives = 96/206 (46%), Gaps = 35/206 (16%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 37 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 94
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
++L + + Y LV E G L ++ + II G+ Y+H+
Sbjct: 95 MKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV 326
K+VHRD+K N+LL+ + N R+ DFGL S + ++ G A++I
Sbjct: 151 N---KIVHRDLKPENLLLESKSKDANIRIIDFGL-----STHFEASKKMKDKIGTAYYIA 202
Query: 327 ------------QVSPLFILLYILLS 340
V ++LYILLS
Sbjct: 203 PEVLHGTYDEKCDVWSTGVILYILLS 228
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 30/172 (17%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLXGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
+LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 49.3 bits (116), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 11/145 (7%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKV-EVEVIGRVRHKNLVRLLGYC 216
IGEG GIV G +VAVK +++ R Q +E EV ++ +H N+V +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVK-MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ G ++ E++ G L D+ L + + + LAYLH V+
Sbjct: 112 LVGEELWVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVI 163
Query: 277 HRDVKSSNILLDRQWNARVSDFGLA 301
HRD+KS +ILL ++SDFG
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFC 188
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 49.3 bits (116), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DFGL + E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR 186
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 48.9 bits (115), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 131 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYM 161
>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
pdb|3N9X|B Chain B, Crystal Structure Of Map Kinase From Plasmodium Berghei,
Pb000659.00.0
Length = 432
Score = 48.9 bits (115), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 40/163 (24%), Positives = 77/163 (47%), Gaps = 18/163 (11%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAE----KEFKVEVEVIGRVRHKNLV 210
+++IG G YG VY + K VA+K + NR + K E+ ++ R++ ++
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYII 88
Query: 211 RLLGYCVEGAY----RMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
RL + + + + + +L + + I N++LG +
Sbjct: 89 RLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGEN----F 144
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
+HE ++HRD+K +N LL++ + +V DFGLA+ + SE+
Sbjct: 145 IHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 92/208 (44%), Gaps = 30/208 (14%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHK 207
T G + IG G Y + R I + + AVK + +++++ E+E++ R +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEIEILLRYGQHP 76
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
N++ L +G Y +V E + G L D+ L + ++ K + Y
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS-----AVLFTITKTVEY 131
Query: 267 LHEGLEPKVVHRDVKSSNIL-LDRQWNA---RVSDFGLAKLL----------CSERSYVT 312
LH VVHRD+K SNIL +D N R+ DFG AK L C ++V
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 313 TRVMGTFGYAHFIVQVSPLFILLYILLS 340
V+ GY + L +LLY +L+
Sbjct: 189 PEVLERQGY-DAACDIWSLGVLLYTMLT 215
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
+ VHRD+ + N+L+ ++ DFGL++ + Y ++
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 551
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 28/227 (12%)
Query: 107 SSGESRGTGSA-CETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYG 165
SSG GT + ++ S + S P + L W +A + E+ +G G
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATS 67
Query: 166 IVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLV 225
IVYR GT+ + + +K + E+ V+ R+ H N+++L LV
Sbjct: 68 IVYR-CKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126
Query: 226 YEYVDNGNLDQ-------WLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
E V G L + D D + + +AYLHE +VHR
Sbjct: 127 LELVTGGELFDRIVEKGYYSERDAADA-----------VKQILEAVAYLHEN---GIVHR 172
Query: 279 DVKSSNILLDR---QWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
D+K N+L +++DFGL+K++ E + V GT GY
Sbjct: 173 DLKPENLLYATPAPDAPLKIADFGLSKIV--EHQVLMKTVCGTPGYC 217
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 48.5 bits (114), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 19/159 (11%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 43 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 100
Query: 211 RLLGYCVEGAYRMLV-YEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH- 268
+L +C + ++ Y NG L +++ +G I+ L YLH
Sbjct: 101 KLY-FCFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHG 155
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 156 KG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 190
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 43/177 (24%), Positives = 75/177 (42%), Gaps = 41/177 (23%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK----------VEVE 199
S E V+G+G +G V V +N L++R A K+ + EV
Sbjct: 5 ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVM 54
Query: 200 VIGRVRH-------------KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDV 245
++ + H +N V+ + + + + EY +NG L +H + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ 114
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
W + I+ + L+Y+H ++HRD+K NI +D N ++ DFGLAK
Sbjct: 115 RDEYWRLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAK 164
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 43/163 (26%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V I G KVA+K L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 90
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLE 272
+ Y++ + ++ D+ + L + ++ KGL Y+H
Sbjct: 91 VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSA-- 145
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
VVHRD+K N+ ++ ++ DFGLA+ +E + YV TR
Sbjct: 146 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 187
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 30/172 (17%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLXGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
+LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 30/172 (17%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLXGIK 133
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
+LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 134 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR 182
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 24/190 (12%)
Query: 125 SGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNL 183
SG EV+ W R+L+ +G G YG V + G KVA+K L
Sbjct: 9 SGFYRQEVTKTAWEVRAVYRDLQP----------VGSGAYGAVCSAVDGRTGAKVAIKKL 58
Query: 184 ---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHG 240
+ A++ ++ E+ ++ +RH+N++ LL + ++ D + ++
Sbjct: 59 YRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDE---TLDDFTDFYLVMPFMGT 114
Query: 241 DVGDV---SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSD 297
D+G + L D ++ KGL Y+H ++HRD+K N+ ++ ++ D
Sbjct: 115 DLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILD 171
Query: 298 FGLAKLLCSE 307
FGLA+ SE
Sbjct: 172 FGLARQADSE 181
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 37/153 (24%), Positives = 74/153 (48%), Gaps = 14/153 (9%)
Query: 159 IGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G + +++G+ + T+V +K L + F ++ ++ HK+LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
G CV G +LV E+V G+LD +L + ++ + W ++ + A + +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCIN-ILW--KLEVAKQLAAAMHFLEEN 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
++H +V + NILL R+ + + + KL
Sbjct: 133 ---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147
pdb|3NIE|B Chain B, Crystal Structure Of Pf11_0147
Length = 429
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 42/164 (25%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 156 ENVIGEGGYGIVYRGILSDGTK-VAVKNLLNNRGQAE----KEFKVEVEVIGRVRHKNLV 210
+++IG G YG VY + K VA+K + NR + K E+ ++ R++ ++
Sbjct: 33 KHLIGRGSYGYVYLAYDKNANKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYII 90
Query: 211 RLLGYCV-EGAYRM----LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
RL + E + +V E D +L + + I N++LG
Sbjct: 91 RLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEQHVKTILYNLLLGEK---- 145
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS 309
++HE ++HRD+K +N LL++ + ++ DFGLA+ + S++
Sbjct: 146 FIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKD 186
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 48.5 bits (114), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++HRD+K SN+ ++ ++ DFGLA+
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFGLAR 173
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 30/172 (17%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 213 LGYCV------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIIL-GTAKGLA 265
L E LV E +D NL Q + ++ RM+ +L G+
Sbjct: 89 LNVFTPQKTLEEFQDVYLVMELMD-ANLXQVIQMELDHE-------RMSYLLYQMLCGIK 140
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
+LH ++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 141 HLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 109 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 164
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++HRD+K SN+ ++ ++ DFGLA+
Sbjct: 165 --DIIHRDLKPSNLAVNEDCELKILDFGLAR 193
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 16/164 (9%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 457 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQLSTALAYLESK 510
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTR 314
+ VHRD+ + N+L+ ++ DFGL++ + Y ++
Sbjct: 511 ---RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 551
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 45 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 104
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 105 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 158
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 159 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 189
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDI 91
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 92 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 147
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 148 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 48.1 bits (113), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 127 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 184 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 14/129 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMN 255
E+ ++ + H N+++L + Y LV E+ + G L +Q ++ D N
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-----N 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQ---WNARVSDFGLAKLLCSERSYVT 312
I+ G+ YLH+ +VHRD+K NILL+ + N ++ DFGL+ + Y
Sbjct: 151 IMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS--KDYKL 205
Query: 313 TRVMGTFGY 321
+GT Y
Sbjct: 206 RDRLGTAYY 214
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
V R L E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 --VFTPARSL-EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ DF LA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR 186
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ FGLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR 186
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ D GLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR 186
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 126
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 127 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 183
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 184 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 47.8 bits (112), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 82 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 135
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 136 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 19 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 78
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 79 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 132
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 133 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 163
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 20 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 79
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 80 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 133
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 134 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 164
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 42/163 (25%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V I G KVA+K L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLD 108
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKGLAYLHEGLE 272
+ Y++ + ++ D+ + + + ++ KGL Y+H
Sbjct: 109 VFTPASSLRNFYDFY---LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSA-- 163
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
VVHRD+K N+ ++ ++ DFGLA+ +E + YV TR
Sbjct: 164 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR 205
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 10/168 (5%)
Query: 159 IGEGGYGIVYR-GILSDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRLLGYC 216
+G G +G V+ S G + +K + +R Q E + E+EV+ + H N++++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 217 VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVV 276
+ +V E + G L + + L+ ++ LAY H VV
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVV 146
Query: 277 HRDVKSSNILLDR---QWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
H+D+K NIL ++ DFGLA+L S+ +T GT Y
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAAGTALY 192
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 47.8 bits (112), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 83 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 140 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 90 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 147 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 74 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 127
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 128 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 158 VIGEGGYGIVYRGIL----SDGTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVRL 212
IGEG +G V++GI + VA+K N + +E F E + + H ++V+L
Sbjct: 17 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 76
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG--TAKGLAYLHEG 270
+G E ++ E G L +L V + D+ I+ + LAYL
Sbjct: 77 IGVITENPV-WIIMELCTLGELRSFLQ-----VRKYSLDLASLILYAYQLSTALAYLESK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+ VHRD+ + N+L+ ++ DFGL++ +
Sbjct: 131 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 161
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 40/166 (24%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNL--LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IGEG YG+V + + +VA+K + ++ ++ + E++++ RH+N++ +
Sbjct: 33 IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDI 91
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ Y+ ++ L+ + L+ D + +GL Y+H V
Sbjct: 92 IRAPTIEQMKDVYIVQDLMETDLYK-LLKTQHLSNDHICYFLYQILRGLKYIHSA---NV 147
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-------YVTTR 314
+HRD+K SN+LL+ + ++ DFGLA++ + YV TR
Sbjct: 148 LHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 47.8 bits (112), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 89
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 90 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 147 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 31 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 87
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 88 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 144
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 145 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 188
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 156 ENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +V + KVA+K + + Q E E++ + + H N+V
Sbjct: 20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 214 GYCVEGAYRMLVYEYVDNGN-LDQWLH--------GDVGDVSPLTWDIRMNIILGTAKGL 264
V LV + + G+ LD H V D S + I+ +GL
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA-----TILREVLEGL 134
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
YLH+ + +HRDVK+ NILL + +++DFG++ L + +V TF
Sbjct: 135 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 81
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 82 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 182
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ D GLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR 186
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y +L VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISL 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 83 LNVFTP---QKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 140 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 18/170 (10%)
Query: 158 VIGEGGYGIVY--RGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
V+G G + V+ + L+ G A+K + + + + E+ V+ +++H+N+V L
Sbjct: 16 VLGSGAFSEVFLVKQRLT-GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 216 CVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ LV + V G L D+ L V T +I + YLHE
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRILERGV-----YTEKDASLVIQQVLSAVKYLHEN---G 126
Query: 275 VVHRDVKSSNIL-LDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGY 321
+VHRD+K N+L L + N++ ++DFGL+K+ E++ + + GT GY
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTACGTPGY 173
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/175 (26%), Positives = 76/175 (43%), Gaps = 19/175 (10%)
Query: 156 ENVIGEGGYGIVYRGILSDGT-KVAVKNLLNNRGQAE-KEFKVEVEVIGRVRHKNLVRLL 213
+ VIG G +V + KVA+K + + Q E E++ + + H N+V
Sbjct: 15 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 74
Query: 214 GYCVEGAYRMLVYEYVDNGN-LDQWLH--------GDVGDVSPLTWDIRMNIILGTAKGL 264
V LV + + G+ LD H V D S + I+ +GL
Sbjct: 75 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIA-----TILREVLEGL 129
Query: 265 AYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTF 319
YLH+ + +HRDVK+ NILL + +++DFG++ L + +V TF
Sbjct: 130 EYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 43/168 (25%), Positives = 72/168 (42%), Gaps = 11/168 (6%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR-GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
IG GG+ V + G VA+K + N G K E+E + +RH+++ +L +
Sbjct: 17 TIGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSDLPRIKTEIEALKNLRHQHICQLY-H 75
Query: 216 CVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+E A ++ +V EY G L ++ L+ + + +AY+H
Sbjct: 76 VLETANKIFMVLEYCPGGELFDYIISQ----DRLSEEETRVVFRQIVSAVAYVHSQ---G 128
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
HRD+K N+L D ++ DFGL + Y G+ YA
Sbjct: 129 YAHRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGSLAYA 176
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 31/204 (15%)
Query: 156 ENVIGEGGYG--IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV----EVEVIGRVRHKNL 209
+ V+G+G +G I+ + ++ G + AVK +++ R +K K EV+++ ++ H N+
Sbjct: 31 QRVLGKGSFGEVILCKDKIT-GQECAVK-VISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 210 VRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
+L + + Y LV E G L ++ + II G+ Y H+
Sbjct: 89 XKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAARIIRQVLSGITYXHK 144
Query: 270 GLEPKVVHRDVKSSNILLD---RQWNARVSDFGLAKLLCSERS---------YVTTRVM- 316
K+VHRD+K N+LL+ + N R+ DFGL+ + + Y+ V+
Sbjct: 145 N---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLH 201
Query: 317 GTFGYAHFIVQVSPLFILLYILLS 340
GT+ V ++LYILLS
Sbjct: 202 GTYDEK---CDVWSTGVILYILLS 222
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 28/200 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRLIFQVLDAVKYLH--- 133
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKL---------LCSERSYVTTRVMGTF 319
+ +VHRD+K N+L LD +SDFGL+K+ C YV V+
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 320 GYAHFIVQVSPLFILLYILL 339
Y+ V + ++ YILL
Sbjct: 194 PYSK-AVDCWSIGVIAYILL 212
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 39/154 (25%), Positives = 75/154 (48%), Gaps = 16/154 (10%)
Query: 159 IGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLV 210
+G+G + +++G+ + T+V +K L + F ++ ++ HK+LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY-LHE 269
G C G +LV E+V G+LD +L + ++ + W + + AK LA+ +H
Sbjct: 76 LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCIN-ILWKLEV------AKQLAWAMHF 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKL 303
E ++H +V + NILL R+ + + + KL
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL 162
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/197 (23%), Positives = 93/197 (47%), Gaps = 25/197 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 148
Query: 275 VVHRDVKSSNILLDRQWNA---RVSDFGLAKLLCSERS---------YVTTRVMGTFGYA 322
+VHR++K N+LL + +++DFGLA + + Y++ V+ Y+
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 323 HFIVQVSPLFILLYILL 339
V + ++LYILL
Sbjct: 209 K-PVDIWACGVILYILL 224
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 47.4 bits (111), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 48/186 (25%), Positives = 86/186 (46%), Gaps = 29/186 (15%)
Query: 157 NVIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ R + + KV K L R + K+E +++ V H
Sbjct: 34 KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT--KMERDILADVNHPF 91
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A GL +L
Sbjct: 92 VVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKF-YLAELALGLDHL 146
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK----------LLCSERSYVTTRVMG 317
H +++RD+K NILLD + + +++DFGL+K C Y+ V+
Sbjct: 147 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVN 203
Query: 318 TFGYAH 323
G++H
Sbjct: 204 RQGHSH 209
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 47.0 bits (110), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/197 (23%), Positives = 93/197 (47%), Gaps = 25/197 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 13 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 71
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 72 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 124
Query: 275 VVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS---------YVTTRVMGTFGYA 322
+VHR++K N+LL + +++DFGLA + + Y++ V+ Y+
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 323 HFIVQVSPLFILLYILL 339
V + ++LYILL
Sbjct: 185 K-PVDIWACGVILYILL 200
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/197 (23%), Positives = 93/197 (47%), Gaps = 25/197 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 125
Query: 275 VVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS---------YVTTRVMGTFGYA 322
+VHR++K N+LL + +++DFGLA + + Y++ V+ Y+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 323 HFIVQVSPLFILLYILL 339
V + ++LYILL
Sbjct: 186 K-PVDIWACGVILYILL 201
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 43/164 (26%), Positives = 78/164 (47%), Gaps = 15/164 (9%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
+G G YG V G +VAVK L + A++ ++ E+ ++ ++H+N++ LL
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHEGL 271
+ E+ D + + D+ ++ LT D +I +GL Y+H
Sbjct: 89 VFTPARS---LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSA- 144
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ ++ D GLA+ E + YV TR
Sbjct: 145 --DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR 186
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRH 206
LCE VIG+G + +V R I + G + AVK ++ G + ++ K E + ++H
Sbjct: 30 LCE--VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNL--DQWLHGDVGDV-SPLTWDIRMNIILGTAKG 263
++V LL +V+E++D +L + D G V S M IL +
Sbjct: 88 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EA 144
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFG 320
L Y H+ ++HRDVK +LL + N+ ++ FG+A L E V G G
Sbjct: 145 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAG---GRVG 197
Query: 321 YAHFI-------------VQVSPLFILLYILLS 340
HF+ V V ++L+ILLS
Sbjct: 198 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 230
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 30/208 (14%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHK 207
T G + IG G Y + R I + + AVK + +++++ E+E++ R +H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKII----DKSKRDPTEEIEILLRYGQHP 76
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
N++ L +G Y +V E G L D+ L + ++ K + Y
Sbjct: 77 NIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-----FSEREASAVLFTITKTVEY 131
Query: 267 LHEGLEPKVVHRDVKSSNIL-LDRQWNA---RVSDFGLAKLL----------CSERSYVT 312
LH VVHRD+K SNIL +D N R+ DFG AK L C ++V
Sbjct: 132 LHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVA 188
Query: 313 TRVMGTFGYAHFIVQVSPLFILLYILLS 340
V+ GY + L +LLY L+
Sbjct: 189 PEVLERQGY-DAACDIWSLGVLLYTXLT 215
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 28/200 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRLIFQVLDAVKYLH--- 133
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKL---------LCSERSYVTTRVMGTF 319
+ +VHRD+K N+L LD +SDFGL+K+ C YV V+
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 320 GYAHFIVQVSPLFILLYILL 339
Y+ V + ++ YILL
Sbjct: 194 PYSK-AVDCWSIGVIAYILL 212
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/197 (23%), Positives = 93/197 (47%), Gaps = 25/197 (12%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKV---EVEVIGRVRHKNLVRLLG 214
+G+G + +V R + + G + A K ++N + + ++F+ E + +++H N+VRL
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
E ++ LV++ V G L + D+ + + I + +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGELFE----DIVAREFYSEADASHCIQQILESIAYCHSN---G 125
Query: 275 VVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS---------YVTTRVMGTFGYA 322
+VHR++K N+LL + +++DFGLA + + Y++ V+ Y+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 323 HFIVQVSPLFILLYILL 339
V + ++LYILL
Sbjct: 186 K-PVDIWACGVILYILL 201
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/204 (23%), Positives = 85/204 (41%), Gaps = 38/204 (18%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G + +V R + T+ ++N + + ++ + E + ++H N+VRL
Sbjct: 39 LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP-- 273
E + LV++ V G L + DI A +H+ LE
Sbjct: 99 ISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASHCIHQILESVN 144
Query: 274 -----KVVHRDVKSSNILLDRQWN---ARVSDFGLAKLLCSERS----------YVTTRV 315
+VHRD+K N+LL + +++DFGLA + E+ Y++ V
Sbjct: 145 HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 316 MGTFGYAHFIVQVSPLFILLYILL 339
+ Y V + ++LYILL
Sbjct: 205 LRKDPYGK-PVDIWACGVILYILL 227
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 28/200 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRLIFQVLDAVKYLH--- 133
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKL---------LCSERSYVTTRVMGTF 319
+ +VHRD+K N+L LD +SDFGL+K+ C YV V+
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 320 GYAHFIVQVSPLFILLYILL 339
Y+ V + ++ YILL
Sbjct: 194 PYSK-AVDCWSIGVIAYILL 212
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 47.0 bits (110), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 37 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 93
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 94 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 150
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 151 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 194
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++HRD+K SNI++ ++ DFGLA+
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 51/200 (25%), Positives = 86/200 (43%), Gaps = 28/200 (14%)
Query: 157 NVIGEGGYGIVYRGILSDGTK----VAVKNLLNNRGQA-EKEFKVEVEVIGRVRHKNLVR 211
+V+G G + V IL++ + VA+K + + E + E+ V+ +++H N+V
Sbjct: 24 DVLGTGAFSEV---ILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L G + L+ + V G L + + T +I + YLH
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGE----LFDRIVEKGFYTERDASRLIFQVLDAVKYLH--- 133
Query: 272 EPKVVHRDVKSSNIL---LDRQWNARVSDFGLAKL---------LCSERSYVTTRVMGTF 319
+ +VHRD+K N+L LD +SDFGL+K+ C YV V+
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 320 GYAHFIVQVSPLFILLYILL 339
Y+ V + ++ YILL
Sbjct: 194 PYSK-AVDCWSIGVIAYILL 212
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 15 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 72
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 73 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 128
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 129 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 162
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 16 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 73
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 74 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 129
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 130 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 163
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 26 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 82
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 83 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 139
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 140 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 183
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 33 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 89
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 90 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 146
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 147 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 20/167 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE---RSYVTTR 314
++HRD+K SNI++ ++ DFGLA+ + YV TR
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 189
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 13 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 70
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 71 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 126
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 127 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 160
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 128 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++HRD+K SNI++ ++ DFGLA+
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 19/176 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
G ++HRD+K NILL+ + +++DFG AK+L E R G A ++
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANAFVGTAQYV 199
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 34 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 90
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 91 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 147
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++HRD+K SNI++ ++ DFGLA+
Sbjct: 148 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 176
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 37/213 (17%)
Query: 153 LCEENVIGEGGYGIVYRGILSD-GTKVAVK-----NLLNNRGQAEKEFKVEVEVIGRVRH 206
LCE VIG+G + +V R I + G + AVK ++ G + ++ K E + ++H
Sbjct: 28 LCE--VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNL--DQWLHGDVGDV-SPLTWDIRMNIILGTAKG 263
++V LL +V+E++D +L + D G V S M IL +
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL---EA 142
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNA---RVSDFGLAKLLCSERSYVTTRVMGTFG 320
L Y H+ ++HRDVK +LL + N+ ++ FG+A L E V G G
Sbjct: 143 LRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAG---GRVG 195
Query: 321 YAHFI-------------VQVSPLFILLYILLS 340
HF+ V V ++L+ILLS
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 46.6 bits (109), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 39 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 97 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 152
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 153 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 17/152 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
IG G GIV Y IL VA+K L N+ A++ ++ E+ ++ V HKN++ L
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGL 88
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD-IRMNIIL-GTAKGLAYLHEG 270
L + + E+ D + + + ++ V + D RM+ +L G+ +LH
Sbjct: 89 LNVFTP---QKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 271 LEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++HRD+K SNI++ ++ DFGLA+
Sbjct: 146 ---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 39 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 96
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 97 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 152
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 153 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 186
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 41 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 98
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 99 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 154
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 155 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 188
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 46.2 bits (108), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 6/149 (4%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGR-VRHKNLVRLLGY 215
+G G YG+V + + G +AVK + Q +K +++++ R V V G
Sbjct: 59 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ E +D +LD++ + + DI I + K L +LH L V
Sbjct: 119 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 175
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+HRDVK SN+L++ ++ DFG++ L
Sbjct: 176 IHRDVKPSNVLINALGQVKMCDFGISGYL 204
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 35 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 93 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 20 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 77
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 78 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 133
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 134 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 167
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 28/236 (11%)
Query: 121 ASFGSGSVGPEVSHLGWGRWYTLRELEAATSG---LCEENVIGEGGYGIVYRGIL-SDGT 176
A G + L + R+ + LEA G + V+G GG+G V+ + + G
Sbjct: 152 AHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGK 211
Query: 177 KVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233
A K L R + K ++ VE +++ +V H + L Y E + + + NG
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGG 270
Query: 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
++ +V + +P + R I TA+ GL +LH+ +++RD+K N+LLD
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRA--IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD 325
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVRYNSS 346
N R+SD GLA L + ++ T GYA +P F+ +LL Y+ S
Sbjct: 326 GNVRISDLGLAVELKAGQT-------KTKGYAG-----TPGFMAPELLLGEEYDFS 369
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 35 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 92
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 93 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 148
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 149 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 182
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 159 IGEGGYGIVYRGILSDGT------KVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLV 210
+G G + IV R GT K K L++ RG + +E + EV ++ +RH N++
Sbjct: 13 LGSGQFAIV-RKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L+ E V G L +L + LT D + G+ YLH
Sbjct: 72 TLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLH-- 125
Query: 271 LEPKVVHRDVKSSNI-LLDRQW-NARVS--DFGLAKLLCSERSYVTTRVMGTFGY-AHFI 325
++ H D+K NI LLD+ N R+ DFG+A + + + + GT + A I
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 326 VQVSPL---------FILLYILLS 340
V PL ++ YILLS
Sbjct: 183 VNYEPLGLEADMWSIGVITYILLS 206
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 28/236 (11%)
Query: 121 ASFGSGSVGPEVSHLGWGRWYTLRELEAATSG---LCEENVIGEGGYGIVYRGIL-SDGT 176
A G + L + R+ + LEA G + V+G GG+G V+ + + G
Sbjct: 152 AHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGK 211
Query: 177 KVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233
A K L R + K ++ VE +++ +V H + L Y E + + + NG
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGG 270
Query: 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
++ +V + +P + R I TA+ GL +LH+ +++RD+K N+LLD
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRA--IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD 325
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVRYNSS 346
N R+SD GLA L + ++ T GYA +P F+ +LL Y+ S
Sbjct: 326 GNVRISDLGLAVELKAGQT-------KTKGYAG-----TPGFMAPELLLGEEYDFS 369
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 28/236 (11%)
Query: 121 ASFGSGSVGPEVSHLGWGRWYTLRELEAATSG---LCEENVIGEGGYGIVYRGIL-SDGT 176
A G + L + R+ + LEA G + V+G GG+G V+ + + G
Sbjct: 152 AHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGK 211
Query: 177 KVAVKNLLNNRGQAEKEFK---VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGN 233
A K L R + K ++ VE +++ +V H + L Y E + + + NG
Sbjct: 212 LYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGG 270
Query: 234 LDQWLHGDVGDVSPLTWDIRMNIILGTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQ 290
++ +V + +P + R I TA+ GL +LH+ +++RD+K N+LLD
Sbjct: 271 DIRYHIYNVDEDNPGFQEPRA--IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD 325
Query: 291 WNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVRYNSS 346
N R+SD GLA L + ++ T GYA +P F+ +LL Y+ S
Sbjct: 326 GNVRISDLGLAVELKAGQT-------KTKGYAG-----TPGFMAPELLLGEEYDFS 369
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 46.2 bits (108), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 40/152 (26%), Positives = 70/152 (46%), Gaps = 6/152 (3%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGR-VRHKNLVRLLGY 215
+G G YG+V + + G +AVK + Q +K +++++ R V V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ E +D +LD++ + + DI I + K L +LH L V
Sbjct: 75 LFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--V 131
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+HRDVK SN+L++ ++ DFG++ L +
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 32/204 (15%)
Query: 159 IGEGGYGIVYRGILSDGT------KVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLV 210
+G G + IV R GT K K L++ RG + +E + EV ++ +RH N++
Sbjct: 20 LGSGQFAIV-RKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
L +L+ E V G L +L + LT D + G+ YLH
Sbjct: 79 TLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILDGVHYLH-- 132
Query: 271 LEPKVVHRDVKSSNI-LLDRQW-NARVS--DFGLAKLLCSERSYVTTRVMGTFGY-AHFI 325
++ H D+K NI LLD+ N R+ DFG+A + + + + GT + A I
Sbjct: 133 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 189
Query: 326 VQVSPL---------FILLYILLS 340
V PL ++ YILLS
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLS 213
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHK 207
+ G + IG G Y R + + + AVK + +++++ E+E++ R +H
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGT-AKGLA 265
N++ L +G + LV E + G L D+ L + + +L T K +
Sbjct: 82 NIITLKDVYDDGKHVYLVTELMRGGELLDKILR------QKFFSEREASFVLHTIGKTVE 135
Query: 266 YLHEGLEPKVVHRDVKSSNIL-LDRQWNA---RVSDFGLAKLL----------CSERSYV 311
YLH VVHRD+K SNIL +D N R+ DFG AK L C ++V
Sbjct: 136 YLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 312 TTRVMGTFGYAHFIVQVSPLFILLYILLS 340
V+ GY + L ILLY +L+
Sbjct: 193 APEVLKRQGYDEG-CDIWSLGILLYTMLA 220
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 45.8 bits (107), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 139 RWYTLRELEAATSG---LCEENVIGEGGYGIVYRGIL-SDGTKVAVKNLLNNRGQAEKEF 194
R+ + LEA G + V+G GG+G V+ + + G A K L R + K +
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGY 229
Query: 195 K---VEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWD 251
+ VE +++ +V H + L Y E + + + NG ++ +V + +P +
Sbjct: 230 QGAMVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQE 288
Query: 252 IRMNIILGTAK---GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSER 308
R I TA+ GL +LH+ +++RD+K N+LLD N R+SD GLA L + +
Sbjct: 289 PRA--IFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ 343
Query: 309 SYVTTRVMGTFGYAHFIVQVSPLFILLYILLSVRYNSS 346
+ T GYA +P F+ +LL Y+ S
Sbjct: 344 T-------KTKGYAG-----TPGFMAPELLLGEEYDFS 369
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + +E + EV ++ +RH N++ L +L+ E V G L +L +
Sbjct: 69 RGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKE 124
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDRQW-NARVS--DFGLAK 302
LT D + G+ YLH ++ H D+K NI LLD+ N R+ DFG+A
Sbjct: 125 SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 181
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + + GT + A IV PL ++ YILLS
Sbjct: 182 KIEAGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 227
>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
pdb|2RIO|B Chain B, Structure Of The Dual Enzyme Ire1 Reveals The Basis For
Catalysis And Regulation Of Non-conventional Splicing
Length = 434
Score = 45.8 bits (107), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 56/185 (30%), Positives = 87/185 (47%), Gaps = 30/185 (16%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 74
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 75 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCSERSYVTTRV 315
K++HRD+K NIL+ D+Q A +SDFGL K L S +S T +
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 316 MGTFG 320
G
Sbjct: 190 NNPSG 194
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + +V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 38 KILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 95
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 96 KLYFTFQDDEKLYFGLSYAKNGCLLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 151
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 152 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 32/209 (15%)
Query: 150 TSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV-RHK 207
+ G + IG G Y R + + + AVK + +++++ E+E++ R +H
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVI----DKSKRDPSEEIEILLRYGQHP 81
Query: 208 NLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGT-AKGLA 265
N++ L +G + LV E + G L D+ L + + +L T K +
Sbjct: 82 NIITLKDVYDDGKHVYLVTELMRGGELLDKILR------QKFFSEREASFVLHTIGKTVE 135
Query: 266 YLHEGLEPKVVHRDVKSSNIL-LDRQWNA---RVSDFGLAKLL----------CSERSYV 311
YLH VVHRD+K SNIL +D N R+ DFG AK L C ++V
Sbjct: 136 YLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 312 TTRVMGTFGYAHFIVQVSPLFILLYILLS 340
V+ GY + L ILLY +L+
Sbjct: 193 APEVLKRQGYDEG-CDIWSLGILLYTMLA 220
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 45.4 bits (106), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 41/177 (23%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK----------VEVE 199
S E V+G+G +G V V +N L++R A K+ + EV
Sbjct: 5 ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVM 54
Query: 200 VIGRVRH-------------KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD-VGDV 245
++ + H +N V+ + + + + EY +N L +H + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQ 114
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
W + I+ + L+Y+H ++HRD+K NI +D N ++ DFGLAK
Sbjct: 115 RDEYWRLFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAK 164
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 17/130 (13%)
Query: 197 EVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
EV+++ +V H N+++L + LV++ + G L +L V T I M
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA---------KLLCS 306
+L L L+ +VHRD+K NILLD N +++DFG + + +C
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCG 185
Query: 307 ERSYVTTRVM 316
SY+ ++
Sbjct: 186 TPSYLAPEII 195
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 45.4 bits (106), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 17/130 (13%)
Query: 197 EVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
EV+++ +V H N+++L + LV++ + G L +L V T I M
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 131
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA---------KLLCS 306
+L L L+ +VHRD+K NILLD N +++DFG + + +C
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 185
Query: 307 ERSYVTTRVM 316
SY+ ++
Sbjct: 186 TPSYLAPEII 195
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 17/158 (10%)
Query: 157 NVIGEGGYGI-VYRGILSDGTKVAVKNLLNNRGQAEKEFKV-----EVEVIGRVRHKNLV 210
++GEG + V L+ + A+K L + KE KV E +V+ R+ H V
Sbjct: 36 KILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFV 93
Query: 211 RLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH-E 269
+L + Y NG L +++ +G I+ L YLH +
Sbjct: 94 KLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDETCTRFYTAEIVS---ALEYLHGK 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
G ++HRD+K NILL+ + +++DFG AK+L E
Sbjct: 150 G----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + I V V N + + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + +V E G L ++ + II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 275 VVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI------ 325
+VHRD+K NILL ++ + ++ DFGL+ C +++ T++ G A++I
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQN---TKMKDRIGTAYYIAPEVLR 196
Query: 326 ------VQVSPLFILLYILLS 340
V ++LYILLS
Sbjct: 197 GTYDEKCDVWSAGVILYILLS 217
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + I V V N + + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + +V E G L ++ + II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 275 VVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI------ 325
+VHRD+K NILL ++ + ++ DFGL+ C +++ T++ G A++I
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS--TCFQQN---TKMKDRIGTAYYIAPEVLR 196
Query: 326 ------VQVSPLFILLYILLS 340
V ++LYILLS
Sbjct: 197 GTYDEKCDVWSAGVILYILLS 217
>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2IWI|B Chain B, Crystal Structure Of The Human Pim2 In Complex With A
Ruthenium Organometallic Ligand Ru1
Length = 312
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 56/199 (28%), Positives = 82/199 (41%), Gaps = 26/199 (13%)
Query: 158 VIGEGGYGIVYRG-ILSDGTKVAVKNLLNNRGQAEKEF------KVEVEVIGRVR----H 206
++G+GG+G V+ G L+D +VA+K + NR +EV ++ +V H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 207 KNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAY 266
++RLL + MLV E Q L + + PL + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 267 LHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSE--------RSYVTTRVMG 317
H VVHRD+K NIL+D R+ A++ DFG LL E R Y +
Sbjct: 155 CHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWIS 211
Query: 318 TFGYAHFIVQVSPLFILLY 336
Y V L ILLY
Sbjct: 212 RHQYHALPATVWSLGILLY 230
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 45.1 bits (105), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 35/130 (26%), Positives = 60/130 (46%), Gaps = 17/130 (13%)
Query: 197 EVEVIGRVR-HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMN 255
EV+++ +V H N+++L + LV++ + G L +L V T I M
Sbjct: 60 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI-MR 118
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLA---------KLLCS 306
+L L L+ +VHRD+K NILLD N +++DFG + + +C
Sbjct: 119 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG 172
Query: 307 ERSYVTTRVM 316
SY+ ++
Sbjct: 173 TPSYLAPEII 182
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 89/201 (44%), Gaps = 30/201 (14%)
Query: 158 VIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
++G+G +G V + I V V N + + + EVE++ ++ H N+++L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + +V E G L ++ + II G+ Y+H+
Sbjct: 89 ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---N 141
Query: 275 VVHRDVKSSNILL---DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFIV----- 326
+VHRD+K NILL ++ + ++ DFGL+ C +++ T++ G A++I
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST--CFQQN---TKMKDRIGTAYYIAPEVLR 196
Query: 327 -------QVSPLFILLYILLS 340
V ++LYILLS
Sbjct: 197 GTYDEKCDVWSAGVILYILLS 217
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 45.1 bits (105), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 44/157 (28%), Positives = 78/157 (49%), Gaps = 18/157 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRH-KNLVRLLGYC 216
+G G Y V+ I +++ KV VK L + + + K E++++ +R N++ L
Sbjct: 45 LGRGKYSEVFEAINITNNEKVVVKIL---KPVKKNKIKREIKILENLRGGPNIITLADIV 101
Query: 217 VEGAYRM--LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ R LV+E+V+N + Q L+ + D +DIR + K L Y H
Sbjct: 102 KDPVSRTPALVFEHVNNTDFKQ-LYQTLTD-----YDIRF-YMYEILKALDYCHSM---G 151
Query: 275 VVHRDVKSSNILLDRQWNA-RVSDFGLAKLLCSERSY 310
++HRDVK N+++D + R+ D+GLA+ + Y
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 188
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 45.1 bits (105), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 16/176 (9%)
Query: 157 NVIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+++G+G V+RG D + V N ++ + + + E EV+ ++ HKN+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 214 GYCVEGA--YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
E +++L+ E+ G+L L + + L + ++ G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 272 EPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+VHR++K NI+ D Q +++DFG A+ L + +V+ + GT Y H
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLH 183
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
IG+G + +V R + L G + A K + + A K+E E + ++H N+VRL
Sbjct: 12 IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E + LV++ V G L + D+ + + I + + + H+ V
Sbjct: 72 ISEEGFHYLVFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 124
Query: 276 VHRDVKSSNILLDRQWN---ARVSDFGLA 301
VHRD+K N+LL + +++DFGLA
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLA 153
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 44.7 bits (104), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 30/159 (18%)
Query: 159 IGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRL 212
+GEG YG VY+ I + VA+K + R + E+E EV ++ ++H+N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRI---RLEHEEEGVPGTAIREVSLLKELQHRNIIEL 98
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG----TAKGLAYLH 268
L++EY +N +L +++ D +P D+ M +I G+ + H
Sbjct: 99 KSVIHHNHRLHLIFEYAEN-DLKKYM-----DKNP---DVSMRVIKSFLYQLINGVNFCH 149
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNA-----RVSDFGLAK 302
+ +HRD+K N+LL + ++ DFGLA+
Sbjct: 150 SR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 44.7 bits (104), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V Y L KVAVK L + A + ++ E+ ++ ++H+N++ L
Sbjct: 28 VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 84
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHE 269
L + ++ + + + D+ ++ L+ + ++ +GL Y+H
Sbjct: 85 LDVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 141
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR
Sbjct: 142 A---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR 184
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 44/175 (25%), Positives = 80/175 (45%), Gaps = 18/175 (10%)
Query: 157 NVIGEGGYGIVY--RGILSDGT------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G G YG V+ R I T KV K + + + + + E +V+ +R
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 209 LVRLLGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILG-TAKGLAY 266
+ L Y + ++ L+ +Y++ G L + H + T + + I +G L +
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL--FTH--LSQRERFT-EHEVQIYVGEIVLALEH 174
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
LH+ +++RD+K NILLD + ++DFGL+K ++ + GT Y
Sbjct: 175 LHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 44.3 bits (103), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V Y L KVAVK L + A + ++ E+ ++ ++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHE 269
L + ++ + + + D+ ++ L+ + ++ +GL Y+H
Sbjct: 93 LDVFTPATS---IEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR 192
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 43/169 (25%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKE-----FKVEVEVIGRVRHKNLVRL 212
IG+G +G V +D K+ +N + E+ FK E++++ + H LV L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNL 80
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ +V + + G+L L +V + I L YL
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH----FKEETVKLFICELVMALDYLQNQ-- 134
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+++HRD+K NILLD + ++DF +A +L E T + GT Y
Sbjct: 135 -RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPY 180
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 42/166 (25%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 159 IGEGGYGIV---YRGILSDGTKVAVKNL---LNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
+G G YG V Y L KVAVK L + A + ++ E+ ++ ++H+N++ L
Sbjct: 36 VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGL 92
Query: 213 LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDV---SPLTWDIRMNIILGTAKGLAYLHE 269
L + ++ + + + D+ ++ L+ + ++ +GL Y+H
Sbjct: 93 LDVFTPATS---IEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS 149
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERS-YVTTR 314
++HRD+K SN+ ++ R+ DFGLA+ E + YV TR
Sbjct: 150 A---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR 192
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 40/152 (26%), Positives = 66/152 (43%), Gaps = 6/152 (3%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNN-RGQAEKEFKVEVEVIGR-VRHKNLVRLLGY 215
+G G YG+V + + G AVK + Q +K ++++ R V V G
Sbjct: 42 LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
+ E D +LD++ + + DI I + K L +LH L V
Sbjct: 102 LFREGDVWICXELXDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 158
Query: 276 VHRDVKSSNILLDRQWNARVSDFGLAKLLCSE 307
+HRDVK SN+L++ + DFG++ L +
Sbjct: 159 IHRDVKPSNVLINALGQVKXCDFGISGYLVDD 190
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 41/177 (23%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFK----------VEVE 199
S E V+G+G +G V V +N L++R A K+ + EV
Sbjct: 5 ASDFEEIAVLGQGAFGQV----------VKARNALDSRYYAIKKIRHTEEKLSTILSEVX 54
Query: 200 VIGRVRHKNLVRLLGYCVE-------------GAYRMLVYEYVDNGNLDQWLHGD-VGDV 245
++ + H+ +VR +E + + EY +N L +H + +
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQ 114
Query: 246 SPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
W + I+ + L+Y+H ++HR++K NI +D N ++ DFGLAK
Sbjct: 115 RDEYWRLFRQIL----EALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAK 164
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 40/174 (22%), Positives = 73/174 (41%), Gaps = 19/174 (10%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEK---------EFKVEVEVIGRVRHKNL 209
+G G +G V+ + + K V + E + +E+ ++ RV H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 210 VRLLGYCVEGAYRMLVYEYVDNG-NLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
+++L + LV E +G +L ++ PL I ++ +A G L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV--SAVGYLRLK 149
Query: 269 EGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
+ ++HRD+K NI++ + ++ DFG A L ER + GT Y
Sbjct: 150 D-----IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYC 196
>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin
pdb|3LJ0|B Chain B, Ire1 Complexed With Adp And Quercetin
pdb|3LJ1|A Chain A, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ1|B Chain B, Ire1 Complexed With Cdk12 INHIBITOR III
pdb|3LJ2|A Chain A, Ire1 Complexed With Jak Inhibitor I
pdb|3LJ2|B Chain B, Ire1 Complexed With Jak Inhibitor I
Length = 434
Score = 43.9 bits (102), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 30/171 (17%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 20 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 74
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 75 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCS 306
K++HRD+K NIL+ D+Q A +SDFGL K L S
Sbjct: 133 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3
Length = 361
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 30/192 (15%)
Query: 159 IGEGGYGIVYRGILSDGTK--VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLLG 214
IG G +G+ R + TK VAVK + RG A E V+ E+I +RH N+VR
Sbjct: 28 IGSGNFGVA-RLMRDKLTKELVAVKYI--ERGAAIDE-NVQREIINHRSLRHPNIVRFKE 83
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ + ++ EY G L+ + + + D G++Y H +
Sbjct: 84 VILTPTHLAIIMEYASGGE----LYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---Q 136
Query: 275 VVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPLF 332
+ HRD+K N LLD R + DFG +K S + ++ T G +P +
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG--------TPAY 183
Query: 333 ILLYILLSVRYN 344
I +LL Y+
Sbjct: 184 IAPEVLLRQEYD 195
>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|B Chain B, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|C Chain C, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|D Chain D, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|E Chain E, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|F Chain F, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|G Chain G, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|H Chain H, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|I Chain I, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|J Chain J, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|K Chain K, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|L Chain L, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|M Chain M, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3FBV|N Chain N, Crystal Structure Of The Oligomer Formed By The
Kinase-Ribonuclease Domain Of Ire1
pdb|3SDM|A Chain A, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|B Chain B, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|C Chain C, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|D Chain D, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|E Chain E, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|F Chain F, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
pdb|3SDM|G Chain G, Structure Of Oligomeric KinaseRNASE IRE1 IN COMPLEX WITH
AN Oligonucleotide
Length = 448
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 30/171 (17%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 38 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 93 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCS 306
K++HRD+K NIL+ D+Q A +SDFGL K L S
Sbjct: 151 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|B Chain B, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|C Chain C, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|D Chain D, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|E Chain E, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|F Chain F, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|G Chain G, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|H Chain H, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|I Chain I, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|J Chain J, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|K Chain K, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|L Chain L, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|M Chain M, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
pdb|3SDJ|N Chain N, Structure Of Rnase-Inactive Point Mutant Of Oligomeric
KinaseRNASE Ire1
Length = 448
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 30/171 (17%)
Query: 156 ENVIGEGGYG-IVYRGILSDGTKVAVKNLLNNRGQ-AEKEFKVEVEVIGRVRHKNLVRLL 213
E ++G G G +V++G G VAVK +L + A E K+ E H N++R
Sbjct: 38 EKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVIRY- 92
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR-----MNIILGTAKGLAYLH 268
YC E R L Y ++ NL+ + +VS ++ ++++ A G+A+LH
Sbjct: 93 -YCSETTDRFL-YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 150
Query: 269 EGLEPKVVHRDVKSSNILL--------DRQWNAR-----VSDFGLAKLLCS 306
K++HRD+K NIL+ D+Q A +SDFGL K L S
Sbjct: 151 SL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 51/170 (30%), Positives = 79/170 (46%), Gaps = 15/170 (8%)
Query: 158 VIGEGGYG-IVYRGILSDGTKVAVKNLLNN---RGQAEKEFKVEVEVIGR-VRHKNLVRL 212
VIG+G +G ++ ++ AVK L + + EK E V+ + V+H LV L
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 213 LGYCVEGAYRM-LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
+ + A ++ V +Y++ G L L + + P I A L YLH
Sbjct: 105 -HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHSL- 158
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
+V+RD+K NILLD Q + ++DFGL K E + T+ GT Y
Sbjct: 159 --NIVYRDLKPENILLDSQGHIVLTDFGLCKENI-EHNSTTSTFCGTPEY 205
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 15/152 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKV--AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
EN IG G +G V + + GT++ A K + + FK E+E++ + H N++RL
Sbjct: 14 ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ LV E G L ++ +H V S I+ +AY H+
Sbjct: 73 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----RIMKDVLSAVAYCHKL-- 125
Query: 273 PKVVHRDVKSSNILL---DRQWNARVSDFGLA 301
V HRD+K N L ++ DFGLA
Sbjct: 126 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 44/176 (25%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 157 NVIGEGGYGIVYRG---ILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
+++G+G V+RG D + V N ++ + + + E EV+ ++ HKN+V+L
Sbjct: 15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 214 GYCVEGA--YRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
E +++L+ E+ G+L L + + L + ++ G+ +L E
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLREN- 131
Query: 272 EPKVVHRDVKSSNILL----DRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAH 323
+VHR++K NI+ D Q +++DFG A+ L + +V + GT Y H
Sbjct: 132 --GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX--LYGTEEYLH 183
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 43.5 bits (101), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 43/152 (28%), Positives = 66/152 (43%), Gaps = 15/152 (9%)
Query: 156 ENVIGEGGYGIVYRGILSDGTKV--AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
EN IG G +G V + + GT++ A K + + FK E+E++ + H N++RL
Sbjct: 31 ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 89
Query: 214 GYCVEGAYRMLVYEYVDNGNL-DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
+ LV E G L ++ +H V S I+ +AY H+
Sbjct: 90 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----RIMKDVLSAVAYCHKL-- 142
Query: 273 PKVVHRDVKSSNILL---DRQWNARVSDFGLA 301
V HRD+K N L ++ DFGLA
Sbjct: 143 -NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 195 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 254
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 255 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 305
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY
Sbjct: 306 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 355
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 306
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 356
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 306
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 356
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 158 VIGEGGYGIVYRGILSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVRHKN--LVR 211
+IG GG+G VY +D K+ L+ + Q E E ++ V + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 212 LLGYCVEGAYRM-LVYEYVDNGNLDQWL--HGDVGDVSPLTWDIRM---NIILGTAKGLA 265
+ Y ++ + + ++ G+L L HG + D+R IILG L
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIILG----LE 306
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
++H VV+RD+K +NILLD + R+SD GLA ++ + + +GT GY
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGY 356
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 157 NVIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ G+ KV K L R + K+E +++ V H
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A L +L
Sbjct: 88 IVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKF-YLAELALALDHL 142
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
H +++RD+K NILLD + + +++DFGL+K
Sbjct: 143 HSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK 174
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 43.1 bits (100), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 38/162 (23%), Positives = 78/162 (48%), Gaps = 26/162 (16%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 69 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 127
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL------ 303
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+
Sbjct: 128 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 178
Query: 304 ---LCSERSYVTTRVMGTFGYAHF--IVQVSPLFILLYILLS 340
LC +Y+ V+ + G A + V L ++L+I LS
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 220
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 43.1 bits (100), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/162 (23%), Positives = 78/162 (48%), Gaps = 26/162 (16%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL------ 303
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+
Sbjct: 122 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 304 ---LCSERSYVTTRVMGTFGYAHF--IVQVSPLFILLYILLS 340
LC +Y+ V+ + G A + V L ++L+I LS
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 214
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 38/162 (23%), Positives = 78/162 (48%), Gaps = 26/162 (16%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 62 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 120
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL------ 303
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+
Sbjct: 121 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 171
Query: 304 ---LCSERSYVTTRVMGTFGYAHF--IVQVSPLFILLYILLS 340
LC +Y+ V+ + G A + V L ++L+I LS
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS 213
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 23/63 (36%), Positives = 36/63 (57%), Gaps = 2/63 (3%)
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
P+ I + + K L YL E + V+HRDVK SNILLD + ++ DFG++ L
Sbjct: 120 PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 307 ERS 309
+++
Sbjct: 178 DKA 180
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 28/163 (17%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL------ 303
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+
Sbjct: 122 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 304 ---LCSERSYVTTRVM---GTFGYAHFIVQVSPLFILLYILLS 340
LC +Y+ V+ GT GY V L ++L+I LS
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLS 214
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 13/155 (8%)
Query: 157 NVIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+++GEG YG V + S+ K+ K L E K E++++ R+RHKN+++
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 212 LLG--YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
L+ Y E +V EY G + + L P+ GL YLH
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQ--AHGYFCQLIDGLEYLHS 127
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLL 304
+VH+D+K N+LL ++S G+A+ L
Sbjct: 128 Q---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 40/163 (24%), Positives = 77/163 (47%), Gaps = 28/163 (17%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 63 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 121
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFG---------L 300
+M + + YLHE ++HRD+K N+LL Q +++DFG L
Sbjct: 122 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 301 AKLLCSERSYVTTRVM---GTFGYAHFIVQVSPLFILLYILLS 340
+ LC +Y+ V+ GT GY V L ++L+I LS
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLS 214
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 157 NVIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ G+ KV K L R + K+E +++ V H
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 87
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A L +L
Sbjct: 88 IVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLA-ELALALDHL 142
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
H +++RD+K NILLD + + +++DFGL+K
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 174
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 42.7 bits (99), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 157 NVIGEGGYGIVYRGILSDGT--------KVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 208
V+G+G +G V+ G+ KV K L R + K+E +++ V H
Sbjct: 31 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPF 88
Query: 209 LVRL-LGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
+V+L + EG L+ +++ G+L L +V D++ + A L +L
Sbjct: 89 IVKLHYAFQTEGKL-YLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLA-ELALALDHL 143
Query: 268 HEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
H +++RD+K NILLD + + +++DFGL+K
Sbjct: 144 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK 175
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 42.0 bits (97), Expect = 5e-04, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 24/161 (14%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRM 254
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + T +
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN-KRLKEATCKLYF 245
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL-------- 303
+L + YLHE ++HRD+K N+LL Q +++DFG +K+
Sbjct: 246 YQML---LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMR 299
Query: 304 -LCSERSYVTTRVM---GTFGYAHFIVQVSPLFILLYILLS 340
LC +Y+ V+ GT GY V L ++L+I LS
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLS 339
>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small
Molecule Inhibitor
pdb|3UMX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indol-3-Yl)methylene]-7-(Azepan-1-Ylmethyl)-6-
Hydroxybenzofuran- 3(2h)-One
pdb|4ENX|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
Inhibitor (2e,5z)-2-
(2-Chlorophenylimino)-5-(4-Hydroxy-3-
Nitrobenzylidene)thiazolidin-4- One
pdb|4ENY|A Chain A, Crystal Structure Of Pim-1 Kinase In Complex With
(2e,5z)-2-(2-
Chlorophenylimino)-5-(4-Hydroxy-3-
Methoxybenzylidene)thiazolidin-4- One
pdb|3UMW|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Inhibitor
(Z)-2-[(1h-
Indazol-3-Yl)methylene]-6-Methoxy-7-(Piperazin-1-
Ylmethyl)benzofuran- 3(2h)-One
Length = 298
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 117
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 313 TRVMGTFGYA 322
T GT Y+
Sbjct: 172 TDFDGTRVYS 181
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 38/159 (23%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 158 VIGEGGYGIVYRGILS--DGT--KVAVKNLLNN--RGQAEKEFKVEVEVIGRVRHKNLVR 211
++G+G +G V L DG+ KVAVK L + +EF E + H ++ +
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 212 LLGYCVEGAYR------MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR--MNIILGTAKG 263
L+G + + M++ ++ +G+L +L +P ++ + ++ A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 264 LAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
+ YL +HRD+ + N +L V+DFGL++
Sbjct: 150 MEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSR 185
>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation
Length = 293
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 82/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E ++ Q L + + L ++ + + + + H
Sbjct: 75 VIRLLDWFERPDSFVLILERMEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 180
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 28/163 (17%)
Query: 195 KVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGD--VGDVSPLTWDI 252
+ E+E++ ++ H ++++ + Y +V E ++ G L + G+ + + + +
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY 260
Query: 253 RMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKL------ 303
+M + + YLHE ++HRD+K N+LL Q +++DFG +K+
Sbjct: 261 QMLL------AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 311
Query: 304 ---LCSERSYVTTRVM---GTFGYAHFIVQVSPLFILLYILLS 340
LC +Y+ V+ GT GY V L ++L+I LS
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLS 353
>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JY0|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
pdb|3JYA|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As
Potent, Highly Selective And Orally Bioavailable Pim
Kinases Inhibitors
Length = 294
Score = 41.6 bits (96), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 117
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 313 TRVMGTFGYA 322
T GT Y+
Sbjct: 172 TDFDGTRVYS 181
>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546
Length = 308
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 23 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 82
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 83 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 139
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 140 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 193
Query: 313 TRVMGTFGYA 322
T GT Y+
Sbjct: 194 TDFDGTRVYS 203
>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770
Length = 285
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 12/184 (6%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---R 205
T+ E IG G +G V++ + DG A+K + E EV +
Sbjct: 6 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 65
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H ++VR E + ++ EY + G+L + + +S +++L +GL
Sbjct: 66 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 125
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
Y+H +VH D+K SNI + +R S A E + + +VM G +
Sbjct: 126 YIHSM---SLVHMDIKPSNIFI-----SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 177
Query: 326 VQVS 329
++S
Sbjct: 178 TRIS 181
>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R01|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R02|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3R04|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As
Potent Pim-1 Inhibitors
pdb|3VBQ|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBT|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBV|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBW|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBX|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VBY|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
pdb|3VC4|A Chain A, Exploitation Of Hydrogen Bonding Constraints And Flat
Hydrophobic Energy Landscapes In Pim-1 Kinase Needle
Screening And Inhibitor Design
Length = 299
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 19/190 (10%)
Query: 143 LRELEAATSGLCEENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVE 197
++E E S ++G GG+G VY GI +SD VA+K++ +R G+ +V
Sbjct: 1 MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 198 VEVIGRVR----HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIR 253
+EV+ + ++RLL + +L+ E + Q L + + L ++
Sbjct: 61 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELA 117
Query: 254 MNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVT 312
+ + + + H V+HRD+K NIL+D + ++ DFG LL + V
Sbjct: 118 RSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVY 171
Query: 313 TRVMGTFGYA 322
T GT Y+
Sbjct: 172 TDFDGTRVYS 181
>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839
pdb|2IO6|A Chain A, Wee1 Kinase Complexed With Inhibitor Pd330961
Length = 287
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 12/184 (6%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---R 205
T+ E IG G +G V++ + DG A+K + E EV +
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H ++VR E + ++ EY + G+L + + +S +++L +GL
Sbjct: 68 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
Y+H +VH D+K SNI + +R S A E + + +VM G +
Sbjct: 128 YIHSM---SLVHMDIKPSNIFI-----SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 179
Query: 326 VQVS 329
++S
Sbjct: 180 TRIS 183
>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed
With Inhibitor Pd0407824
Length = 289
Score = 41.6 bits (96), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 12/184 (6%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---R 205
T+ E IG G +G V++ + DG A+K + E EV +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H ++VR E + ++ EY + G+L + + +S +++L +GL
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
Y+H +VH D+K SNI + +R S A E + + +VM G +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFI-----SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181
Query: 326 VQVS 329
++S
Sbjct: 182 TRIS 185
>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396
pdb|3BIZ|A Chain A, Wee1 Kinase Complex With Inhibitor Pd331618
pdb|3CQE|A Chain A, Wee1 Kinase Complex With Inhibitor Pd074291
pdb|3CR0|A Chain A, Wee1 Kinase Complex With Inhibitor Pd259_809
Length = 287
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 12/184 (6%)
Query: 150 TSGLCEENVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQAEKEFKVEVEVIGRV---R 205
T+ E IG G +G V++ + DG A+K + E EV +
Sbjct: 8 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 67
Query: 206 HKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLA 265
H ++VR E + ++ EY + G+L + + +S +++L +GL
Sbjct: 68 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 127
Query: 266 YLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYAHFI 325
Y+H +VH D+K SNI + +R S A E + + +VM G +
Sbjct: 128 YIHSM---SLVHMDIKPSNIFI-----SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 179
Query: 326 VQVS 329
++S
Sbjct: 180 TRIS 183
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 50/214 (23%), Positives = 89/214 (41%), Gaps = 41/214 (19%)
Query: 157 NVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVR-HKNLVRLLG 214
++GEG Y V + L +G + AVK + G + EVE + + + +KN++ L+
Sbjct: 19 ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 215 YCVEGAYRMLVYEYVDNGNL----DQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEG 270
+ + LV+E + G++ + H + + S + D+ A L +LH
Sbjct: 79 FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDV--------AAALDFLHTK 130
Query: 271 LEPKVVHRDVKSSNILLDRQWN---ARVSDFGLAKLL-----------------CSERSY 310
+ HRD+K NIL + ++ DF L + C Y
Sbjct: 131 ---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEY 187
Query: 311 VTTRVMGTF-GYAHFIVQVSPLF---ILLYILLS 340
+ V+ F A F + L+ ++LYI+LS
Sbjct: 188 MAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLS 221
>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Pyrrolo[2,3- A]carbazole Ligand
pdb|3QF9|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Furan- Thiazolidinedione Ligand
pdb|4GW8|A Chain A, Human Proto-Oncogene Serine Threonine Kinase (Pim1) In
Complex With A Consensus Peptide And Leucettine L41
Length = 313
Score = 41.2 bits (95), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa
Length = 300
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 90 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 195
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 20/161 (12%)
Query: 191 EKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTW 250
E + E+ V+ +++H+N+V L + LV + V G L + + T
Sbjct: 64 ESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGE----LFDRIVEKGFYTE 119
Query: 251 DIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL---DRQWNARVSDFGLAKL---- 303
+I + YLH +VHRD+K N+L D + +SDFGL+K+
Sbjct: 120 KDASTLIRQVLDAVYYLHRM---GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG 176
Query: 304 -----LCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYILL 339
C YV V+ Y+ V + ++ YILL
Sbjct: 177 DVMSTACGTPGYVAPEVLAQKPYSK-AVDCWSIGVIAYILL 216
>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution
pdb|1XR1|A Chain A, Crystal Structure Of Hpim-1 Kinase In Complex With Amp-Pnp
At 2.1 A Resolution
Length = 300
Score = 41.2 bits (95), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 30 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 89
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 90 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 146
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 147 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 195
>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With
4-(4-
Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One
pdb|3T9I|A Chain A, Pim1 Complexed With A Novel 3,6-Disubstituted Indole At
2.6 Ang Resolution
Length = 328
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 223
>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From
Crystallographic Fragment Screen
Length = 301
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 91 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 196
>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand I
pdb|3CY2|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Beta Carboline Ligand Ii
Length = 314
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
pdb|4ALW|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1
Length = 328
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 58 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 117
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 118 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 174
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 175 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 223
>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain
Length = 313
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From
Crystallographic Fragment Screen
Length = 301
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 91 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 196
>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And A
Naphtho-Difuran Ligand
Length = 313
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With
Ly333531
Length = 312
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261
pdb|2BZI|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru2
Length = 313
Score = 41.2 bits (95), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its
Consensus Peptide Pimtide
pdb|2BZJ|A Chain A, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru3
pdb|2BZK|B Chain B, Crystal Structure Of The Human Pim1 In Complex With Amppnp
And Pimtide
pdb|2C3I|B Chain B, Crystal Structure Of Human Pim1 In Complex With
Imidazopyridazin I
pdb|2BZH|B Chain B, Crystal Structure Of The Human Pim1 In Complex With A
Ruthenium Organometallic Ligand Ru1
pdb|2OI4|X Chain X, Crystal Structure Of Human Pim1 In Complex With
Fluorinated Ruthenium Pyridocarbazole
pdb|3BWF|A Chain A, Crystal Structure Of The Human Pim1 In Complex With An
Osmium Compound
Length = 313
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 43 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 102
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 103 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 159
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 160 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 208
>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine
Kinase (Pim1) In Complex With A Consensus Peptide And
The Jnk Inhibitor V
Length = 314
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 44 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 103
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 104 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 160
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 161 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 209
>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From
Crystallographic Fragment Screen
pdb|2XIZ|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-3 From
Crystallographic Fragment Screen
pdb|2XJ1|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inibitor
pdb|2XJ2|A Chain A, Protein Kinase Pim-1 In Complex With Small Molecule
Inhibitor
Length = 301
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 31 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 90
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 91 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 147
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 148 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 196
>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With
Inhibitor
pdb|3BGP|A Chain A, Human Pim-1 Complexed With A Benzoisoxazole Inhibitor Vx1
pdb|3BGQ|A Chain A, Human Pim-1 Kinase In Complex With An Triazolo Pyridazine
Inhibitor Vx2
pdb|3BGZ|A Chain A, Human Pim-1 Kinase In Complex With Diphenyl Indole
Inhibitor Vx3
Length = 333
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 63 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 122
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 123 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 179
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 180 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 228
>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of
P27kip1 Carboxy-Terminal Peptide
Length = 320
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 167 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 215
>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target
Of Aberrant Somatic Hypermutations In Diffuse Large Cell
Lymphoma
pdb|1YXT|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amppnp
pdb|1YXU|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|B Chain B, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|C Chain C, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXU|D Chain D, Crystal Structure Of Kinase Pim1 In Complex With Amp
pdb|1YXV|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
3,4-Dihydroxy-1- Methylquinolin-2(1h)-One
pdb|1YXX|A Chain A, Crystal Structure Of Kinase Pim1 In Complex With
(3e)-3-[(4- Hydroxyphenyl)imino]-1h-Indol-2(3h)-One
pdb|2O3P|A Chain A, Crystal Structure Of Pim1 With Quercetin
pdb|2O63|A Chain A, Crystal Structure Of Pim1 With Myricetin
pdb|2O64|A Chain A, Crystal Structure Of Pim1 With Quercetagetin
pdb|2O65|A Chain A, Crystal Structure Of Pim1 With Pentahydroxyflavone
Length = 293
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 15 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 74
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 75 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 131
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 132 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 180
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 24/156 (15%)
Query: 158 VIGEGGYGIVYRGILSD--------GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNL 209
V+G+G +G V +L+D K+ K+++ E VE V+ +
Sbjct: 26 VLGKGSFGKV---MLADRKGTEELYAIKILKKDVVIQDDDVECTM-VEKRVLALLDKPPF 81
Query: 210 VRLLGYCVEGAYRM-LVYEYVDNGNLDQWLH--GDVGDVSPLTWDIRMNIILGTAKGLAY 266
+ L C + R+ V EYV+ G+L + G + + + ++I GL +
Sbjct: 82 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GLFF 135
Query: 267 LHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
LH+ +++RD+K N++LD + + +++DFG+ K
Sbjct: 136 LHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK 168
>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1
Length = 361
Score = 40.8 bits (94), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 32/193 (16%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ E V+ E+I +RH N+VR
Sbjct: 26 IGSGNFGVA--RLMRDKQSNELVAVKYI--ERGEKIDE-NVKREIINHRSLRHPNIVRFK 80
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 81 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM--- 133
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPL 331
+V HRD+K N LLD R + DFG +K S + ++ T G +P
Sbjct: 134 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG--------TPA 180
Query: 332 FILLYILLSVRYN 344
+I +LL Y+
Sbjct: 181 YIAPEVLLKKEYD 193
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 27/156 (17%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
+G+G + +V R + + G + A K + + A K+E E + ++H N+VRL
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP-- 273
E + LV++ V G L + DI A + + LE
Sbjct: 72 ISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASHCIQQILESVN 117
Query: 274 -----KVVHRDVKSSNILLDRQWNA---RVSDFGLA 301
+VHRD+K N+LL + +++DFGLA
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 18/150 (12%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + +AE E+ + +V L G
Sbjct: 101 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 153
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q V + L D + + +GL YLH ++
Sbjct: 154 VREGPWVNIFMELLEGGSLGQL----VKEQGCLPEDRALYYLGQALEGLEYLHSR---RI 206
Query: 276 VHRDVKSSNILLDRQWN-ARVSDFGLAKLL 304
+H DVK+ N+LL + A + DFG A L
Sbjct: 207 LHGDVKADNVLLSSDGSHAALCDFGHAVCL 236
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 38/149 (25%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
+G+G + +V R + + G + A K + + A K+E E + ++H N+VRL
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E + L+++ V G L + D+ + + I + + + H+ V
Sbjct: 90 ISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 142
Query: 276 VHRDVKSSNILLDRQWNA---RVSDFGLA 301
VHRD+K N+LL + +++DFGLA
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLA 171
>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors
Length = 273
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 176
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 27/156 (17%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVE--VIGRVRHKNLVRLLGY 215
+G+G + +V R + + G + A K + + A K+E E + ++H N+VRL
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP-- 273
E + LV++ V G L + DI A + + LE
Sbjct: 72 ISEEGFHYLVFDLVTGGELFE--------------DIVAREYYSEADASHCIQQILESVN 117
Query: 274 -----KVVHRDVKSSNILLDRQWN---ARVSDFGLA 301
+VHRD+K N+LL + +++DFGLA
Sbjct: 118 HCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLA 153
>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor
Length = 276
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 14 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 73
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 74 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 130
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 131 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 179
>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|B Chain B, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|C Chain C, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
pdb|3C4E|D Chain D, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7-
Azaindole
Length = 273
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 176
>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6
pdb|3UDB|B Chain B, Crystal Structure Of Snrk2.6
pdb|3UDB|C Chain C, Crystal Structure Of Snrk2.6
pdb|3UDB|D Chain D, Crystal Structure Of Snrk2.6
pdb|3UDB|E Chain E, Crystal Structure Of Snrk2.6
pdb|3UDB|F Chain F, Crystal Structure Of Snrk2.6
Length = 317
Score = 40.4 bits (93), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 52/197 (26%), Positives = 85/197 (43%), Gaps = 28/197 (14%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ E V+ E+I +RH N+VR
Sbjct: 27 IGAGNFGVAR--LMRDKQANELVAVKYI--ERGEKIDE-NVKREIINHRSLRHPNIVRFK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 82 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYAHAM--- 134
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAK--LLCSE-------RSYVTTRVMGTFGYA 322
+V HRD+K N LLD R ++DFG +K +L S+ +Y+ V+ Y
Sbjct: 135 QVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYD 194
Query: 323 HFIVQVSPLFILLYILL 339
+ V + LY++L
Sbjct: 195 GKVADVWSCGVTLYVML 211
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 43/150 (28%), Positives = 69/150 (46%), Gaps = 18/150 (12%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + +AE E+ + +V L G
Sbjct: 82 LGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFRAE-----ELMACAGLTSPRIVPLYGA 134
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q V + L D + + +GL YLH ++
Sbjct: 135 VREGPWVNIFMELLEGGSLGQL----VKEQGCLPEDRALYYLGQALEGLEYLHSR---RI 187
Query: 276 VHRDVKSSNILLDRQWN-ARVSDFGLAKLL 304
+H DVK+ N+LL + A + DFG A L
Sbjct: 188 LHGDVKADNVLLSSDGSHAALCDFGHAVCL 217
>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine
pdb|1YI3|A Chain A, Crystal Structure Of Pim-1 Bound To Ly294002
pdb|1YI4|A Chain A, Structure Of Pim-1 Bound To Adenosine
Length = 273
Score = 40.4 bits (93), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 46/175 (26%), Positives = 81/175 (46%), Gaps = 19/175 (10%)
Query: 158 VIGEGGYGIVYRGI-LSDGTKVAVKNLLNNR----GQAEKEFKVEVEVIGRVR----HKN 208
++G GG+G VY GI +SD VA+K++ +R G+ +V +EV+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 209 LVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLH 268
++RLL + +L+ E + Q L + + L ++ + + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPV---QDLFDFITERGALQEELARSFFWQVLEAVRHCH 127
Query: 269 EGLEPKVVHRDVKSSNILLD-RQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
V+HRD+K NIL+D + ++ DFG LL + V T GT Y+
Sbjct: 128 NX---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYS 176
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 30/203 (14%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGY-AHFIV 326
K+ H D+K NI LLD+ + ++ DFGLA + E + GT + A IV
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 327 QVSPL---------FILLYILLS 340
PL ++ YILLS
Sbjct: 191 NYEPLGLEADMWSIGVITYILLS 213
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLA 301
K+ H D+K NI LLD+ + ++ DFGLA
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 40.0 bits (92), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 30/203 (14%)
Query: 159 IGEGGYGIVYRG-ILSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLAKLLCSERSYVTTRVMGTFGY-AHFIV 326
K+ H D+K NI LLD+ + ++ DFGLA + E + GT + A IV
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIV 190
Query: 327 QVSPL---------FILLYILLS 340
PL ++ YILLS
Sbjct: 191 NYEPLGLEADMWSIGVITYILLS 213
>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein
Kinase Ck2alpha Prime With A Potent Indazole-Derivative
Inhibitor
Length = 339
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 11/88 (12%)
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
LV+EY++N + Q L+ + D +DIR + K L Y H ++HRDVK
Sbjct: 117 LVFEYINNTDFKQ-LYQILTD-----FDIRF-YMYELLKALDYCHSK---GIMHRDVKPH 166
Query: 284 NILLDRQWNA-RVSDFGLAKLLCSERSY 310
N+++D Q R+ D+GLA+ + Y
Sbjct: 167 NVMIDHQQKKLRLIDWGLAEFYHPAQEY 194
>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform
Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo
Sapiens
Length = 350
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 11/88 (12%)
Query: 224 LVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSS 283
LV+EY++N + Q L+ + D +DIR + K L Y H ++HRDVK
Sbjct: 112 LVFEYINNTDFKQ-LYQILTD-----FDIRF-YMYELLKALDYCHSK---GIMHRDVKPH 161
Query: 284 NILLDRQWNA-RVSDFGLAKLLCSERSY 310
N+++D Q R+ D+GLA+ + Y
Sbjct: 162 NVMIDHQQKKLRLIDWGLAEFYHPAQEY 189
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 39.7 bits (91), Expect = 0.002, Method: Compositional matrix adjust.
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLA 301
K+ H D+K NI LLD+ + ++ DFGLA
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 32/54 (59%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFGLAK LC Y+ ++ + GY
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLA 301
K+ H D+K NI LLD+ + ++ DFGLA
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 57/245 (23%), Positives = 96/245 (39%), Gaps = 36/245 (14%)
Query: 113 GTGSACETASFGSGSVGPEVSHLGWGRWYTLRELEAATSGLCEENVIGEGGYGIVYRGIL 172
G+G E + + G S LG + LR VIG G Y V L
Sbjct: 27 GSGIEEEKEAMNTRESGKASSSLGLQDFDLLR-------------VIGRGSYAKVLLVRL 73
Query: 173 SDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRML-VYE 227
++ VK L N + + E V + + + L C + R+ V E
Sbjct: 74 KKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133
Query: 228 YVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL 287
YV+ G+L H P + + A L YLHE +++RD+K N+LL
Sbjct: 134 YVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER---GIIYRDLKLDNVLL 186
Query: 288 DRQWNARVSDFGLAK----------LLCSERSYVTTRVMGTFGYAHFIVQVSPLFILLYI 337
D + + +++D+G+ K C +Y+ ++ Y F V L +L++
Sbjct: 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFE 245
Query: 338 LLSVR 342
+++ R
Sbjct: 246 MMAGR 250
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 EYLAPEIILSKGY 216
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 EYLAPEIILSKGY 216
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 170
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 171 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 223
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 224 EYLAPEIILSKGY 236
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 EYLAPEIILSKGY 216
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 EYLAPEIILSKGY 216
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 203
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 EYLAPEIILSKGY 216
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 39.7 bits (91), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major
pdb|3E3P|B Chain B, Glycogen Synthase Kinase From Leishmania Major
Length = 360
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 46/190 (24%), Positives = 81/190 (42%), Gaps = 19/190 (10%)
Query: 156 ENVIGEGGYGIVYRGI-LSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLG 214
E + G+G +G V G S G VA+K ++ + +E ++ ++ + + H N+V+L
Sbjct: 28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQLQS 86
Query: 215 YCV-------EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYL 267
Y Y +V EYV + + V+P I++ + + + L
Sbjct: 87 YFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKV-FLFQLIRSIGCL 145
Query: 268 HEGLEPKVVHRDVKSSNILLDR-QWNARVSDFGLAKLLCSER---SYVTTRVMGT----F 319
H V HRD+K N+L++ ++ DFG AK L +Y+ +R F
Sbjct: 146 HLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIF 204
Query: 320 GYAHFIVQVS 329
G H+ V
Sbjct: 205 GNQHYTTAVD 214
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 159 IGEGGYGIVYRGI-LSDGTKVAVKNL------LNNRGQAEKEFKVEVEVIGRVRHKNLVR 211
+G G + IV + S G + A K + + RG + +E + EV ++ +V H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L +L+ E V G L +L L+ + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILDGVNYLHTK- 134
Query: 272 EPKVVHRDVKSSNI-LLDRQW---NARVSDFGLA 301
K+ H D+K NI LLD+ + ++ DFGLA
Sbjct: 135 --KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 151
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 152 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 204
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 205 YLAPEIILSKGY 216
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EY+ G++ L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EY+ G++ L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 170
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 171 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCGTP 223
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 224 EYLAPEIILSKGY 236
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 167 KIDFGNEF--KNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 YLAPEIILSKGY 215
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 84 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFSEPHARFYAAQ 142
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 143 IVLT----FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 195
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 196 EYLAPEIILSKGY 208
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH E VV+RD+K N++LD+ + +++DFGL K
Sbjct: 120 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 157
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH E VV+RD+K N++LD+ + +++DFGL K
Sbjct: 122 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 159
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 YLAPEIILSKGY 215
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 27/148 (18%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVE 218
+G G +GIV+R + + K + + +G + K E+ ++ RH+N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 219 GAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHR 278
++++E++ ++ + ++ +++ ++ + + L +LH + H
Sbjct: 73 MEELVMIFEFISGLDIFERINTSAFELNEREI---VSYVHQVCEALQFLHSH---NIGHF 126
Query: 279 DVKSSNILLD--RQWNARVSDFGLAKLL 304
D++ NI+ R ++ +FG A+ L
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQL 154
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH E VV+RD+K N++LD+ + +++DFGL K
Sbjct: 121 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 158
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 32/54 (59%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFGLAK LC Y+ ++ + GY
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 YLAPEIILSKGY 215
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 39.3 bits (90), Expect = 0.003, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 53 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 108
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 109 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 166 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLA 301
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 112 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 171
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 172 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 224
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 225 YLAPEIILSKGY 236
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLA 301
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIILSKGY 215
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 39.3 bits (90), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 77 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRR-IGRFSEPHARFYAAQ 135
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 136 IVLT----FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP 188
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 189 EYLAPEIILSKGY 201
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 92 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 150
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 203
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 EYLAPEIILSKGY 216
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 84 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQI 143
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 144 VLT----FEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 196
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 197 YLAPEIILSKGY 208
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 18/54 (33%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+L+D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 53 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 108
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 109 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 166 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 15/85 (17%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
GL +LH +V+RD+K NILLD+ + +++DFG +C E + G
Sbjct: 131 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG----MCKENMLGDAKTNEFCG-- 181
Query: 323 HFIVQVSPLFILLYILLSVRYNSST 347
+P +I ILL +YN S
Sbjct: 182 ------TPDYIAPEILLGQKYNHSV 200
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLA 301
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 27/85 (31%), Positives = 41/85 (48%), Gaps = 15/85 (17%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGYA 322
GL +LH +V+RD+K NILLD+ + +++DFG +C E + G
Sbjct: 130 GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG----MCKENMLGDAKTNXFCG-- 180
Query: 323 HFIVQVSPLFILLYILLSVRYNSST 347
+P +I ILL +YN S
Sbjct: 181 ------TPDYIAPEILLGQKYNHSV 199
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH E VV+RD+K N++LD+ + +++DFGL K
Sbjct: 260 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 297
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 18/40 (45%), Positives = 27/40 (67%), Gaps = 2/40 (5%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH E VV+RD+K N++LD+ + +++DFGL K
Sbjct: 263 ALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 300
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 YLAPEIILSKGY 215
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 8/142 (5%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLL--NNRGQAEKEFKVEVEVIGRVRHKNLVRLLGYC 216
+ E G +++G G + VK L + + ++F E + H N++ +LG C
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 217 --VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
+ L+ ++ G+L LH V + ++ L A+G+A+LH LEP
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK--FALDMARGMAFLH-TLEPL 133
Query: 275 VVHRDVKSSNILLDRQWNARVS 296
+ + S ++++D AR+S
Sbjct: 134 IPRHALNSRSVMIDEDMTARIS 155
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLA 301
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 YLAPEIILSKGY 215
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 38.9 bits (89), Expect = 0.004, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 150
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 151 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 203
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 204 YLAPEIILSKGY 215
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 35/132 (26%), Positives = 56/132 (42%), Gaps = 14/132 (10%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNI 256
E ++ V LV+L + + +V EYV G + L P I
Sbjct: 86 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQI 145
Query: 257 ILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERS 309
+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 146 VLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE 198
Query: 310 YVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 199 YLAPEIILSKGY 210
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 32/206 (15%)
Query: 132 VSHLGWGRWYT--LRELEAATSGLCEENVIGEGGYGIVYRGILSDGTKVAVKNLLNNRGQ 189
+ +L W + +T ++++ VIG G +G V L + KV +LN
Sbjct: 53 LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN---- 108
Query: 190 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYR---MLVYEYVDNGNL----DQWLHGDV 242
+ E++ R V G + L Y + D+ NL D ++ GD+
Sbjct: 109 -------KWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL 161
Query: 243 GDVSPLTWDIRMNIILGTAKGLAYLHEGL-------EPKVVHRDVKSSNILLDRQWNARV 295
LT + L YL E + + VHRD+K NIL+D + R+
Sbjct: 162 -----LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRL 216
Query: 296 SDFGLAKLLCSERSYVTTRVMGTFGY 321
+DFG L + + ++ +GT Y
Sbjct: 217 ADFGSCLKLMEDGTVQSSVAVGTPDY 242
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 38.9 bits (89), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLA 301
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6
pdb|3UC4|B Chain B, The Crystal Structure Of Snf1-Related Kinase 2.6
Length = 362
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 50/193 (25%), Positives = 81/193 (41%), Gaps = 32/193 (16%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ + V+ E+I +RH N+VR
Sbjct: 27 IGSGNFGVAR--LMRDKQSNELVAVKYI--ERGE-KIAANVKREIINHRSLRHPNIVRFK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 82 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM--- 134
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPL 331
+V HRD+K N LLD R + DFG +K S + ++ T G +P
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVG--------TPA 181
Query: 332 FILLYILLSVRYN 344
+I +LL Y+
Sbjct: 182 YIAPEVLLKKEYD 194
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 38.5 bits (88), Expect = 0.005, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPAIILSKGY 215
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNL-DQWLHG-DVGDVSPLTWDIRM 254
EV V+ + H N+++L + + LV E G L D+ +H +V
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV----- 140
Query: 255 NIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLD-RQWNA--RVSDFGLAKLLCSERSYV 311
II G+ YLH+ +VHRD+K N+LL+ ++ +A ++ DFGL+ + +++
Sbjct: 141 -IIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--- 193
Query: 312 TTRVMGTFGYAHFIV------------QVSPLFILLYILLS 340
++ G A++I V + ++L+ILL+
Sbjct: 194 --KMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLA 232
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 38.5 bits (88), Expect = 0.006, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 216
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 105 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 159
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 160 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 218
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 219 LGVIMYILL 227
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 37/133 (27%), Positives = 58/133 (43%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 78 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQ 136
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+L+D Q +V+DFG AK LC
Sbjct: 137 IVLT----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCGTP 189
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 190 EYLAPEIILSKGY 202
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 23/200 (11%)
Query: 158 VIGEGGYGIVYRGILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
VIG G Y V L ++ VK L N + + E V + + + L
Sbjct: 27 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 86
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V EYV+ G+L H P + + A L YLHE
Sbjct: 87 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER-- 140
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK----------LLCSERSYVTTRVMGTFGYA 322
+++RD+K N+LLD + + +++D+G+ K C +Y+ ++ Y
Sbjct: 141 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYG 199
Query: 323 HFIVQVSPLFILLYILLSVR 342
F V L +L++ +++ R
Sbjct: 200 -FSVDWWALGVLMFEMMAGR 218
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 26/59 (44%), Positives = 34/59 (57%), Gaps = 5/59 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL LH ++V+RD+K NILLD + R+SD GLA + E + RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGY 351
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 23/168 (13%)
Query: 187 RGQAEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS 246
RG + ++ + EV ++ ++H N++ L +L+ E V G L +L +
Sbjct: 54 RGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL----AEKE 109
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNI-LLDR---QWNARVSDFGLAK 302
LT + + G+ YLH ++ H D+K NI LLDR + ++ DFGLA
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166
Query: 303 LLCSERSYVTTRVMGTFGY-AHFIVQVSPL---------FILLYILLS 340
+ + + GT + A IV PL ++ YILLS
Sbjct: 167 KIDFGNEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 23/200 (11%)
Query: 158 VIGEGGYGIVYRGILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
VIG G Y V L ++ VK L N + + E V + + + L
Sbjct: 12 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 71
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V EYV+ G+L H P + + A L YLHE
Sbjct: 72 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER-- 125
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK----------LLCSERSYVTTRVMGTFGYA 322
+++RD+K N+LLD + + +++D+G+ K C +Y+ ++ Y
Sbjct: 126 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 323 HFIVQVSPLFILLYILLSVR 342
F V L +L++ +++ R
Sbjct: 185 -FSVDWWALGVLMFEMMAGR 203
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 91 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 145
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 204
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 205 LGVIMYILL 213
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 26/59 (44%), Positives = 34/59 (57%), Gaps = 5/59 (8%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYVTTRVMGTFGY 321
GL LH ++V+RD+K NILLD + R+SD GLA + E + RV GT GY
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIKGRV-GTVGY 351
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 97 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 151
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 152 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 210
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 211 LGVIMYILL 219
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 38.1 bits (87), Expect = 0.007, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 141 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 195
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 196 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 254
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 255 LGVIMYILL 263
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 17/54 (31%), Positives = 31/54 (57%), Gaps = 7/54 (12%)
Query: 275 VVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+++D+Q +V+DFG AK LC Y+ ++ + GY
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCGTPEYLAPEIILSKGY 215
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 135 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 189
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 248
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 249 LGVIMYILL 257
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 48/200 (24%), Positives = 83/200 (41%), Gaps = 23/200 (11%)
Query: 158 VIGEGGYGIVYRGILSDGTKV----AVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLL 213
VIG G Y V L ++ VK L N + + E V + + + L
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 214 GYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLE 272
C + R+ V EYV+ G+L H P + + A L YLHE
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLA--LNYLHER-- 129
Query: 273 PKVVHRDVKSSNILLDRQWNARVSDFGLAK----------LLCSERSYVTTRVMGTFGYA 322
+++RD+K N+LLD + + +++D+G+ K C +Y+ ++ Y
Sbjct: 130 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYG 188
Query: 323 HFIVQVSPLFILLYILLSVR 342
F V L +L++ +++ R
Sbjct: 189 -FSVDWWALGVLMFEMMAGR 207
>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From
Cryptosporidium Parvum, Cgd7_40
Length = 345
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 44/189 (23%), Positives = 70/189 (37%), Gaps = 47/189 (24%)
Query: 158 VIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKE-FKVEVEVIGRVRHKNLVR 211
IG+G YG+V I + K+ KN + + E K EV ++ ++ H N+ R
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 212 LLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGD-------------VSPLT--------- 249
L + Y LV E G+L L+ + D + P
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 250 --------------WDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILL--DRQWNA 293
+ NI+ L YLH + HRD+K N L ++ +
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209
Query: 294 RVSDFGLAK 302
++ DFGL+K
Sbjct: 210 KLVDFGLSK 218
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 36/133 (27%), Positives = 59/133 (44%), Gaps = 16/133 (12%)
Query: 197 EVEVIGRVRHKNLVRLLGYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVS-PLTWDIRMN 255
E ++ V LV+L + + +V EYV G + L +G S P
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEPHARFYAAQ 149
Query: 256 IILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK-------LLCSER 308
I+L YLH +++RD+K N+++D+Q +V+DFG AK LC
Sbjct: 150 IVLT----FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCGTP 202
Query: 309 SYVTTRVMGTFGY 321
Y+ ++ + GY
Sbjct: 203 EYLAPEIIISKGY 215
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 38.1 bits (87), Expect = 0.008, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 95 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 149
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 150 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 208
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 209 LGVIMYILL 217
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + + E E+ + +V L G
Sbjct: 82 VGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 134
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q + + L D + + +GL YLH ++
Sbjct: 135 VREGPWVNIFMELLEGGSLGQL----IKQMGCLPEDRALYYLGQALEGLEYLHTR---RI 187
Query: 276 VHRDVKSSNILLDRQWN-ARVSDFGLAKLL 304
+H DVK+ N+LL + A + DFG A L
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCL 217
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 89 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 143
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 202
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 203 LGVIMYILL 211
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 37.7 bits (86), Expect = 0.009, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 96 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 150
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 151 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 209
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 210 LGVIMYILL 218
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 89 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 143
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 144 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWS- 202
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 203 LGVIMYILL 211
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 120 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 156
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 20/65 (30%), Positives = 34/65 (52%), Gaps = 3/65 (4%)
Query: 247 PLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCS 306
P+T + ++ A+G+ +L K +HRD+ + NILL ++ DFGLA+ +
Sbjct: 195 PITMEDLISYSFQVARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK 251
Query: 307 ERSYV 311
YV
Sbjct: 252 NPDYV 256
Score = 36.6 bits (83), Expect = 0.020, Method: Compositional matrix adjust.
Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 10/126 (7%)
Query: 159 IGEGGYGIVYR----GILSDGT--KVAVKNLLNNRGQAE-KEFKVEVEVIGRV-RHKNLV 210
+G G +G V + GI T VAVK L +E K E++++ + H N+V
Sbjct: 35 LGRGAFGKVVQASAFGIKKSPTCRTVAVKMLKEGATASEYKALMTELKILTHIGHHLNVV 94
Query: 211 RLLGYCV-EGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
LLG C +G M++ EY GNL +L D+ L D +++ K L +
Sbjct: 95 NLLGACTKQGGPLMVIVEYCKYGNLSNYLKSK-RDLFFLNKDAALHMEPKKEKMEPGLEQ 153
Query: 270 GLEPKV 275
G +P++
Sbjct: 154 GKKPRL 159
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153
>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase
pdb|3ZUT|B Chain B, The Structure Of Ost1 (D160a) Kinase
Length = 362
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 50/193 (25%), Positives = 80/193 (41%), Gaps = 32/193 (16%)
Query: 159 IGEGGYGIVYRGILSDGTK---VAVKNLLNNRGQAEKEFKVEVEVIGR--VRHKNLVRLL 213
IG G +G+ ++ D VAVK + RG+ E V+ E+I +RH N+VR
Sbjct: 27 IGSGNFGVAR--LMRDKQSNELVAVKYI--ERGEKIDE-NVKREIINHRSLRHPNIVRFK 81
Query: 214 GYCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEP 273
+ + +V EY G L + + + + D G++Y H
Sbjct: 82 EVILTPTHLAIVMEYASGGELFER----ICNAGRFSEDEARFFFQQLISGVSYCHAM--- 134
Query: 274 KVVHRDVKSSNILLDRQWNAR--VSDFGLAKLLCSERSYVTTRVMGTFGYAHFIVQVSPL 331
+V HRD+K N LLD R + FG +K S + ++ T G +P
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICAFGYSK-----SSVLHSQPKSTVG--------TPA 181
Query: 332 FILLYILLSVRYN 344
+I +LL Y+
Sbjct: 182 YIAPEVLLKKEYD 194
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 90 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 144
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 145 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 203
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 204 LGVIMYILL 212
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 40/129 (31%), Positives = 59/129 (45%), Gaps = 18/129 (13%)
Query: 223 MLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKVVHRDVKS 282
++V E +D G L + D GD + T I+ + + YLH + HRDVK
Sbjct: 91 LIVMECLDGGELFSRIQ-DRGDQA-FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKP 145
Query: 283 SNIL-LDRQWNA--RVSDFGLAKLLCSERS---------YVTTRVMGTFGYAHFIVQVSP 330
N+L ++ NA +++DFG AK S S YV V+G Y S
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS- 204
Query: 331 LFILLYILL 339
L +++YILL
Sbjct: 205 LGVIMYILL 213
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 37.7 bits (86), Expect = 0.010, Method: Compositional matrix adjust.
Identities = 41/150 (27%), Positives = 68/150 (45%), Gaps = 18/150 (12%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G G +G V+R + D G + AVK + + E E+ + +V L G
Sbjct: 66 VGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
EG + + E ++ G+L Q + + L D + + +GL YLH ++
Sbjct: 119 VREGPWVNIFMELLEGGSLGQL----IKQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 276 VHRDVKSSNILLDRQWN-ARVSDFGLAKLL 304
+H DVK+ N+LL + A + DFG A L
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCL 201
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 37.7 bits (86), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 158
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 17/40 (42%), Positives = 26/40 (65%), Gaps = 3/40 (7%)
Query: 263 GLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
L YLH VV+RD+K N++LD+ + +++DFGL K
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 153
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 37.4 bits (85), Expect = 0.011, Method: Compositional matrix adjust.
Identities = 19/51 (37%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 203 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 32/149 (21%), Positives = 68/149 (45%), Gaps = 13/149 (8%)
Query: 159 IGEGGYGIVYRGILSDGTKVAVKNLLNNR---GQAEKEFKVEVEVIGRVRHKNLVRLLGY 215
+G+G + +V R + + ++N + + ++ + E + ++H N+VRL
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 216 CVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPKV 275
E + L+++ V G L + D+ + + I + + + H+ V
Sbjct: 79 ISEEGHHYLIFDLVTGGELFE----DIVAREYYSEADASHCIQQILEAVLHCHQM---GV 131
Query: 276 VHRDVKSSNILLDRQWN---ARVSDFGLA 301
VHR++K N+LL + +++DFGLA
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLA 160
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 19/51 (37%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 208 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 255
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 36/153 (23%), Positives = 70/153 (45%), Gaps = 14/153 (9%)
Query: 157 NVIGEGGYGIVYRGILS-DGTKVAVKNLLNNRGQ--AEKEFKVEVEVIGRVRHKNLVRLL 213
++IG G YG V + VA+K +L K E+ ++ R+ H ++V++L
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL 118
Query: 214 GYC----VEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHE 269
VE + V + + + + V + N+++G + Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG----VKYVHS 174
Query: 270 GLEPKVVHRDVKSSNILLDRQWNARVSDFGLAK 302
++HRD+K +N L+++ + +V DFGLA+
Sbjct: 175 A---GILHRDLKPANCLVNQDCSVKVCDFGLAR 204
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 19/51 (37%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 210 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 257
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 20/151 (13%)
Query: 159 IGEGGYGIVYRGILSD---GTKVAVKNLLNNRGQAEKEFKVEVEV-IGRVRHKNLVRLLG 214
+G G +G V+R + D G + AVK + + F+VE V + +V L G
Sbjct: 80 LGRGSFGEVHR--MKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYG 131
Query: 215 YCVEGAYRMLVYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGLEPK 274
EG + + E ++ G+L Q + + L D + + +GL YLH +
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQL----IKQMGCLPEDRALYYLGQALEGLEYLHTR---R 184
Query: 275 VVHRDVKSSNILLDRQWN-ARVSDFGLAKLL 304
++H DVK+ N+LL + A + DFG A L
Sbjct: 185 ILHGDVKADNVLLSSDGSRAALCDFGHALCL 215
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 43/199 (21%), Positives = 80/199 (40%), Gaps = 25/199 (12%)
Query: 158 VIGEGGYGIVYRGILSD-----GTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKNLVRL 212
V+G+G +G V + + KV K+++ E E ++ R+ +
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM-TEKRILSLARNHPFLTQ 88
Query: 213 LGYCVEGAYRML-VYEYVDNGNLDQWLHGDVGDVSPLTWDIRMNIILGTAKGLAYLHEGL 271
L C + R+ V E+V+ G+L + II L +LH+
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEII----SALMFLHDK- 143
Query: 272 EPKVVHRDVKSSNILLDRQWNARVSDFGLAK----------LLCSERSYVTTRVMGTFGY 321
+++RD+K N+LLD + + +++DFG+ K C Y+ ++ Y
Sbjct: 144 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 322 AHFIVQVSPLFILLYILLS 340
V + +LLY +L
Sbjct: 202 GP-AVDWWAMGVLLYEMLC 219
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 37.4 bits (85), Expect = 0.012, Method: Compositional matrix adjust.
Identities = 19/51 (37%), Positives = 30/51 (58%), Gaps = 3/51 (5%)
Query: 261 AKGLAYLHEGLEPKVVHRDVKSSNILLDRQWNARVSDFGLAKLLCSERSYV 311
AKG+ +L K +HRD+ + NILL + ++ DFGLA+ + + YV
Sbjct: 201 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 248
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.137 0.409
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 9,584,059
Number of Sequences: 62578
Number of extensions: 397846
Number of successful extensions: 2542
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 849
Number of HSP's successfully gapped in prelim test: 226
Number of HSP's that attempted gapping in prelim test: 907
Number of HSP's gapped (non-prelim): 1107
length of query: 348
length of database: 14,973,337
effective HSP length: 100
effective length of query: 248
effective length of database: 8,715,537
effective search space: 2161453176
effective search space used: 2161453176
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 52 (24.6 bits)